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SCIENTIFIC OPINION 
Scientific Opinion on the evaluation of the substances currently on the list 
in the annex to Commission Directive 96/3/EC as acceptable previous 
cargoes for edible fats and oils – Part III of III
1 
EFSA Panel on Contaminants in the Food Chain (CONTAM)
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Shipping of edible fats and oils into Europe is permitted in bulk tanks, in which substances, included 
in a positive list, had been previously transported. The European Commission requested EFSA to 
evaluate the list of substances in the Annex to Commission Directive 96/3/EC as acceptable previous 
cargoes for edible fats and oils, taking into account its review of the Scientific Committee on Food 
criteria for acceptable previous cargoes and criteria proposed by the Codex Committee for Fats and 
Oils. This is the third and last scientific opinion of the EFSA Panel on Contaminants in the Food 
Chain (CONTAM Panel) on this topic, in which sixteen of these substances or groups of substances 
have been evaluated. The CONTAM Panel concluded that sodium silicate (water glass) solution, iso-
octanol,  iso-nonanol,  iso-decanol,  1,3-propanediol,  isobutyl  acetate,  sec-butyl  acetate,  tert-butyl 
acetate,  n-butyl  acetate,  propylene  tetramer,  paraffin  wax,  candelilla  wax,  white  mineral  oils  and 
glycerol would not be of health concern as previous cargoes. The CONTAM Panel concluded that 
carnauba wax was not acceptable as a previous cargo because of its insolubility in water and high 
melting point, which raise concerns regarding the efficiency of tank cleaning. There was insufficient 
information available on the composition of montan wax for the CONTAM Panel to conclude that it 
would be of no health concern when used as previous cargo and hence it does not meet the criteria for 
acceptability as previous cargo. The CONTAM Panel made several recommendations regarding the 
way in which the substances are described in the Annex to Commission Directive 96/3/EC, to correct 
inaccuracies and to better reflect current transport practices. 
© European Food Safety Authority, 2012 
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SUMMARY 
The worldwide trade of edible fats and oils in bulk requires their transport by road, railroad, inland 
waterways and sea. The carriage by sea of edible fats and oils into Europe is also permitted in bulk 
tanks that have previously been used to transport substances included in a positive list of acceptable 
previous cargoes. The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) reviewed 
the Scientific Committee on Food (SCF) criteria for acceptable previous cargoes and criteria proposed 
by the Codex Committee for Fats and Oils in 2009. In addition, the CONTAM Panel identified the 
importance of taking into account possible impurities and reaction products with edible fats and oils of 
the chemicals shipped as previous cargoes, as these might be more toxic than the chemical itself. Since 
usually no specifications of the impurities are available for the often rather crude substances shipped 
in bulk, those potentially present were determined primarily by assessing information on the source or 
starting substances, making worse case assumptions in each case. In November 2009, the CONTAM 
Panel published an opinion on a limited number of substances that had been proposed at Codex level 
for addition to the list of Codex acceptable previous cargoes, which were evaluated against the criteria 
in the previously mentioned opinion of the CONTAM Panel.  
Following a request from the European Commission, the CONTAM Panel was asked to deliver a 
scientific opinion on the evaluation of the substances listed in the Annex to Commission Directive 
96/3/EC as acceptable previous cargoes for edible fats and oils. This was to ensure that substances 
currently on the list of acceptable previous cargoes had been evaluated against the same criteria as 
recently agreed by EFSA. 
This is the third and last scientific opinion of the CONTAM Panel on the evaluation of the substances 
listed in the Annex to Commission Directive 96/3/EC. The CONTAM Panel considered that sodium 
silicate (water glass) solution, 1,3-propanediol, isobutylacetate, sec-butyl acetate, tert-butyl acetate, n-
butyl acetate, propylene tetramer, paraffin wax, candelilla wax, white mineral oils and glycerol when 
used  as  previous  cargoes  would  not  raise  any  concerns  regarding  their  acute  or  chronic  toxicity, 
genotoxicity, carcinogenicity or reproductive toxicity. In addition there were no concerns regarding 
possible allergenicity or adjuvant effects from such transport. In the case of iso-octanol, iso-nonanol 
and iso-decanol, because of data gaps in the respective toxicological profiles, the CONTAM Panel 
used ‗read-across‘ from the assessment profile of oxo-alcohols C9-C13 category and concluded that 
the iso-alcohols under consideration are of low toxicity following acute and chronic exposure, they are 
not genotoxic or allergenic and therefore they are of no toxicological concern when used as previous 
cargoes.  
The CONTAM Panel noted that four of these substances are authorized for use in food either as 
flavouring (isobutyl acetate, sec-butyl acetate, n-butyl acetate) or glazing (candelilla wax) agents. For 
two substances, acceptable daily intakes of ‗not specified‘ or ‗not limited‘ have been established by 
the  Joint  FAO/WHO  Expert  Committee  on  Food  Additives  (JECFA)  or  SCF  because  of  low 
toxicological concern. These are sodium silicate (water glass) solution and glycerol. n-Butyl acetate 
has an ADI established by the SCF greater than 0.1 mg/kg body weight (b.w.) per day. In the case of 
sec-butyl  acetate,  it  is  a  Cramer  Class  I  substance  for  which  exposures  below  a  threshold  of 
toxicological concern of 1 800  g/person per day (30  g/kg b.w. per day) would not be expected to be 
of safety concern, and the available information does not indicate any toxicological concern at the 
exposure levels that might occur from transport as a previous cargo. The remaining substances (iso-
octanol, iso-nonanol and iso-decanol, 1,3-propanediol, tert-butyl acetate, propylene tetramer) are of 
relatively low toxicity and the margin of exposure that would occur comparing the maximum assumed 
carryover from their transport as previous cargo and the respective no-observed-adverse-effect level 
would indicate no concern for human health. 
For all these substances no reaction products with fats and oil of toxicological concern were identified 
or anticipated. The CONTAM Panel noted that the only impurities of potential concern are aromatic 
hydrocarbons, which may be present in paraffin wax and white mineral oils. While in the case of white 
mineral oils they are controlled to very low levels, in the case of paraffin waxes the CONTAM Panel Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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concluded that this entry should be restricted to paraffin waxes that have been treated to remove 
aromatic hydrocarbons and which otherwise meet relevant standards to be considered as ‗food grade‘.   
Regarding  mineral  oil  hydrocarbons  the  CONTAM  Panel  notes  that  some  aliphatic  hydrocarbons 
bioaccumulate in the body, such as branched and cyclic species in the mass range of 16 - 35 carbon 
atoms. However, since exposure to mineral oil hydrocarbons via contamination of edible fats and oils 
from previous cargoes occurs only rarely and mostly at levels lower than those observed anyway in 
edible oils, it will contribute little to overall exposure.  
In  the  case  of  montan  wax,  there  was  insufficient  information  available  on  the  composition  and 
toxicological profile of this substance for the CONTAM Panel to conclude that it does not contain 
components that would be of concern to human health when used as previous cargo. The CONTAM 
Panel therefore concludes that it does not meet the criteria for acceptability as a previous cargo for 
edible fats and oils. 
Although the CONTAM Panel considered that there would be no health concerns arising from the use 
of carnauba wax as a previous cargo, using normal assumptions regarding worst case carryover, the 
Panel concluded that it does not meet the criteria for its acceptability as previous cargo because of its 
insolubility  in  water  and  high  melting  point  and  hence  doubts  concerning  the  efficiency  of  tank 
cleaning. 
In addition, the CONTAM Panel noted a number of inaccuracies in the chemical identification and 
inconsistencies in the chemical specification of substances with respect to current transport practices, 
in the Annex to Commission Directive 96/3/EC. The CONTAM Panel therefore made a number of 
recommendations regarding the way in which the substances are described in this Annex, to correct 
such inaccuracies and inconsistencies. 
The CONTAM Panel also made recommendations on the information that should be provided by 
interested parties when new substances are to be evaluated as previous cargoes. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
General hygiene requirements relating to transport of food applicable to all food business operators 
laid  down  in  Regulation  (EC)  No  852/2004
4  (Annex II, Chapter IV) state, amongst   others, that 
"receptacles in vehicles and/or containers are not to be used for transporting  anything other than 
foodstuffs where this may result in contamination." 
Information showed that the application of this principle to the bulk transport was not  practical and 
imposed an unduly onerous burden on food business when applied to bulk  transport in sea-going 
vessels of liquid fats and oils and of raw sugar. This led to the adoption of two derogations
5,6 providing 
equivalent protection to public health. 
Equivalent protection to public health is guaranteed on technical (e.g. tank design) and procedural (e.g. 
intermediate cleaning) conditions, on record keeping (e.g. on effectiveness of cleaning and on the 
nature of the previous cargoes) and, in the case of bulk transport of liquid fats and oils in sea-going 
vessels, on a list of acceptable previous cargoes. The presence of substances on the list of acceptable 
previous cargoes for fats and oils in the Annex to Commission Directive 96/3/EC is based on three 
opinions of the former Scientific Committee on Food (SCF).
7,8,9 
On 26 May 2009, the Panel on Contaminants in the Food Chain (CONTAM Panel) issued a scientific 
opinion on the criteria for acceptable previous cargoes for edible fats and oils. In this opinion, the 
CONTAM Panel reviewed the 5 criteria for the assessment of acceptability as previous cargoes for 
edible fats and oils previously used by the SCF and evaluated the appropriateness of four criteria 
developed for the same purpose by the Codex Committee for Fats and Oils (CCFO). 
The CONTAM Panel noted that by application of CCFO criterion 2 some substances will turn out to 
be unacceptable as previous cargoes. This could include substances with ADI (or TDI) < 0.1 mg/kg 
b.w. or substances with genotoxic activity. The Panel considers that the exclusion of such substances 
as previous cargoes is appropriate.  
The criteria in this Scientific Opinion were subsequently applied in the CONTAM Scientific Opinion 
on the evaluation of substances as acceptable previous cargoes for edible fats and oils, adopted on 
29 November 2009. In this opinion, a limited number of substances that had been proposed at Codex 
level for addition to the list of acceptable previous cargoes were evaluated against the criteria in the 
previously mentioned Scientific Opinion. 
In order to assure that the substances currently on the list of acceptable previous cargoes are evaluated 
against the same criteria, an additional Scientific Opinion covering an evaluation of the substances 
currently on the list of acceptable previous cargoes against the criteria used in the Opinion on the 
                                                       
4  Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs 
(OJ L 139, 30.4.2004, p. 1). 
5  Commission Directive 96/3/EC of 26 Jan uary 1996 granting a derogation from certain provisions of Council Directive 
93/43/EEC on the hygiene of foodstuffs as regards the transport of bulk liquid oils and fats by sea (OJ L 21, 27.01.1996, p. 
42). 
6  Commission Directive 98/28/EC of 29 April 1998 granting a derogation from certain provisions of Directive 93/43/EEC on 
the hygiene of foodstuffs as regards the transport by sea of bulk raw sugar (OJ L 140, 12.05.1998, p. 10). 
7  SCF, 1996. Scientific Committee on Food. Opinion on the potential risk to  human health arising from the transport in 
ships‘ tanks of oils and fats from substances proposed as acceptable previous cargoes, expressed on 20 September 1996 - 
Fortieth  Series  (1997)  Catalogue  No:  GT  07  97652-EN-DE-FR). 
http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_40.pdf 
8  SCF, 2003. Updated opinion of the Scientific Committee on Food on the potential risk to human health arising from the 
transport in ships‘ tanks of oils and fats from substances proposed as acceptable previous cargoes, expressed on 4 April 
2003.  Health  and  Consumer  Protection  Directorate-General,  European  Commission,  Brussels. 
http://ec.europa.eu/food/fs/sc/scf/out189_en.pdf 
9  SCF, 1997. Scientific Committee on Food. Amendment of its previous opinion of 20 September (SCF 1996). Opinion on 
Methyl esters of fatty acids in previous cargoes, expressed on 12-13 June 1997. Minutes of the 107th Meeting of the 
Scientific Committee for Food http://ec.europa.eu/food/fs/sc/oldcomm7/out13_en.html 
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evaluation of substances as acceptable previous cargoes for edible fats and oils carried out by EFSA 
would be needed.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Art 29 (1) of Regulation (EC) No 178/2002, the European Commission asks the 
European Food Safety Authority for a scientific opinion on the evaluation of the substances currently 
on the list in the Annex to Commission Directive 1996/3/EC as acceptable previous cargoes for edible 
fats and oils. The evaluation should be based on the SCF criteria and the criteria proposed by the 
CCFO as reviewed by the Panel on Contaminants in Food Chain in 2009
10 for acceptable previous 
cargoes for edible fats and oils. 
                                                       
10   http://www.efsa.europa.eu/en/scdocs/scdoc/1110.htm  Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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ASSESSMENT 
 
1.  Introduction 
General hygiene requirements relating to transport of food applicable to all food business operators are 
laid down in Annex II, Chapter IV of Regulation (EC) No 852/2004
11 and state, amongst others, that 
‗receptacles in  vehicles  and/or containers  are  not  to  be  used  for  transporting  anything  other  than 
foodstuffs where this may result in contamination‘. However, the application of this principle to bulk 
transport is not practical and imposes an unduly onerous burden on food businesses when applied to 
bulk transport in sea-going vessels of liquid fats and oils. Commission Directive 96/3/EC
5
 permits sea 
transport of fats and oils in bulk tanks, which have previously been used to transport substances 
included in a positive list of acceptable previous cargoes. 
The majority of the global trade in oils and fats is done under contracts of the Federation of Oils, 
Seeds and Fats Associations (FOSFA), a professional international contract-issuing and arbitral body 
concerned exclusively with the world trade in oilseeds, oils and fats, which provides a wide range of 
standards covering different methods of transportation and different terms of trade. FOSFA does not 
require dedicated containers and allows transport in tanks that have previously been used to transport 
substances  from  an  approved  positive  list.  A  FOSFA  list  of  banned  previous  cargoes  also  exists 
(FOSFA, 2008). 
In 1996, the Scientific Committee on Food (SCF) assessed the risk to human health arising from 
potential contamination of fats and oils shipped in tanks, which may have been used to transport the 
substances as given in the Annex to Commission Directive 96/3/EC
5 (SCF, 1997a). A number of 
substances were evaluated and a set of criteria for acceptable previous cargoes (SCF criteria) was 
proposed. In 2003, the SCF issued an update of its previous opinion in the light of new toxicological 
information, where available (SCF, 2003).  
Based on the evaluations carried out by the SCF in 1996 and 2003, the list of substances acceptable as 
previous  cargoes  set  out  in  the  Annex  to  Commission  Directive  96/3/EC
5  was  amended  by 
Commission Decision 2004/4/EC.
12 However, the substances in the list were only considered to be 
acceptable as long as the legal provisions were applied, especially regarding the cleaning and 
condition of the tanks and accurate documented evidence relating to the nature of the three previous 
cargoes, and to the efficacy of the cleaning process between cargoes, to be kept by the captain of the 
vessel. 
The  Codex  Alimentarius Commission  (CAC)  also  sets international  food  standards to  protect the 
health of consumers and ensure fair practices in the food trade. Under the Codex system, the Codex 
Committee for Fats and Oils (CCFO) has been established to elaborate standards for fats and oils of 
animal,  vegetable  and  marine  origin,  including  margarine  and  olive  oil.  It  has  adopted  the 
Recommended International Code of Practice for the Storage and Transport of Edible Fats and Oils in 
Bulk, which includes a Draft Codex List of Acceptable Previous Cargoes and a Proposed Draft List of 
Acceptable Previous Cargoes. In addition, a set of criteria (CCFO criteria) has been developed to 
determine the acceptability of substances as previous cargoes, based on the criteria proposed by the 
Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization 
(WHO) (FAO/WHO) Joint Technical Meeting (FAO/WHO, 2007). Both the draft lists of acceptable 
previous cargoes and the criteria were adopted by the CAC (Geneva, 4-9 July 2011) (FAO/WHO, 
2011).   
                                                       
11   Regulation (EC) No 854/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific rules 
for  the  organisation  of  official  controls  on  products  of  animal  origin  intended  for  human  consumption.  OJ  L  139, 
30.4.2004, p. 206-320. 
12  Commission Directive 2004/4/EC of 15 January 2004 amending Directive 96/3/EC granting a derogation from certain 
provisions of Council Directive 93/43/EEC on the hygiene of foodstuffs as regards the transport of bulk liquid oils and fats 
by sea. OJ L 15, 22.1.2004, p. 25-30. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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In 2009, the European Commission requested the European Food Safety Authority (EFSA) to review 
the SCF criteria for acceptable previous cargoes for edible fats and oils, in the light of the CCFO 
criteria (CCFO, 2009). The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) issued 
an opinion in May 2009 and concluded that the criteria for evaluation of acceptable previous cargoes 
as proposed by the CCFO were not in conflict with any of the five criteria developed by the SCF 
(EFSA, 2009a). Most of the SCF criteria were either explicitly or implicitly covered by the CCFO 
criteria. The last SCF criterion, dealing with the availability of analytical methods is not explicitly 
addressed  in  the  CCFO  criteria  and  the  CONTAM  Panel  considered  that  this  criterion  is  still 
important, though rather in the sense that the development of a corresponding method is considered to 
be  feasible  rather  than  the  immediate  availability  of  such  a  method  (as  most  substances  used  as 
previous cargoes are not routinely analyzed in fats and oils). The Panel also considered relevant the 
inclusion of criteria covering possible allergenicity and the potential for reaction of compounds with 
oils and fats. 
The criteria in the Scientific Opinion of 2009 were subsequently applied by the CONTAM Panel for 
the  evaluation  of  the  acceptability  as  previous  cargoes  of  the  substances  included  in  the  Codex 
Proposed Draft List of Acceptable Previous Cargoes (EFSA, 2009b).  
The European Commission asked EFSA for a scientific opinion on the evaluation of the substances 
currently on the list in the Annex to Commission Directive 96/3/EC as acceptable previous cargoes for 
edible fats and oils. The evaluation should be based on the review of the criteria performed by the 
CONTAM Panel in 2009, in order to ensure that the substances currently on the list are evaluated 
against the same criteria.  
The outcome of the evaluation of the substances is presented in three scientific opinions, for practical 
purposes. A first opinion was published in December 2011 reporting the evaluation of 13 substances in 
the list (EFSA, 2011). A second opinion reporting the evaluation of 35 substances (or groups of) in the 
list  was  published  in  May  2012  (EFSA,  2012a).  In  this  third  and  last  output,  the  evaluation  of 
16 substances (or groups of) listed in Table 1 is described. The entries in Table 1 are as listed in the 
Annex  to  Commission  Directive  96/3/EC.
5  In  reviewing  these  substances,  the  CONTAM  Panel 
concluded that modifications to some of these entries would improve accuracy and these are discussed 
in the Opinion (see Table 4).        
Substances transported in bulk as previous cargoes are often rather crude and usually no specific 
information is available on the impurities present. Hence, for many substances, the CONTAM Panel 
had to determine which impurities might be present primarily by assessment of the source or starting 
material and likely method of preparation of the substance to be transported. Chemicals transported as 
previous cargoes may vary in composition, depending on the starting materials and the method of 
preparation,  details for which were obtained, in part, from information obtained from FOSFA. The 
CONTAM Panel based its evaluations on worst case assumptions on these aspects.  Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Table 1:   Substances  on  the  list  in  the  Annex  to  Commission  Directive  96/3/EC  as  acceptable 
previous cargoes for edible fats and oils and re-evaluated in the present opinion.  
Substance (synonyms)  CAS Number 
Sodium silicate (water glass)  1344-09-8 
iso-Octanol (isooctyl alcohol)  26952-21-6 
iso-Nonanol (isononyl alcohol)  27458-94-2 
iso-Decanol (isodecyl alcohol)  25339-17-7 
1,3-Propylene glycol (trimethylene glycol; 1.3-propanediol)  504-63-2 
iso-Butyl acetate  110-19-0 
sec-Butyl acetate  105-46-4 
tert-Butyl acetate  540-88-5 
n-Butyl acetate  123-86-4 
Propylene tetramer  6842-15-5 
Montan wax  8002-53-7 
Paraffin wax  8002-74-2 / 63231-60-7 
Carnauba wax — (Brazil wax)  8015-86-9 
Candelilla wax  8006-44-8 
White mineral oils  8042-47-5 
Glycerine (glycerol; glycerin)  56-81-5 
 
2.  Previous risk assessments  
2.1.  Scientific Committee on Food (SCF) 
In 1996, the SCF issued an opinion on the potential risk to human health arising from the transport of 
fats and oils in ships‘ tanks from substances proposed as acceptable previous cargoes (SCF, 1997a). 
The Committee was asked to examine the substances given in the Annex to Commission Directive 
96/3/EC
5 and other substances that may be proposed for addition to the list. The SCF was asked to 
take into account the information provided by industry concerning (i) the likelihood and potential 
levels of contamination in the light of the information regarding cleaning procedures, dilution and 
limits of detection of analytical methods and (ii) the additional processing of fats and oils. The SCF 
focused  its  attention  on  the  evaluation  of  the  toxicological  properties  of  the  substances  without 
considering  other  aspects  such  as  the  ecotoxicological  characteristics,  the  microbial  status  or 
nutritional  relevance.  The  Committee‘s  view  on  the  acceptability  of  the  substances  in  the  list  of 
acceptable previous cargoes from Commission Directive 96/3/EC
5 was based on the criteria shown in 
Table 2. 
Table 2:   Criteria for the inclusion of substances in the list of acceptable previous cargoes according 
to the SCF (SCF, 1997a, 2003). 
SCF Criteria
(a) 
1.  No toxicological concerns, particularly with regard to their genotoxic and carcinogenic potential, for 
which a threshold is difficult to establish. 
2.  Efficacy of procedures used to clean ships‘ tanks between cargoes 
3.  Dilution factor in relation to the potential amount of residue of the previous cargo and any impurity 
which the previous cargo might have contained and the quantity of oil or fat transported. 
4.  Subsequent  application  of  refining  processes  and  solubility  relevant  to  the  occurrence  of  possible 
contaminating residues. 
5. 
 
Availability of analytical methods to verify the presence of trace amounts of residues or the absence of 
contamination of oils and fats. 
(a): The SCF criteria have no numbering in the original reference. In the present opinion they have been included for an 
easier referral throughout the document. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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The substances in the list were only considered to be acceptable as long as  the provisions of the 
Hygiene of Foodstuffs Directive 93/43/EEC,
13 later replaced by Regulation (EC) 852/2004 ,
14 were 
applied, and especially regarding the cleaning and condition of the tanks, as well as the requirement 
included in Commission Directive 96/3/ EC,
5 where accurately documented evidence relating to the 
three previous cargoes, and the efficacy of the cleaning process between cargoes, should be kept by 
the captain of the vessel. 
Some of the substances evaluated were accepted as previous cargoes by the SCF because they are food 
or food components. A number of other substances were considered acceptable from a toxicological 
point of view. 
For  others,  although  the  available  toxicological  information  was  insufficient  to  enable  a  full 
evaluation, the SCF was able to accept a number of compounds provisionally on the basis of their 
unlikely  genotoxic  potential,  their  easy  removal  by  tank  cleaning  procedures,  and  the  very  low 
residues expected as a result of these factors and their likely dilution in a subsequent cargo of edible 
fats or oils (e.g. iso-decanol, iso-nonanol, iso-octanol, montan and paraffin wax, white mineral oils and 
methyl tertiary butyl ether (MTBE)).  
Ten substances were considered as not acceptable due to inadequate toxicological and/or technical 
data (2,3-butanediol, 1,3-propylene glycol, methyl esters of fatty acids (laurate, palmitate, stearate, and 
oleate) and nonane) or because their genotoxic and carcinogenic potential were a reason for concern 
(iso-butanol, cyclohexanol and cyclohexanone).  
Later, the SCF was requested to update the list of substances from its previous opinion in the light of 
new  toxicological  information,  if  available  (SCF,  2003).  Priority  was  given  to  those  substances 
provisionally  accepted  as  previous  cargoes.  As  in  its  previous  opinion,  the  SCF  focused  on  the 
potential toxicological concerns, without considering other aspects. Neither the specifications of the 
transported fats and oils nor the purity of the previous cargo were taken into account. The criteria used 
for  re-evaluation  were  the  same  as  those  described  in  its  opinion  from  1996  (Table  2).  The  re-
evaluation led to the full acceptance of some substances previously considered as not acceptable (e.g. 
methyl esters of the following fatty acids: laureate, palmitate, stearate and oleate) or provisionally 
acceptable (e.g. MTBE) in view of the new toxicological information. Others were still considered to 
be not acceptable as previous cargoes since the new information did not allow for a re-evaluation of 
their  carcinogenicity  or  genotoxicity  (e.g.  2,3-butanediol,  isobutanol,  cyclohexanol  and 
cyclohexanone). Finally, some were considered to be still only provisionally acceptable, as there was 
insufficient new information on their toxicity to allow re-evaluation (iso-decanol, iso-nonanol, iso-
octanol, montan and paraffin wax and white mineral oils). 
Details  of  the  SCF  conclusions  are  given  in  the  corresponding  Section  for  each  substance  under 
evaluation.   
2.2.  European Food Safety Authority (EFSA) 
At the request of the European Commission, the EFSA reviewed the criteria for acceptable previous 
cargoes for edible fats and oils set by the SCF (Table 2). In doing so, the CONTAM Panel assessed the 
appropriateness of the four CCFO criteria (Table 3), one by one, by comparing them with those set by 
the SCF for acceptable previous cargoes for edible fats and oils in 1996.  
 
 
                                                       
13   Council Directive 93/43/EEC on the hygiene of foodstuffs of 14 June 1993. OJ L 175, 19.7.1993, p. 1-11. 
14   Regulation (EC) No 852/2004 of the European   Parliament and of the Council of 29 April 2004 on the hygiene of 
foodstuffs. OJ L 139, 30.4.2004, p. 1. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Table 3:   Criteria proposed for immediate previous cargoes by the CCFO during their 21
st meeting 
(CCFO, 2009) and adopted by the CAC (FAO/WHO, 2011). 
CCFO Criteria (adopted at Step 5) 
1.  The  substance  is  transported/stored  in  an  appropriately  designed  system;  with  adequate  cleaning 
routines, including the verification of the efficacy of cleaning between cargoes, followed by effective 
inspection and recording procedures. 
2.  Residues of the substance in the subsequent cargo of fat or oil should not result in adverse human health 
effects. The ADI (or TDI) of the substance should be greater than or equal to 0.1 mg/kg b.w./day. 
Substances for which there is no numerical ADI (or TDI) should be evaluated on a case by case basis. 
3.  The substance should not be or contain a known food allergen, unless the identified food allergen can be 
adequately removed by subsequent processing of the fat or oil for its intended use. 
4.  Most substances do not react with edible fats and oils under normal shipping and storage conditions. 
However,  if  the  substance  does  react  with  edible  fats  and  oils,  any  known  reaction  products  must 
comply with criteria 2 and 3. 
ADI: acceptable daily intake; b.w.: body weight; CAC: Codex Alimentarius Commission; CCFO: Codex Committee for Fats 
and Oils; TDI: tolerable daily intake. 
 
Criterion 2 was based on the fact that it could be estimated, as a worst case, that the residue of the 
substance remaining in the tanks after cleaning could give rise to a maximum of 100 mg residue/kg of 
fat or oil (FAO/WHO, 2007). Average consumption of fats and oils, based on the WHO-GEMS/Food 
Consumption Cluster diets is 25 g/day for a single type of fat or oil. Using a factor of 2.5 to take 
account of high consumers, an ADI of 0.1 mg/kg body weight (b.w.) per day would be the minimum 
requirement  to  ensure  sufficient  protection  of  all  consumers,  including  children  and  high-intake 
consumers. 
The CONTAM Panel concluded that the criteria for evaluation of acceptable previous cargoes for 
edible fats and oils as proposed by the CCFO are not in conflict with any of the five criteria developed 
by the SCF. SCF criteria 1 to 4 are either explicitly or implicitly covered by the CCFO criteria. SCF 
criterion 5 dealing with the availability of analytical methods is not explicitly addressed in the CCFO 
criteria. The CONTAM Panel considers that SCF criterion 5 is still important. The CCFO criteria also 
cover food allergens and the potential for compounds to react with edible fats and oils. The CONTAM 
Panel considers these additions relevant.  
In addition, the CONTAM Panel made the following remarks: 
  The CCFO criteria specifically apply to the immediate previous cargo. The CCFO criterion 1, 
which addresses among other issues, documentation procedures, does not specify for how 
many previous cargoes records should be kept. This might be particularly important in the 
event that earlier previous cargoes comprise substances for which an acceptable daily intake 
(ADI) (or tolerable daily intake (TDI)) has not been established. The CONTAM Panel was of 
the opinion that records of the three previous cargoes should be kept, in accordance with the 
Codex Recommended International Code of Practice for the Storage and Transport of Edible 
Fats and Oils in Bulk.  
  With respect to CCFO criterion 2, the CONTAM Panel agreed with the proposed threshold of 
an ADI (or TDI) of ≥ 0.1 mg/kg b.w. For substances for which there is no numerical ADI (or 
TDI) a case by case evaluation is needed. The Panel also considered the situation of second 
and third previous cargoes and concluded that for non-genotoxic substances their transport as 
second and third previous cargoes is not of concern, taking into account their very limited 
carry  over.  However,  the  CONTAM  Panel  noted  that  genotoxic  substances  would  not  be 
acceptable as previous cargoes. Also in relation to CCFO criterion 2, the CONTAM Panel 
noted that as consequence of the above some substances will turn out to be unacceptable as Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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previous cargoes. This could include substances with an ADI (or TDI) < 0.1 mg/kg b.w. or 
substances with genotoxic activity. The Panel was of the opinion that the exclusion of such 
substances as previous cargoes is appropriate.  
  CCFO  criterion  3 is  sufficient to  cover  ‗known  food  allergens‘.  However,  the  CONTAM 
Panel considered that the scope of the CCFO criterion is too narrow, and should apply to all 
known allergens, not just to known food allergens, given the fact that the same cargo may be 
sold for cosmetic use.  
  The CONTAM Panel endorsed CCFO criterion 4 without any further remarks. 
3.  Evaluation of the substances currently on the list in the annex to Commission Directive 
96/3/EC as acceptable previous cargoes for edible fats and oils 
The CONTAM Panel has evaluated the acceptability of the substances listed in Table 1 (as amended, 
see Table 4) as previous cargoes for edible fats and oils. The evaluation is based on its review of the 
criteria for acceptable previous cargoes as described in Section 2.2. (EFSA, 2009a) and the experience 
gained  in  its  subsequent  evaluation  of  13  substances  as  previous  cargoes  which  highlighted  the 
importance of addressing any impurities that might be present (EFSA, 2009b): 
  The  substance  is  transported/stored  in  an  appropriately  designed  system;  with  adequate 
cleaning  routines,  including  the  verification  of  the  efficacy  of  cleaning  between  cargoes, 
followed by effective inspection and recording procedures. The CONTAM Panel was of the 
opinion that records of the three previous cargoes should be kept, in accordance with the 
Codex Recommended International Code of Practice for the Storage and Transport of Edible 
Fats and Oils in Bulk. The CONTAM Panel noted that the choices made with respect to 
design  of  the  transport  system  and  the  cleaning  methods  are  the  responsibility  of  those 
managing the transport of previous cargoes. It was the nature and amount of substances that 
might be carried over into a subsequent cargo of edible fats and oils that  was taken into 
account by the CONTAM Panel in its evaluation of previous cargoes. 
  Residues of the substance in the subsequent cargo of fat or oil should not result in adverse 
human health effects. The ADI (or TDI) of the substance should be greater than or equal to 
0.1 mg/kg b.w. per day. Substances for which there is no numerical ADI (or TDI) should be 
evaluated on a case by case basis. For non-genotoxic substances their transport as second and 
third previous cargoes is not of concern, taking into account their very limited carry over. 
However, genotoxic substances would not be acceptable as previous cargoes.  
  The substance should not be or contain a known allergen, unless the identified allergen can be 
adequately  removed  by  subsequent  processing  of  the  fat  or  oil  for  its  intended  use.  This 
criterion covers all allergens, not only food allergens.  
  If the substance reacts with edible fats and oils, any known reaction products must comply 
with the above two criteria. Reactions may be promoted by the acidity from free fatty acids 
(crude oils) and may occur over many months; they do not need to result in high yields to be 
potentially  relevant.  Transesterifications  are  known  to  occur  under  such  conditions 
(Biedermann et al., 2008). Prominent reactive functions of lipids are hydroxyl groups on the 
alkyl chain of fatty acids or non-esterified positions of the glycerol moiety and epoxides from 
epoxidized fatty acids (Fankhauser-Noti et al., 2006). 
  The development of analytical methods of sufficient sensitivity to verify the presence of trace 
amounts of residues or the absence of contamination of fats and oils should be feasible, e.g. 
for control authorities. Such methods are seldom routinely available, since most substances 
used as previous cargoes are not commonly analyzed in fats and oils. The CONTAM Panel 
therefore evaluated the feasibility of developing such methodology as part of its assessment of Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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each substance. In those cases where, due to the nature or composition of the substance (or 
group of) to be evaluated as previous cargo, the feasibility of developing suitable analytical 
methods was considered questionable, this was indicated when discussing the substance (or 
group  of)  in  the  respective  chapter  and  was  used  as  an  argument  for  the  rejection  of  a 
substance as previous cargo.  
  It is unrealistic to assume that chemical analysis would regularly be applied to check the 
suitability of a material used as previous cargo or the efficiency of a cleaning procedure for a 
substance. Therefore the substances were evaluated under worst case assumptions with regard 
to cleaning efficiency and material composition (in particular the potential presence of toxic 
impurities or the formation of reaction products with edible fats and oils). 
  Potentially relevant impurities in the previous cargo should be taken into account since they 
may be toxicologically more important than the substance itself. As most products exist in 
different  grades,  a  reasonable  worst-case  product  within  the  specification  provided  was 
assumed, the concentration of the impurity estimated from available literature and evaluated in 
the same way as a listed substance.  Impurities are often specified for fine chemicals and 
highly  purified  products.  However,  these  are  unlikely  to  be shipped in  bulk.  Those  more 
commonly encountered are likely to be of intermediate to low purity grade and no specific 
information  about  impurities  is  publicly  available  (methods  of  synthesis  are  usually 
confidential). Due to this lack of information, the source and most probable way (or ways) of 
synthesis of the substance was investigated to determine potentially relevant impurities, such 
as unreacted starting substances or products of side reactions. 
The  current  evaluation  of  the  substances  as  acceptable  previous  cargoes  is  based  on  available 
studies/information from literature searches carried out, up to the time of the evaluation, on public 
databases, e.g. PubMed, International Uniform Chemical Information Database (IUCLID), European 
Chemicals Agency (ECHA), evaluations made by national and international bodies, e.g. WHO and 
Organisation for Economic Co-operation and Development (OECD) and on information requested 
from FOSFA.  
The safety of the substances as identified chemically in the Annex (Table 1, with any clarifications 
necessary as indicated in Table 4) was evaluated first. If the substance was considered acceptable as a 
previous cargo from a toxicological point of view, it was further evaluated in accordance with the 
additional criteria listed above (EFSA, 2009a,b).  
As part of the evaluation of safety for human health, responses of the immune system have been 
considered.  This  is  necessary  for  allergens,  but  it  is  also  relevant  for  substances  which  are  not 
allergens themselves but can promote allergy, so-called adjuvants. Adjuvant activity has been shown 
e.g. for various natural lipids such as pollen-associated oxylipins (Traidl-Hoffmann et al., 2009), for 
plant lectins (reviewed by Lavelle et al., 2001), for saponins from a variety of plants (Lacaille-Dubois, 
2005; Sun et al., 2009), and for inulin and certain other carbohydrates (Petrovsky and Cooper, 2011). 
It  has  been  determined  on  a  case-to-case  basis  whether  any  documented  adjuvant  activity  is 
sufficiently strong to be of concern in the context of transport as a previous cargo. 
3.1.  SODIUM SILICATE (water glass) (CAS No 1344-09-8) 
Sodium silicate, also called water glass, is traded as a solid (powder) or as a viscous liquid when 
dissolved in water. In reality, solid sodium silicate is a metasilicate of oligomeric structure containing 
on average 3-5 silicate moieties. Sodium silicate solutions are strongly basic and barely soluble in 
edible fats and oils. 
Sodium silicate is prepared by heating sodium carbonate with silicium dioxide (quartz sand). Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Sodium  silicate  has  many  different  uses.  Large  amounts  are  used  in  the  building  industry  as  an 
additive to special cements (e.g. to improve tightness of concrete), but also for ceramics, as a binder 
for mineral dyes, for bleaching pulp, repairing cars, etc. 
3.1.1.  Previous evaluations 
The SCF evaluated sodium silicate (water glass) in 1996 as a previous cargo for edible fats and oils 
and considered this substance acceptable in view of the fact that it was approved as a food additive by 
the European Union (E550) (Annex 1 of Directive 95/2/EC
15), with an  ADI ‗not specified‘ (SCF, 
1997a). In the 2003 SCF evaluation of acceptable previous cargoes, sodium silicate was not further 
evaluated as it was already considered acceptable (SCF, 2003). 
In 1974, an ADI ‗not limited‘ was also assigned by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) to sodium silicate (JECFA, 1974). 
In 2004, OECD reviewed the toxicological data of soluble silicates including  sodium silicate and 
concluded  that  soluble  silicates  possess  properties  indicating  a  hazard  for  human  health 
(irritancy/corrosivity) but, provided that adequate risk reduction measures are in place (classification 
and labelling), they were currently considered of low priority for further work (OECD, 2004a). 
3.1.2.  Current evaluation 
Sodium silicate is a solid at normal temperature and pressure, with a melting point above 800 °C.  
Hence, in this form it is not a suitable cargo for the type of tanker used to transport edible fats and oils 
by sea. When used as a previous cargo to edible fats and oils it has to be transported as a solution, to 
enable effective transfer and tank cleaning (see Documentation provided to EFSA). 
3.1.2.1.  Expected impurities 
Sodium silicate is often made starting from crude minerals, and for many applications purity is not 
critical. It will contain other alkali or earth alkali ions and also other anions. These tend to be easily 
removed from the tank by washing with water. Hence, these substances are unlikely to be of any 
concern at the levels that would occur in edible fats and oils when sodium silicate is transported as the 
previous cargo. 
3.1.2.2.  Reactivity and reaction products 
Sodium silicate solution is strongly basic. When mixed into fats and oils at low amounts (below 
100 mg/kg),  it  will  interact  immediately  with  free  fatty  acids  in  the  oil  and  be  neutralised.  The 
resulting salts of organic acids are not reactive. This is also why it does not cause saponification when 
mixed with fats and oils at the concentrations expected when used as a previous cargo. 
3.1.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
Silicon is an essential trace element that participates in important metabolic processes including bone, 
cartilage  and  connective  tissue  formation.  The  silicon  is  present  almost  entirely  as  free  soluble 
monosilicic acid (Carlisle, 1986, as cited in OECD, 2004a). No reliable toxicokinetic, metabolic or 
mechanistic studies are available for soluble silicates. Since concentrated silicate solutions are only 
stable at pH >11.5 and lowering the pH leads to the formation of an insoluble silica gel, after ingestion 
gel formation is expected to occur due to the hydrochloric acid of the stomach. The degree of gel 
formation will depend on the amount of ingested silicate solution and the neutralising and buffering 
capacity of the gastrointestinal tract. Gastrointestinal absorption of insoluble silica will be insignificant 
as compared to that of soluble anions. Absorbed soluble silicates are excreted via urine and to a lesser 
                                                       
15   European Parliament and Council Directive No 95/2/EC of 20 February 1995 on food additives other than colours and 
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extent via the faeces. Markedly increased and rapid urinary excretion of silica was observed when 
soluble  sodium  silicates  were  administered  by  various  routes  to  different  animal  species (OECD, 
2004a).  The  excretion  rate  of  sodium  silicate  administered  to  rats  via  stomach  tube  (Benke  and 
Osborn, 1979, as cited in OECD, 2004a) was independent of the doses applied, indicating that the 
limiting factor is the rate of production of soluble or absorbable silicon in the gastrointestinal tract.  
Acute toxicity 
Exposure to silicate solutions involves not only exposure to silica in the form of its various silicate 
anions but also to alkalinity. Both distribution of the various silicate anion species and alkalinity 
depend on the silica to alkali-oxide ratio and the concentration of a given solution.  
Sodium and potassium silicates can be irritating or corrosive to the skin of animals as well as of 
humans, depending on their molar ratio and concentration. Any effects on the skin decrease with 
increasing molar ratio, superimposed by increasing irritancy with increasing concentrations (OECD, 
2004a). 
The oral toxicity of sodium silicate in rats decreased at increasing molar ratio SiO2:Na2O. The LD50 
ranged from 500 mg/kg b.w. for molar ratio 0.5 to 8 650 mg/kg b.w. for 3.38, thus showing the inverse 
correlation between molar ratio and toxicity (Schleyer and Blumberg, 1982 and references therein, as 
cited in OECD, 2004a). Clinical signs observed near to or exceeding the LD50 values (Saiwai et al., 
1980,  as  cited  in  OECD,  2004a)  consisted  of  apathy,  staggering  gait,  dyspnoea,  piloerection, 
abdominal  discomfort,  and  unconsciousness.  Autopsy  revealed  acute  gastro-enteritis,  vascular 
congestion, mottled livers, changes in pH of body fluids, shock, chemical irritation and/or corrosion of 
the viscera. In another study in rats the acute oral LD50 was 1 960 mg/kg in groups receiving the 
2.0 molar ratio and 2 710 mg/kg in groups receiving the 2.4 ratio sodium silicate (Rhone-Poulenc, 
1971, as cited in Elmore, 2005). Although it is not possible to attribute unequivocally any observed 
toxicity  of  a  silicate  solution  to  either  silicate,  alkalinity  or  a  combination  of  both,  the  observed 
toxicological signs are indicative of effects due to high alkalinity. 
Subacute, subchronic and chronic toxicity studies 
Soluble silicates have been tested in drinking water in a number of repeated dose studies. Sodium 
silicate had a no-observed-adverse-effect level (NOAEL) of 159 mg/kg b.w. per day (highest tested 
dose) in rats exposed for 180 days (Smith et al., 1973, as cited in OECD, 2004a). The NOAEL for 
sodium metasilicate in rats exposed for 3 months was 227 and 237 mg/kg b.w. per day for males and 
females, respectively (Ito et al., 1975, as cited in OECD, 2004a). When rats were administered sodium 
metasilicate pentahydrate in the diet at 1 259 mg/kg b.w. per day for 8 weeks no effects on body or 
organ weights were observed but plasma calcium and magnesium and liver zinc were significantly 
reduced (Kayongo-Male and Jia, 1999, as cited in OECD, 2004a).  
Genotoxicity 
In vitro, soluble silicates did not induce gene mutations in a series of in vitro bacterial assays including 
Salmonella typhimurium Ames test (Saiwai et al., 1980; Ito et al., 1986, as cited in OECD, 2004a). An 
aqueous sodium silicate solution (36 % active ingredient) induced no chromosomal aberrations in V79 
cells, either in the absence or in the presence of metabolic activation (Schulz, 2006, as cited in OECD, 
2004a, amended in 2006). In vivo, sodium metasilicate did not induce chromosomal aberrations in 
bone marrow cells of mice (Saiwai et al., 1980, as cited in OECD, 2004a). Although the reliability of 
these studies cannot be fully evaluated, the lack of structural alerts and these negative results indicate 
that sodium silicate is unlikely to present any genotoxic potential. 
Carcinogenicity 
There were no carcinogenicity studies available. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Developmental and reproductive toxicity 
The available data on toxicity to reproduction are limited and do not allow any firm conclusions to be 
drawn. In a developmental toxicity study with mice, sodium metasilicate in aqueous solution was 
administered at doses of 12.5, 50 or 200 mg/kg b.w. per day from day 0 until day 17/18 of gestation by 
gavage. No treatment-related effects were observed either in mothers or in pups (Saiwai et al., 1980, as 
cited in OECD, 2004a). 
3.1.2.4.  Allergenicity 
There is a single report on immediate type allergic contact reactions in a worker exposed to 20 % 
aqueous sodium silicate (Tanaka et al., 1982). A mouse study on allergy-prone BALB/c mice reported 
an  allergic  reaction  at  high  concentrations  (4-6  %  sodium  metasilicate),  but  no  effects  on  cell 
proliferation in the auricular lymph nodes were observed at concentrations up to 6 % (Karrow et al., 
2002, as cited in OECD, 2004a). Available data give no indication that sodium silicate is an allergen 
or an adjuvant at concentrations expected from its use as a previous cargo. 
3.1.3.  Conclusions 
Current shipping practices mean that when sodium silicate is transported prior to edible fats and oils, 
the design of the tanker will be such that sodium silicate has to be transported as a solution. Hence, the 
CONTAM Panel recommends that the entry for the substance in the Annex to Commission Directive 
96/3/EC be amended to ‗Sodium silicate (water glass) solution (CAS No 1344-09-8)‘. 
Toxicological effects of sodium silicate following acute and repeat dosing are mostly due to high 
alkalinity. However, following ingestion it will be diluted and buffered by the neutralising capacity of 
the  gastrointestinal  tract.  Thus  the  CONTAM  Panel  considered  that  the  levels  that  would  occur 
following oral ingestion of fats and oils transported subsequent to sodium silicate as a previous cargo 
would  not  give  rise  to  any  toxicological  concern.  Although  there  are  no  carcinogenicity  studies 
available sodium silicate did not show any genotoxic activity in a variety of in vitro and in vivo assays 
thus indicating no genotoxic potential. Available data give no indication that sodium silicate is an 
allergen or an adjuvant at concentrations expected from its use as a previous cargo. Exposure to 
sodium silicates can be irritating or corrosive to the skin, however the potential levels arising in fats 
and oils following its transport as previous cargo would be of no concern. There are no reactions of 
concern with edible fats and oils, nor are any anticipated impurities likely to be present at levels of 
toxicological concern. 
The  CONTAM  Panel  therefore  concludes  that  sodium  silicate  solution  meets  the  criteria  for 
acceptability as a previous cargo for edible fats and oils. 
3.2.  ISO-OCTANOL  (isooctyl  alcohol)  (CAS  No  26952-21-6),  ISO-NONANOL  (isononyl 
alcohol) (CAS No 27458-94-2) and ISO-DECANOL (isodecyl alcohol) (CAS No 25339-
17-7) 
Iso-octanol, iso-nonanol and iso-decanol are grouped as a family of saturated alcohols. They consist of 
complex mixtures of straight chain and branched alcohols and are usually not completely separated 
from each other, e.g. iso-nonanol may contain some iso-octanol as well as some iso-decanol.  
Iso-octanol, iso-nonanol and iso-decanol are slightly viscous, high boiling liquids, less dense than 
water and insoluble in water. 
These iso-alcohols are also called oxo-alcohols, as they are produced by hydroformylation (also called 
‗oxo‘ process); this process involves reaction of an olefin with carbon monoxide and hydrogen to 
produce an aldehyde that then undergoes hydrogenation to an alcohol. The olefins are obtained by 
condensation  of  propylene  and  butenes  with  phosphoric acid  at  200  °C  under  pressure to  give  a 
mixture of branched olefins. A recent development in the oxo technology uses a modified rhodium 
catalyst in order to enable working with a broader range of olefins. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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These iso-alcohols are traded as mixtures of isomers. 
Iso-octanol, iso-nonanol and iso-decanol are used as intermediates for the production of plasticizers, 
such  as  diisononyl-  and  diisodecyl  phthalate  (DINP  and  DIDP)  or  corresponding  adipates,  as 
ingredient  in  synthetic  lubricants,  agents  in  uranium  refining,  specialty  solvents  and  antifoaming 
agents in textile processing. Iso-octanol is also used as an intermediate for non-ionic detergents and 
surfactants,  synthetic  drying  oils,  cutting  and  lubricating  oils,  hydraulic  fluids,  resin  solvents, 
emulsifiers and antifoaming agents. 
3.2.1.  Previous evaluations 
The SCF evaluated iso-decanol, iso-nonanol and iso-octanol as previous cargoes in 1996 and they 
were included in the list of Annex 2 of its Opinion as substances provisionally acceptable because of a 
lack of toxicological data and uncertainty as to their composition. It was also noted that they can be 
easily removed if vegetable oil is refined (SCF, 1997a). 
In  2003  the  SCF  re-evaluated  a  series  of  provisionally  accepted  previous  cargoes,  including  iso-
decanol,  iso-nonanol  and  iso-octanol,  on  the  basis  of  further  information  provided  by  FOSFA. 
However,  the  information  available  was  considered  inadequate  or  needed  additional  clarification. 
Therefore, the SCF decided to maintain its previous opinion unchanged (SCF, 2003).  
In 2006, OECD published an initial assessment report on the environmental fate and human health 
effects of oxo-alcohols (C9 to C13) including a mixture of alcohols C8-C10-iso, iso-nonanol and iso-
decanol (OECD, 2006). A detailed assessment of the available toxicological database was carried out. 
It was concluded that the chemicals of this category are of a low order of toxicity, do not posses 
mutagenic activity, there is no evidence of carcinogenic potential or adverse effects on fertility and 
reproduction and therefore they are of low priority for further work.  
3.2.2.  Current evaluation 
3.2.2.1.  Expected impurities 
Iso-octanol, iso-nonanol and iso-decanol are mixtures in themselves and mostly of technical quality. 
The starting substances are volatile and their byproducts would easily be removed when not integrated 
into the product. The residual amounts of intermediate alkenes and aldehydes would not be of concern 
at the levels present in products used as previous cargoes. Hydroformylation is not expected to result 
in byproducts of concern.  
3.2.2.2.  Reactivity and reaction products 
Iso-octanol, iso-nonanol and iso-decanol may react with lipids by interesterification, but this does not 
result in any products of concern.  
3.2.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
The  C8-C10  oxo-alcohols  are  readily  absorbed  from  the  gastrointestinal  tract  and  are  rapidly 
eliminated  from  the  blood.  The  main  metabolic  pathway  involves  initial  oxidation  to  the 
corresponding  aldehyde,  catalysed  primarily  by  cytosolic  alcohol  dehydrogenases  (ADH),  with  a 
lesser contribution from P450 and other oxidases. The aldehydes are then converted to the respective 
carboxylic  acids,  by  aldehyde  dehydrogenases  (ALDH).  The  carboxylic  acids  are  subsequently 
metabolized to carbon dioxide via mitochondrial beta-oxidation pathways and the tricarboxylic acid 
cycle, in the same way as dietary fatty acids (OECD, 2006). This stepwise removal of C2 units is more 
efficient for linear acids than for the corresponding branched acids. The latter can also be metabolised 
by microsomal ω- or ω–1 oxidation followed by β-oxidation, which is relatively efficient for such 
compounds (Verhoeven et al., 1998). For unsaturated carboxylic acids, cleavage of C2-units continues Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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until  a  double  bond  is  reached. These  double  bonds  will  be  in  the cis-configuration,  and  can  be 
isomerised to the trans-configuration by enoyl-CoA isomerase. β-Oxidation then continues with the 
trans-isomer (JECFA, 1999). The alcohols (both parent substances and their primary metabolites) or 
their  oxidation  products  can  be  conjugated  with  sulphate  or  glucuronic  acid,  catalysed  by 
sulphotransferases  and  UDP-glucuronosyltransferases  respectively,  the  extent  of  these  reactions 
increasing with the degree and complexity of branching (Williams, 1959; Bevan, 2001; OECD, 2006).   
The CONTAM Panel undertook a limited exercise on the prediction of the main metabolites of two 
examples  of  oxo-alcohols,  representing  the  potential  for  most  branching  amongst  the  compounds 
likely to be present in the technical mixtures being assessed as previous cargoes (See Figure 1a and 
1b).   
 
 
 
 
Figure 1:   Two examples of oxo-alcohols representing the potential for most branching amongst the 
compounds likely to be present in the technical mixtures being assessed as previous cargoes. 
Using  the  METEOR  software  13.0.0  (Lhasa  Ltd),  plausible  metabolic  transformations  of  the 
compounds depicted in Figure 1a and Figure 1b included terminal methyl oxidation, primary alcohol 
oxidation  and  glucuronide  conjugation  of  the  resulting  carboxylic  acids.  These  pathways  were 
supported  by  reference  to  several  known  examples  in  each  case  (Wim  Mennes,  2012,  personal 
communication). 
The CONTAM Panel concluded that the potential for retention or bioaccumulation for the parent 
alcohols and their biotransformation products is likely to be limited. 
Acute toxicity 
In the OECD assessment (2006) it was concluded that the sub-category of oxo-alcohols C9 to C13 is 
practically non-toxic with oral LD50s ranging from > 2 000 to 5 400 mg/kg b.w. Acute oral LD50s of 
6 500 and 3 950 mg/kg b.w. were reported in rats orally administered iso-decanol (Nishimura et al., 
1994), and iso-nonanol (Anonymous 1986a, as cited in ECHA, online) respectively. Oral LD50s of 
1 480 and 1 670 mg/kg b.w. were reported in rats and mice respectively, upon oral administration of 
iso-octanol.
16,17 Dermal LD50s ranged from > 2 600 to 5 010 mg/kg b.w. and inhalation exposures 
conducted at saturated vapour pressures generally produced no deaths (OECD, 2006). Members of this 
category were moderately irritating to the skin and irritating to the eyes of rabbits and, in addition, the 
alcohols  C9-C11-iso,  C9  rich,  produced  moderate  upper  airway  sensory  irritation  in  male  mice 
exposed to vapours. There is no indication of skin sensitizing potential for the oxo-alcohols C9-C13 
category (OECD, 2006). 
Subacute, subchronic and chronic toxicity studies 
In a 14-day study in rats, designed to evaluate potential effects on liver and testes,  iso-decanol and 
iso-nonanol given by gavage produced minimal or no effects on the liver, and no testicular effects at 
doses of 168 and 144 mg/kg b.w. per day, respectively (Rhodes et al., 1984; OECD, 2006). No oral 
repeated dose toxicity studies were identified for iso-octanol. In general, the available data suggest that 
                                                       
16   ChemID Plus, online. Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidheavy.jsp  
17   RTECS, online. Available at: http://www.cdc.gov/niosh/rtecs/  
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the members of the oxo-alcohols C9-C13 category present low order of subchronic toxicity (OECD, 
2006). 
Genotoxicity 
Bacterial mutagenicity studies (using Salmonella typhimurium as well as Escherichia coli) for four 
members of the oxo-alcohols C9-C13 category showed a consistent lack of mutagenic activity (OECD, 
2006).  In  particular,  iso-nonanol  (Anonymous  1986d,  as  cited  in  ECHA  online)  and  iso-octanol 
(Henkel KgaA, 1982a; HLS, 1996k, both as cited in OECD, 2006) were negative in the Ames test with 
and without metabolic activation. Iso-decanol was also tested in an in vitro chromosomal aberration 
assay with V79 Chinese hamster lung fibroblasts, and no mutagenic effects were noted with or without 
metabolic activation (OECD, 2006). In addition to these in vitro results, two category members and 
the analogue linear alcohol 1-dodecanol were negative in an in vivo mouse bone marrow micronucleus 
test (OECD, 2006) thus indicating that the members of the oxo-alcohols C9-C13 category are unlikely 
to present any genotoxic potential either in vitro or in vivo. 
Carcinogenicity 
No carcinogenicity studies  have been conducted on oxo-alcohols C9-C13 category  members. The 
potential for initiation, promotion or co-carcinogenicity has been investigated for several aliphatic 
alcohols including the analogue linear alcohol 1-dodecanol. Even taking into account the limitations 
and low reliability of these experiments, the data show that none of the aliphatic alcohols tested have a 
potential to induce local skin tumours upon repeated dermal application at or above the maximum 
tolerated (irritant) dose (Sicé, 1966; Bingham and Falk, 1969; Van Duuren and Goldschmidt, 1976, as 
cited in OECD, 2006). 
In other assays, oxo-alcohols C10-C12 members were repeatedly injected into the peritoneal cavity or 
implanted in the bladder of mice. Although there are limitations to these studies, no induction of 
tumours was observed (Bryan and Springberg, 1966; Stoner et al., 1973, both as cited in OECD, 2006) 
and in one study (Ando et al., 1972, as cited in OECD, 2006) a prolongation of survival time was 
reported.  
Based on the lack of genotoxic effects both in vitro and in vivo and on the absence of any structural 
alerts, members of the oxo-alcohols C9-C13 category are unlikely to possess genotoxic carcinogenic 
potential. 
Developmental and reproductive toxicity  
In a comparative developmental toxicity study with rats, iso-decanol (a mixture of different isomers) 
was administered by gavage at doses of 0, 1, 5 and 10 mmol/kg (0, 158, 790, and 1 580 mg/kg b.w. per 
day) during gestation day (GD) 6 to 15. Iso-decanol elicited maternal toxicity at 10 mmol/kg and 
caused a low incidence of retardations and rare malformations at that dose level. Body weight, uterus 
weight, and fetal weights were all significantly lower than controls in the highest dose group. Overt 
maternal  mortality  (4/10)  was  observed  only  in  this  dose  group  thus  accounting  for  the  effects 
observed. Some maternal signs of toxicity, but no fetal effects, were observed at 5 mmol/kg. The 
NOAELs for maternal and fetal effects were 1 mmol/kg and 5 mmol/kg, respectively (Hellwig and 
Jäckh, 1997). 
In  another  study  maternal  toxicity,  including  decreased  feed  intake  and  body  weight  gain  and 
abnormal clinical signs, was observed at 790 mg/kg b.w. given by gavage to rats from gestation day 
6 to 15. No embryo-fetal toxicity was observed (Eastman Kodak Co., 2009).  
No  effects  to  parents  or  offspring  were  observed  in  a  combined  repeated  dose 
developmental/reproductive toxicity study with the analogue 1-dodecanol at doses up to 2 000 mg/kg Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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b.w. per day (OECD, 2006) thus supporting the conclusion that members of the oxo-alcohols C9-C13 
category are not reprotoxic.  
3.2.2.4.  Allergenicity 
Available  data  give  no  indication  that  iso-decanol,  iso-nonanol  or  iso-octanol  are  allergens  or 
adjuvants.  
3.2.3.  Conclusion 
Iso-octanol, iso-nonanol and iso-decanol were classified by the SCF in its more recent re-evaluation 
(SCF, 2003) as provisionally acceptable as previous cargoes because the information available was 
considered inadequate or limited. The CONTAM Panel used a ‗read across‘ approach (OECD, 2006) 
to fill data gaps on the toxicological profile of iso-octanol, iso-nonanol and iso-decanol. They are of a 
low  order  of  toxicity  following  acute  and  repeated  exposures  upon  oral,  dermal  or  inhalational 
exposure.  The  lack  of  effects  found  in  the  limited  studies  available  suggests  that  they  are  not 
genotoxic. They are not allergenic and there are no reactions of concern with edible fats and oils, nor 
are any anticipated impurities likely to be present at levels of toxicological concern. 
The CONTAM Panel therefore concludes that iso-decanol, iso-nonanol or iso-octanol meet the criteria 
for acceptability as previous cargoes for edible fats and oils.  
3.3.  1,3-PROPYLENE GLYCOL (trimethylene glycol; 1.3-propanediol) (CAS No 504-63-2) 
The term ‗propylene glycol‘ is misleading: when used without specification of the position of the 
hydroxyl groups, 1,2-propylene glycol is meant, which is produced in far larger quantities than the 
1,3-analogue. For this reason, ‗1,3-propanediol‘ is the preferred name of the substance considered 
here. 1,2-Propylene glycol was evaluated for its acceptability as a previous cargo for edible fats and 
oils by the CONTAM Panel in 2011 and it was concluded that it met the criteria for acceptability 
(EFSA, 2011). 
1,3-Propanediol is a flammable, colourless, stable liquid. 1,3-Propanediol is produced commercially 
from acrolein (addition of water in acidic medium followed by hydrogenation), by hydroformylation 
of ethylene oxide or biochemical fermentation from glycerol (a by-product of the biodiesel chain) or  
by starch fermentation. 1,3-Propanediol is then separated and purified by several means, including 
ultrafiltration and/or distillation. 
Between  75  and  90  %  of  1,3-propanediol  is  used  in  a  polymerization  process  to  manufacture 
polytrimethylene terephthalate (PTT). 1,3-Propanediol may also be a component of de-icing fluids, 
engine  coolants,  heat  transfer  fluids,  chemical  intermediates,  personal  care  products,  or  process 
solvents. 
3.3.1.  Previous evaluations 
In  the  SCF‘s  1996  opinion  on  acceptable  previous  cargoes  (SCF,  1997a),  1,3-propanediol  was 
considered not acceptable as a previous cargo because of inadequate toxicological data on a substance 
that is structurally of concern.  
In 1998, the SCF considered 1,3-propanediol for use as a co-monomer in polyesters. On the basis of 
new  mutagenicity  and  developmental  toxicity  studies,  the  SCF  concluded  that  the  use  of 
1,3-propanediol was acceptable and should be classified in SCF List 3 (defined as substances for 
which an ADI or a TDI could not be established, but where the present use could be accepted) with a 
restriction of not more than 0.05 mg/kg in food (SCF, 1998).  
In 2003 the SCF, on the basis of new information from a sub-chronic toxicity study showing low oral 
toxicity of 1,3-propanediol and provided that residues would be low after tank cleaning, considered 
that 1,3-propanediol was acceptable as a previous cargo (SCF, 2003). Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.3.2.  Current evaluation 
3.3.2.1.  Expected impurities 
After production, 1,3-propanediol is purified by distillation. As the boiling point is far above that of 
acrolein (211-217 °C versus 53 °C), an efficient separation and removal of acrolein is expected. 
3.3.2.2.  Reactivity and reaction products 
1,3-Propanediol  slowly  reacts  with  lipids  by  transesterification,  but  no  products  of  concern  are 
expected when it is transported as a previous cargo.  
3.3.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
Pollitt et al. (1987) proposed that 1,3-propanediol can be metabolized to 3-hydroxypropionaldehyde 
and then to 3-hydroxypropionic acid or to malonaldehyde. Malonaldehyde is expected to be a short-
lived metabolic intermediate which can be further converted to malonic semialdehyde and then to 
malonic acid (Gingell et al., 2000).  
Acute toxicity 
1,3-Propanediol was administered to rats by gavage at doses ranging between 9.0 and 18.7 mL/kg b.w. 
(Spanjers  and Til,  1979, as  cited  in  ACC  1,3-Propanediol  Panel,  2007). Sluggishness, ataxia  and 
sedation  were  the  only  signs  observed  within  a  few  hours.  The  LD50  was  14.9  mL/kg  b.w., 
corresponding to 15.8 g/kg b.w. In another experiment with rats administered by gavage the LD50 was 
10  mL/kg  b.w.  corresponding  to  10.5  g/kg  b.w.  (Coombs  and  Clark,  1977,  as  cited  in  ACC 
1,3-Propanediol Panel, 2007). 
Subacute, subchronic and chronic toxicity studies 
1,3-Propanediol was orally administered to rats by gavage at doses up to 1 000 mg/kg b.w. per day for 
13  weeks  (Gingell  et  al.,  2000).  All  animals  survived  and  showed  no  evidence  of  any  systemic 
toxicity.  In  particular,  no  effects  on  haematology  or  serum  chemistry  parameters  were  reported, 
spermatogenic end-points were unaffected and no apparent pathological or functional effects were 
observed in the liver. The NOAEL for this study was therefore 1 000 mg/kg b.w. per day, the highest 
dose tested (Kirkpatrick, 1999, as cited in ACC 1,3-Propanediol Panel, 2007; Gingell et al., 2000). A 
NOAEL of 1 000 mg/kg b.w. per day (highest dose tested) was also identified in a 2-week oral toxicity 
study with rats (Mertens, 1997, as cited in ACC 1,3-Propanediol Panel, 2007).  
Genotoxicity 
1,3-Propanediol  was  negative  in the  Ames  test  (Degussa,  1994a,  as  cited  in SCF,  2003;  Wollny, 
1994a,  as  cited  in  ACC  1,3-Propanediol  Panel,  2007)  and  in  a  gene  mutation  assay  in  cultured 
mammalian  cells  (Degussa,1994b,  as  cited  in  SCF,  2003;  Wollny,  1994b,  as  cited  in  ACC 
1,3-Propanediol Panel, 2007). Contrasting data were reported for clastogenic effects in mammalian 
cells  in  culture  (Degussa,  1994c,  as  cited  in  SCF,  2003;Volkner,  1994,  as  cited  in  ACC 
1,3-Propanediol Panel, 2007; Gudi and Brown, 2001, as cited in ACC 1,3-Propanediol Panel, 2007).  
In 1984 one study was published (Summerfield and Tappel, 1984) indicating that administration of 
1,3-propanediol  at  500  mg/kg  in  the  diet  of  rats  for  up  to  15  weeks  caused  DNA-protein  and 
interstrand DNA cross-links, as detected by high-performance liquid chromatography, in liver and, to 
a limited extent, in testis. This was associated with the fact that liver but not testis can metabolize 
1,3-propanediol to malondialdehyde, a cross-linking agent. In a well conducted mouse micronucleus 
study (Krauser, 1995, as cited in ACC 1,3-Propanediol Panel, 2007), male and female mice received a 
single oral dose of 1,3-propanediol (at 1 000, 1 470 or 2 150 mg/kg b.w.) and were euthanized at Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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24 and 48 hours after treatment. The assay was conducted on two separate occasions. All animals, in 
both assays, survived to scheduled termination and no treatment-related toxic signs were observed. In 
the initial assay, 1,3-propanediol was not considered to induce chromosome mutations in mice by 
damage  to  chromosomes  or  the  mitotic  apparatus,  but  a  statistically  significant  increase  in 
micronucleated polychromatic erythrocytes (PCEs) was observed at 48 hours in the sexes combined, 
as compared to the negative control (23/1000 cf 11/1000, P < 0.05). Hence, it was not possible to 
exclude a weak clastogenic effect. However, in the second assay, there was no increase in the number 
of micronucleated PCEs following exposure to 1,3-propanediol. In conclusion, based on the overall 
weight of evidence, 1,3-propanediol does not have genotoxic potential. 
Carcinogenicity 
No data are available on the carcinogenicity of 1,3-propanediol. 
Developmental and reproductive toxicity 
In 90-day oral toxicity studies with rats there were no effects of 1,3-propanediol at any dose up to 
1 000 mg/kg per day on reproductive organs or on spermatogenic endpoints (Kirkpatrick, 1999, as 
cited in ACC 1,3-Propanediol, 2007; Gingell et al., 2000). 
In  a  developmental  toxicity  study  with  rats,  1,3-propanediol  orally  administered  at  doses  up  to 
1 000 mg/kg b.w. per day (Mitterer, 1992) did not induce  any treatment-related adverse effect. The 
NOAEL for maternal and fetal toxicity was therefore 1 000 mg/kg b.w., the highest dose tested (ACC 
1,3-Propanediol Panel, 2007).  
3.3.2.4.  Allergenicity 
In the guinea pig maximization test and in the guinea pig Landsteiner/Draize test, 1,3-propanediol did 
not  act  as  a  sensitizer  (Coombs  and  Clark,  1977;  Til  and  Keizer,  1979,  both  as  cited  in  ACC 
1,3-Propanediol Panel, 2007). In a study with human volunteers, 1,3-propanediol did not produce 
adverse  skin  responses  in  any  of  the  study  participants  (Anonymous,  2006b,  as  cited  in  ECHA, 
online).  
Available data give no indication that 1,3-propanediol is an allergen or an adjuvant.  
3.3.3.  Conclusions 
The term ‗propylene glycol‘ is misleading: when used without specification of the position of the 
hydroxyl groups, 1,2-propylene glycol is meant, which is produced in far larger quantities than the 
1,3-analogue. For this reason, ‗1,3-propanediol‘ is the preferred name of the substance considered 
here. The CONTAM Panel therefore recommends that the entry for the substance in the Annex to 
Commission Directive 96/3/EC is amended to ‗1,3-propanediol (1,3-propylene glycol; trimethylene 
glycol) (CAS No 504-63-2)‘.  
1,3-Propanediol  is  of  low  systemic  toxicity  when  administered  by  the  oral  route.  There  are  no 
carcinogenicity  data  but  the  available  evidence  indicates  that  1,3-propanediol  does  not  have  any 
genotoxic potential. 1,3-Propanediol is not an allergen. There are no reactions of concern with edible 
fats and oils, nor are any anticipated impurities likely to be present at levels of toxicological concern. 
Therefore, the CONTAM Panel concludes that 1,3-propanediol meets the criteria for acceptability as a 
previous cargo for edible fats and oils. 
3.4.  ISO-BUTYL ACETATE (CAS No 110-19-0)  
Chemically,  the  term  iso-butyl  refers  to  a  number  of  branched  butyl  groups  (including  1-methyl 
propyl, also called sec-butyl, and 1,1-dimethyl ethyl, also called tert-butyl). Isobutyl is a trivial name Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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standing for 2-methyl propyl. For this reason ‗isobutyl acetate‘ is the preferred name, i.e. without the 
hyphen. The IUPAC name of isobutyl acetate is 2-methylpropyl acetate.  
Isobutyl acetate is used as a solvent for coatings, thinners, sealants, adhesives, printing inks, caulks, 
leather  treatment,  cleaners,  cosmetics  (nail  polishes),  and  as  a  process  solvent  in  numerous 
applications. It is also used in perfumes and as a flavouring agent in various foods and non-alcoholic 
beverages. 
It is produced from the esterification of isobutanol with acetic acid in the presence of a strong acid 
(usually sulphuric acid). 
All of the butyl acetate isomers have been found to occur naturally in a range of fruits, such as bananas 
(Macku and Jennings, 1987; Bisesi, 1994, as cited in WHO, 2005) and nectarines (Takeoka et al., 
1988, as cited in WHO, 2005). 
3.4.1.  Previous evaluations 
The SCF evaluated isobutyl acetate in 1996 as a previous cargo for edible fats and oils and considered 
this substance was acceptable on the basis that it was ‗generally used as a flavouring in food on FEMA 
and GRAS lists‘ (SCF, 1997a). In the 2003 SCF evaluation of acceptable previous cargoes, isobutyl 
acetate was not further evaluated as it was already considered acceptable (SCF, 2003). 
Isobutyl acetate was given Generally Recognized as Safe (GRAS) status by the Flavor and Extract 
Manufacturers Association of the US (FEMA) in 1965. 
In a monograph on fragrance raw materials, published in 1978, Opdyke states that the Council of 
Europe listed isobutyl acetate as an acceptable flavouring substance, with an ADI of 1.0 mg/kg b.w. 
(Opdyke, 1978). 
The SCF (1992a) considered isobutyl acetate acceptable as a flavouring substance for use in food, on 
the basis of an evaluation by the Expert Committee on Flavourings of the Council of Europe. The 
Expert  Committee  classified  it  as  category  A,  which  may  be  used  in  foodstuffs,  and  established 
practical upper levels of 150 mg/kg in food and 10 mg/kg in beverages (CoE, 1992). 
JECFA (1998) evaluated isobutyl acetate as a flavouring agent and concluded that there was ‗no safety 
concern at current levels of intake‘, estimated to be 1 200-1 300 µg/person per day. This was because 
isobutyl acetate is a Cramer class I substance, and it can be predicted to be metabolised to innocuous 
products. Hence, exposures below a threshold of toxicological concern (TTC) of 1 800 µg/person per 
day (30 µg/kg b.w. per day) would not be expected to be of safety concern.   
OECD (2003) concluded that isobutyl acetate was currently of low priority for further work. 
WHO (2005) published a Concise International Chemical Assessment of isobutyl acetate, in which it 
was  concluded  that  there  was  insufficient  information,  including  an  absence  of  data  on  potential 
carcinogenicity, to enable derivation of tolerable intakes or concentrations. 
Isobutyl  acetate  is  approved  under  US  Food  and  Drug  Administration  (FDA),  Title  21  US  CFR 
citations  for  food  additives  permitted  for  direct  addition  to  food  for  human  consumption  (FDA, 
2011a). 
3.4.2.  Current evaluation 
3.4.2.1.  Expected impurities 
Technical grades of butyl acetates contain butyl alcohol as an impurity (Syracuse Research Corp., 
1979, as cited in WHO, 2005). This would not be of toxicological concern.  Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.4.2.2.  Reactivity and reaction products 
Isobutyl acetate may be hydrolysed to isobutanol and acetic acid or transesterified with lipids. Neither 
these nor any other reaction products of concern are expected when isobutyl acetate is transported as a 
previous cargo. 
3.4.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
There is little specific information on the absorption and disposition of isobutyl acetate. Given its 
physicochemical  characteristics  (log  Pow  2.3;  molecular  weight  116.2)  it  is  likely  to  be  readily 
absorbed from the gastrointestinal tract and distributed throughout the body. Isobutyl acetate partitions 
somewhat  more into tissues than blood, with tissue/blood ratios of 2-5 for most tissues, but approx 
20 for fat (Kaneko et al., 1994). Metabolism is by hydrolysis to acetic acid and isobutanol, most likely 
by carboxylesterases, which are found in a variety of tissues, including liver and gastrointestinal tract 
(Longland et al., 1977; Dahl et al., 1987). As the hydrolysis rate of n- and isobutyl acetate are similar 
(Dahl et al., 1987), it is likely that isobutyl acetate, by analogy with n-butyl acetate, will have a very 
short half-life in rats, as will its hydrolysis products, in the order of minutes (Teeguarden, 2005, as 
cited in ECHA online). Acetic acid is oxidised via the citric acid cycle to carbon dioxide and water. 
Isobutanol is rapidly metabolised by alcohol dehydrogenase (mainly class 1) to isobutyraldehyde and 
then  by  aldehyde  dehydrogenase  to  isobutyric  acid.  These  are  further  oxidised  to  carbon  dioxide 
(JECFA, 1999; WHO, 2005). Small amounts of isobutanol may be excreted unchanged or conjugated 
with glucuronic acid (WHO/IPCS, 1987; OECD, 2004b).  
Acute toxicity 
 Isobutyl acetate is of low acute oral toxicity, with LD50 values in rats and rabbits of the order of 
several grams per kg b.w. (Smyth et al., 1962; Munch, 1972, as cited in OECD, 2007). 
The irritant properties of isobutyl acetate to the skin have not been well characterised. In an early 
study (1962) it was reported not to be irritating to skin following uncovered application, whereas in a 
later study (1978), with limited information available, it was reported to be irritating when applied 
under  occlusion.  Isobutyl  acetate  caused  only  minor,  reversible  irritation  to  the  eyes  in  a  well 
conducted study.
18 Isobutyl acetate was tested as a 2 % preparation in petrolatum in human volunteers, 
in a 48-h closed-patch test. It was not irritating to skin in this test (Opdyke, 1978). This substance has 
not been classified as irritating to either skin or to eyes in the ECHA database.
19 
Subacute, subchronic and chronic toxicity studies 
No data are available on the repeat dose toxicity of isobutyl acetate.  
The toxicity of its major metabolite, isobutanol, has been investigated by the oral and inhalation route. 
Groups of 30 Crj: CD(SD) rats of both sexes received isobutanol (purity not stated) by oral gavage 
daily at doses of 0, 100, 316 and 1 000 mg/kg b.w. per day for 90 days. Effects were seen only at the 
highest dose. There was an early reduction in body weight in males and in food consumption in both 
sexes. Clinical signs, including hypoactivity, ataxia a nd salivation, were observed in males and 
females for the first few weeks. Serum potassium was reduced by 11 -15  % at week 4 or 5. No 
histopathological changes were observed. The NOAEL was 316 mg/kg b.w. per day (OECD, 2007).   
                                                       
18   European  Chemicals  Agency  (ECHA).  Isobutyl  acetate.  CAS  No  110-19-0.  Available  at: 
http://apps.echa.europa.eu/registered/data/dossiers/DISS-9d8c29e4-9219-2519-e044-00144f67d249/AGGR-ec680302-
4ca3-4ee8-a91e-723cf0590511_DISS-9d8c29e4-9219-2519-e044-00144f67d249.html#section_1.1   
19   European  Chemicals  Agency  (ECHA).  Summary  Of  Classification  and  Labelling.  Available  at:    http://clp-
inventory.echa.europa.eu/SummaryOfClassAndLabelling.aspx?SubstanceID=24499&HarmOnly=no?fc=true&lang=en; 
accessed 17/05/2012 Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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In an inhalation study, groups of 10 or 20 male and female Sprague-Dawley (SD) rats were exposed 
(whole body) to isobutanol (purity > 99 %) at concentrations of up to 2 500 ppm (ca. 7 700 mg/m³) 
(ca. 2 200 mg/kg b.w. per day) for 13 weeks, for 6 h per day, 5 days per week. At the highest 
concentration, there were slight increases in total erythrocyte count, haemoglobin, and haematocrit in 
females. There were no other toxicologically relevant treatment-related effects (Li et al., 1999).   
In a study of a structural analogue, isobutyl isobutyrate (purity ≥ 98 %) was administered by oral 
gavage at doses of 0, 10, 100, and 1 000 mg/kg b.w. per day to groups of 15 Wistar rats/sex daily for 
18 weeks. No treatment-related effects of toxicological significance were observed in any dose group.  
The NOAEL was 1 000 mg/kg b.w. per day, the highest dose tested.
18 
Genotoxicity 
Isobutyl acetate was negative in an Ames/Salmonella test with Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA1538, either with or without metabolic activation by hepatic post-
mitochondrial supernatant (S9 preparation) (OECD, 2007).   
Isobutanol,  a  major  metabolite,  had  no  effect  on  the  frequency  of  micronuclei  and  there  was  no 
evidence  of  clastogenicity  or  ‗impairment  of  chromosome  distribution‘  in  bone  marrow  of  mice 
administered doses of up to 2 000 mg/kg b.w. by oral gavage (OECD, 2007).   
Carcinogenicity 
No studies on the potential carcinogenicity of isobutyl acetate were identified. 
Developmental and reproductive toxicity 
No studies on the reproductive or developmental toxicity of isobutyl acetate could be identified. 
Studies  on  the  major  metabolite,  isobutanol,  following  inhalation  exposure,  are  available.  In  a 
2-generation  study  of  possible  effects  on  reproduction,  groups  of  30  male  and  30  female, 
Crl:CD(SD)IGS BR rats were exposed (whole body) to isobutanol (purity > 99 %) at concentrations of 
500  ppm,  1 008  ppm  and  2  522  ppm  (approx  0,  1  515,  3  030  or  7  575  mg/m
3)  for  6  h/day, 
7 days/week, for 10 weeks prior to mating. Females were exposed during gestation and lactation (from 
postnatal day 5). F1 pups were exposed directly from the day of weaning, on postnatal day 29, for 
10 weeks prior to mating. No treatment-related effects were observed on parents or offspring at any 
exposure  level.  The  no-observed-adverse-effect  concentration  (NOAEC)  was  7  600  mg/m
3  (ca. 
3 100 mg/kg b.w. per day), the highest concentration tested (WHO, 2005; OECD, 2007). 
In developmental toxicity studies, groups of pregnant Wistar rats (25 per dose group) and Himalayan 
rabbits (15 per group) were exposed by inhalation (whole body) to concentrations of 0, 500, 2 500 and 
10 000 mg/m
3 isobutanol for 6 hours per day during gestation (rats: GD6-GD15; rabbits: GD7-GD19). 
Body weight gain was slightly reduced in rabbits exposed to the highest concentration. No treatment-
related effects were observed in rat dams. There was no evidence for either developmental or fetotoxic 
effects in either species. The NOAEC for developmental toxicity was 10 000 mg/m
3 (ca. 4 100 and 
900 mg/kg b.w. per day for rats and rabbits, respectively), the highest concentration tested, in both rats 
and rabbits (OECD, 2007). 
3.4.2.4.  Allergenicity 
A maximization test was carried out on 28 volunteers with 2 % isobutyl acetate in petrolatum. No 
dermal sensitization was observed (Epstein, 1976, as cited in OECD, 2003). Isobutyl acetate did not 
cause sensitization in the guinea pig maximization test (OECD TG 406) (Huels, 1988, as cited in 
OECD, 2003 and WHO, 2005). 
Available data give no indication that isobutyl acetate is an allergen or an adjuvant.  Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.4.3.  Conclusions 
The CONTAM Panel notes that the name iso-butyl acetate is rarely used to refer to this substance. It is 
more normally referred to as isobutyl acetate. The preferred IUPAC name is 2-methylpropyl acetate. 
The  CONTAM  Panel  therefore  recommends  that  the  entry  for  the  substance  in  the  Annex  to 
Commission Directive 96/3/EC
5 to be amended to ‗Isobutyl acetate (2-methylpropyl acetate) (CAS No 
110-19-0)‘.  
The toxicity of acetate, one of the major metabolites of isobutyl acetate, was addressed in a previous 
Opinion of the CONTAM Panel, when it was considered that there would be no health concerns 
following  the  maximum  potential  carryover  into  edible  fats  and  oils  when  it  is  transported  as  a 
previous cargo (EFSA, 2012a). 
In its evaluation of previous cargoes in 1996, the SCF concluded that isobutanol, the other major 
metabolite,  was  ‗not  acceptable‘,  because  ‗limited  toxicological  data  indicates  a  suspicion  of 
carcinogenic concerns.‘ In a re-evaluation in 2003, the SCF maintained its previous opinion that this 
substance was not acceptable as a previous cargo because the Committee was aware of a number of 
issues that still needed clarification. The CONTAM Panel considered isobutanol as a previous cargo 
for edible fats and oils in 2009, and concluded that it was acceptable, based on the low level of toxicity 
observed in a more recent chronic toxicity study, as well as its volatility and ease of tank cleaning 
(EFSA, 2009b).  
Although the toxicological database for isobutyl acetate is limited, available data on this substance and 
on its hydrolysis products, acetic acid and isobutanol, suggest that isobutyl acetate is of relatively low 
systemic  toxicity.  It  is  not  genotoxic  or  allergenic.  There  are  no  reaction  products  or  impurities 
expected to be of toxicological concern.   
The CONTAM Panel therefore concludes that isobutyl acetate meets the criteria for acceptability as a 
previous cargo for edible fats and oils.  
3.5.  SEC-BUTYL ACETATE (CAS No 105-46-4)  
sec-Butyl acetate, s-butyl acetate, 2-butanol acetate or 1-methylpropyl acetate is a racemic mixture. It 
is a solvent commonly used in lacquers and enamels.  
The first method of production of sec-butyl acetate was the esterification of sec-butanol and acetic 
anhydride. sec-Butyl acetate is now prepared by direct esterification of acetic acid with secondary 
butyl alcohol at 100-110 °C in the presence of H2SO4 in a continuous process. sec-Butyl acetate is 
purified by distillation. 
3.5.1.  Previous evaluations 
The  SCF  evaluated  sec-butyl  acetate  in  1996  as  a  previous  cargo  for  edible  fats  and  oils  and 
considered this substance was acceptable, with the explanation  ‗Limited toxicological data but no 
indication of a hazard. Easily removed by tank cleaning.‘ (SCF, 1997a). In the 2003 SCF evaluation of 
acceptable previous cargoes, sec-butyl acetate was not further evaluated as it was already considered 
acceptable (SCF, 2003). 
WHO  (2005)  concluded  that  there  was  insufficient  information  on  sec-butyl  acetate  to  enable  a 
tolerable intake to be established. 
EFSA (2008a) evaluated sec-butyl acetate as a flavouring agent and concluded that it was a Cramer 
class  I  substance,  and  that  it  can  be  predicted  to  be  metabolised  to  innocuous  products.  Hence, 
exposures below a TTC of 1 800 µg/person per day (30 µg/kg b.w. per day) would not be expected to 
be of safety concern. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.5.2.  Current evaluation 
3.5.2.1.  Expected impurities 
sec-Butyl  acetate  is  synthesised  from  substances  which  are  not  expected  to contain  impurities  of 
concern. Also, the esterification step is not expected to result in impurities of concern. 
3.5.2.2.  Reactivity and reaction products 
sec-Butyl  acetate  may  be  hydrolysed  to  sec-butanol  and  acetic acid  or  transesterified  with  lipids. 
Neither these nor any other reaction products are expected to be of concern when sec-butyl acetate is 
transported as a previous cargo. 
3.5.2.3.  Toxicological profile 
There is very little specific information on the toxicity of sec-butyl acetate.  
Absorption, distribution, metabolism and excretion  
There is little specific information on the absorption and disposition of sec-butyl acetate. Given its 
physicochemical  characteristics  (log  Pow  1.51;  molecular  weight  116.2)  it  is  likely  to  be  readily 
absorbed  from  the  gastrointestinal  tract  and  distributed  throughout  the  body.  Metabolism  is  by 
hydrolysis to acetic acid and sec-butanol, most likely by carboxylesterases, which are found in a 
variety of tissues, including liver and gastrointestinal tract (Longland et al., 1977; Dahl et al., 1987).  
As the hydrolysis rates of n- and sec-butyl acetate are similar (Dahl et al., 1987), it is likely that sec-
butyl acetate, by analogy  with n-butyl acetate, will have a very short half-life in rats, as will its 
hydrolysis products, in the order of minutes (Teeguarden et al., 2005, as cited in ECHA online). Acetic 
acid  is  oxidised  via  the  citric  acid  cycle  to  carbon  dioxide  and  water.  sec-Butanol  is  rapidly 
metabolised by alcohol dehydrogenase (mainly class 1) to 2-butanone (methyl ethyl ketone), which is 
then either excreted unchanged in breath and urine or further metabolised to 3-hydroxy-2-butanone 
and 2,3-butanediol (WHO, 2005). There is evidence that sec-butyl acetate can also be hydroxylated by 
at  least  one  form  of  P450  to  yield  an  unstable  hemiketal  (2-hydroxy-2-acetoxybutane),  which  is 
cleaved non-hydrolytically to 2-butanone (Peng et al., 1995; WHO, 2005). 
The toxicity of methyl ethyl ketone (MEK) was reviewed in a previous opinion of the CONTAM 
Panel (EFSA, 2012a), when it was considered to meet the criteria for acceptability as a previous cargo 
for edible fats and oils. 
Acute toxicity 
sec-Butyl acetate is of low acute toxicity, with an oral LD50 value in rats of 3 200-6 400 mg/kg b.w. 
(WHO, 2005). 
Some information sheets suggest that sec-butyl acetate is mildly irritating to the eyes, but no specific 
information is provided (e.g. ICSC, 1994). In their review of 2005, WHO was unable to identify any 
data on the irritation or sensitization potential of sec-butyl acetate. sec-Butyl acetate has not been 
classified in the ECHA database for irritation to skin or eyes.
20 
Subacute, subchronic and chronic toxicity studies 
No data were identified on the repeat dose toxicity of sec -butyl acetate. Nor could any data be found 
for the effects of the major metabolite, sec-butanol. 
                                                       
20   European  Chemicals  Agency  (ECHA).  Summary  of  Classification  and  Labelling.  Available  at:  http://clp-
inventory.echa.europa.eu/SummaryOfClassAndLabelling.aspx?SubstanceID=120101&HarmOnly=no?DisclaimerAgr=Agr
ee&Index=105-46-4&ExecuteSearch=true&fc=true&lang=en (accessed 17/05/2012) Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
 
 
30  EFSA Journal 2012;10(12):2984 
Genotoxicity 
No information on the genotoxicity of sec-butyl acetate could be identified.   
The major metabolite sec-butanol has been tested for genotoxicity in a number of organisms in vitro. It 
did  not  cause  mutations in  Salmonella  typhimurium  strains TA98, TA100, TA1535, TA1537 and 
TA1538,  Escherichia  coli  WP2uvrA/pKM101,  not  did  it  cause  gene  conversion  in  yeast 
(Saccharomyces  cerevisiae  JD1),  either  with  or  without  metabolic  activation  by  hepatic 
postmitochondrial supernatant (S9 preparation) from Aroclor 1254-treated rats (Brooks et al., 1988, as 
cited in WHO, 2005).  
Carcinogenicity 
No  information  could  be found  on the  carcinogenicity  of  either  sec-butyl  acetate  or  of  its  major 
metabolite, sec-butanol. 
Developmental and reproductive toxicity 
No studies on the developmental or reproductive toxicity of sec-butyl acetate could be identified. The 
reproductive toxicity of its major metabolite, sec-butanol, has been evaluated in a two-generation 
study in rats. Groups of 30 male and 30 female Wistar rats received sec-butanol in their drinking water 
at concentrations of 0, 0.3, 1 and 3 % (equivalent to 0, 450, 1 500 and 4 500 mg/kg b.w. per day). The 
highest dose was reduced to 2 % (3 000 mg/kg b.w. per day) in the second generation, because of 
toxicity. In a developmental phase of the study, fetuses were examined on gestation day 20. Exposure 
to sec-butanol at 3 000 mg/kg b.w. per day resulted in a significant reduction in fetal weight and 
retardation of skeletal maturation. There were no skeletal or visceral malformations. There were no 
effects on fertility. The NOAEL for developmental toxicity was 1 500 mg/kg b.w. per day (Gallo et 
al., 1977, as cited in WHO, 2005).  
The  developmental  toxicity  of  sec-butanol  has  been  investigated  in  rats  following  exposure  by 
inhalation. Groups of 15 pregnant SD rats were exposed to sec-butanol by inhalation for 7 h/day from 
gestation day 1-19, at concentrations of 0, 3 500, 5 000 and 7 000 ppm (i.e. 0, 11 000, 15 000 or 
22 000  mg/m
3).  There  was  a  reduction  in  body  weight  gain  in  dams  in  all  groups  exposed  to 
sec-butanol. At the highest concentration, there was a reduction in the number of live fetuses and an 
increase in the number of resorptions. Fetal body weight was reduced at ≥15 000 mg/m
3. There was no 
increase  in  the  incidence  of  malformations.  The  NOAEC  for  developmental  toxicity  was 
11 000 mg/m
3 (ca. 5 200 mg/kg b.w. per day) (Nelson et al., 1989, as cited in WHO, 2005). 
3.5.2.4.  Allergenicity 
Available data give no indication that sec-butyl acetate is an allergen or an adjuvant.  
3.5.3.  Conclusion 
There are no data on repeated-dose toxicity of sec-butyl acetate. It is a Cramer class I substance, with a 
TTC of 1 800 µg/person per day. It is rapidly metabolised to acetate and sec-butanol, which can be 
further metabolised to MEK. The CONTAM Panel has previously evaluated acetic acid and MEK for 
their suitability as previous cargoes for edible fats and oils and concluded that they meet the criteria 
for acceptability (EFSA, 2012a).  Sec-Butanol is not genotoxic. The information available on sec-
butanol does not indicate any toxicological concern at the exposure levels that might occur from the 
transport of sec-butyl acetate as a previous cargo to edible fats and oils. sec-Butyl acetate is not 
allergenic. There are no reaction products or impurities of toxicological concern.   
The CONTAM Panel therefore concludes that sec-butyl acetate meets the criteria for acceptability as a 
previous cargo for edible fats and oils. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.6.  TERT-BUTYL ACETATE (CAS No 540-88-5)  
Tert-butyl acetate or t-butyl acetate is used as a solvent in the production of lacquers, enamels, inks, 
adhesives, thinners and industrial cleaners. 
Tert-butyl acetate is synthesised by reaction of acetic acid with isobutylene. 
3.6.1.  Previous evaluations 
The  SCF  evaluated  tert-butyl  acetate  in  1996  as  a  previous  cargo  for  edible  fats  and  oils  and 
considered this substance was acceptable, with the explanation  ‗Limited toxicological data but no 
indication of a hazard. Easily removed by tank cleaning.‘ (SCF, 1997a). In the 2003 SCF evaluation of 
acceptable previous cargoes, tert-butyl acetate was not further evaluated as it was already considered 
acceptable (SCF, 2003). 
WHO  (2005)  concluded  that  there  was  insufficient  information  on  tert-butyl  acetate  to  enable  a 
tolerable intake to be established. 
3.6.2.  Current evaluation 
3.6.2.1.  Expected impurities 
Available information does not suggest that there are any impurities of concern in tert-butyl acetate. 
3.6.2.2.  Reactivity and reaction products 
tert-Butyl acetate  may be  hydrolysed to tert-butanol and acetic acid or transesterified with lipids. 
Neither these nor any other reaction products are expected to be of concern when tert-butyl acetate is 
transported as a previous cargo. 
3.6.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
There is little specific information on the absorption and disposition of tert-butyl acetate. Given its 
physicochemical  characteristics  (log  Pow  1.64;  molecular  weight  116.2)  it  is  likely  to  be  readily 
absorbed from the gastrointestinal tract and distributed throughout the body. Elimination becomes 
saturated at  high  exposure  levels in experimental  animals.  Saturation  of  elimination  of  the  major 
metabolite,  tert-butanol,  persists  for  longer  than  for  that  of  the  parent  compound  (WHO,  2005).  
Metabolism is by hydrolysis to acetic acid and tert-butanol, most likely by carboxylesterases, which 
are found in a variety of tissues, including liver and gastrointestinal tract (Longland et al., 1977; Dahl 
et  al.,  1987).  The  hydrolysis  rate  is  somewhat  slower  than  that  of  n-butyl  acetate,  most  likely  a 
consequence of steric hindrance (Dahl et al., 1987). Hydrolysis by rat or human blood ex vivo was up 
to two orders of magnitude slower than that of n-butyl acetate (WHO, 2005). A second major route of 
metabolism involves hydroxylation of the tertiary-butyl moiety to yield 2-hydroxymethylisopropyl 
acetate. Hydroxylation of the tert-butyl side chain appears to predominate at lower exposures whilst 
hydrolysis predominates at higher exposures. Oxidation of the acetate side chain can also occur to a 
minor extent (Cruzan and Kirkpatrick, 2006). tert-Butanol is not a substrate for alcohol dehydrogenase 
and  is  metabolised  only  slowly,  either  by  glucuronide  conjugation  of  the  hydroxyl  group,  with 
excretion in the urine, or oxidation of one or more of the alkyl substituents, which can be catalysed by 
P450 enzymes. The oxidation products include acetone, which is excreted in the urine and expired air, 
either unchanged or following metabolism to carbon dioxide (Cederbaum et al., 1983; WHO/IPCS, 
1987). Acetic acid is oxidised via the citric acid cycle to carbon dioxide and water. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Acute toxicity 
tert-Butyl acetate is of low acute toxicity by the oral route, with reported LD50 values in rats from 
3 300-4 500 mg/kg b.w. (WHO, 2005). 
tert-Butyl acetate is slightly irritating to the skin and slightly irritating to the eyes. The effects are 
readily reversible. tert-Butyl acetate has not been classified in the ECHA database for irritation to skin 
or eyes.  
Subacute, subchronic and chronic toxicity studies 
Groups of 30 male and 30 female CD-1 mice were exposed by inhalation (whole-body) to tert-butyl 
acetate (>  99 % purity) at target concentrations of 0, 100, 400 and 1 600 ppm (actual concentrations 
were 0, 101, 400 and 1 698 ppm) for 6 h/day, 7 days/week for 90 days. Mid- and high-dose animals 
showed transient clinical signs, hyperactivity, excessive grooming, impaired equilibrium and laboured 
respiration (at 1 600 ppm). Both males and females in the high-dose group showed a slight increase in 
liver weights. Circulating T4 levels were statistically significantly reduced in the 1 600 ppm group 
males. The NOAEC in this study was 100 ppm (ca. 240 mg/kg b.w. per day).
21 
Groups of 10 male and 10 female SD rats were  exposed by inhalation (whole-body) to tert-butyl 
acetate (> 99 % purity) at target concentrations of 0, 100, 400 and 1  600 ppm (actual concentrations 
were 0, 101, 400 and 1 600 ppm) for 6 h/day, 7 days/week for 13 weeks. Absolute and relative adrenal 
gland and liver weights were increased in both sexes at the highest dose. Relative kidney weights were 
increased in a dose-dependent manner in all treated groups of males, and was slightly increased in 
high-dose  females.  Renal  histopathology  revealed  an  increased  incidence  of  hyaline  droplets 
(primarily  alpha-2u-globulin  accumulation),  100  %  at  the  lowest  dose  and  tubular  basophilia 
(increasing with dose) in males of all treated groups . No such effects were seen in females .
21 The 
NOAEC was 400 ppm (ca. 780 mg/kg b.w. per day), on the basis that the renal effects observed in 
males  were  a  consequence  of  accumulation  of  alpha-2u-globulin,  and  therefore  not  relevant  to 
humans. Exposure of rats to tert-butanol, a major metabolite of tert-butyl acetate, via the drinking 
water also resulted in a male-specific increase in the incidence of hyaline droplets in the kidney (NTP, 
1995). 
The chronic toxicity of tert-butanol administered in drinking water has been investigated in rats and 
mice (NTP, 1995). Groups of 60 male and 60 female B6C3F1 mice received drinking water with 
concentrations of tert-butanol of 0, 5.0, 10 and 20 mg/ml, corresponding to received doses of 0, 540, 
1 040 and 2 070 mg/kg b.w. in males and 0, 510, 1 020 and 2 110 mg/kg b.w. in females, for 2 years. 
Survival  in  the  high-dose  group  was  reduced.  Final  body  weight  of  high-dose  females  was 
significantly lower than in controls. The incidence of follicular cell hyperplasia of the thyroid gland 
was statistically significantly increased in all male dose groups, but there was little dependency on 
dose (5/60 [13 %] in controls; 18/59 [26 %] at 5 mg/mL; 15/59 [25 %] at 10 mg/mL; 18/57 [32 %] at 
20 mg/mL). The incidence of this lesion was statistically significantly and dose-dependently increased 
in mid- and high-dose females. The incidence of chronic inflammation of the bladder was statistically 
significantly increased in high dose males and females, and there was also an increase in the incidence 
of transitional epithelial hyperplasia in the high-dose males. The NOAEL is this study was 510 mg/kg 
b.w. per day, based on an increased incidence of follicular cell hyperplasia of the thyroid gland in 
females at the LOAEL, and assuming that the changes observed in low-dose males were spurious, as 
reflected by the absence of any difference in incidence between the low- and mid-dose groups. 
Groups of 60 male and 60 female Fischer F334/N rats received drinking water with concentrations of 
tert-butanol in males of 0, 1.25, 2.5 and 5.0 mg/mL, corresponding to received doses of 0, 90, 200 and 
420 mg/kg b.w. and in females of 0, 2.5, 5.0 and 10 mg/mL, corresponding to received doses of 0, 
                                                       
21   European  Chemicals  Agency  (ECHA).  tert-Butyl  acetate.  CAS  No  540-88-5.  Available  at: 
http://apps.echa.europa.eu/registered/data/dossiers/DISS-9d9b886e-dba3-571e-e044-00144f67d249/DISS-9d9b886e-dba3-
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180, 330 and 650 mg/kg b.w., for 2 years. Ten rats per group were evaluated after 15 months. Final 
body  weights  were  reduced  in  high-dose  males  and  females,  as  was  survival.  Urine  volume  was 
reduced in mid- and high-dose females after 15 months. At the interim time point (15 months), relative 
kidney weights were increased in mid- and high-dose males and in all female dose groups. At 2 years, 
in males there was increased mineralisation of the kidney and renal tubule hyperplasia, which was 
statistically significant in the high-dose group. The severity and incidence of nephropathy and the 
incidence of transitional cell hyperplasia in the kidney were increased at the high dose in both males 
and females (NTP, 1995). The NOAEL for this study was 200 mg/kg b.w. per day in males and 330 
mg/kg b.w. per day in females, if one considers that effects seen at lower doses in males were due to 
accumulation of alpha-2u-globulin and hence not relevant to humans. 
Genotoxicity 
tert-Butyl acetate was negative in tests for mutagenicity with Salmonella typhimurium strains TA98, 
TA100,  TA102,  TA1535,  and  TA1537  and  with  E.  coli  WP2uvrA/pKM101,  with  and  without 
metabolic activation by hepatic postmitochondrial supernatant (S9 preparation) from Aroclor 1254-
treated  rats  (McGregor  et  al.,  2005).  tert-Butyl  acetate  was  negative  in  a  test  for  induction  of 
chromosomal aberrations in isolated human lymphocytes at concentrations up to 10 mM, with and 
without metabolic activation by hepatic postmitochondrial supernatant (S9 preparation) from Aroclor 
1254-treated rats (WHO, 2005). Groups of male and female SD rats were exposed to tert-butyl acetate, 
at concentrations of 480, 1 900 and 7 700 mg/m
3 for 6 hours and then killed 24 h or 48 h later. There 
was  no  statistically  significant  effect  on  the  frequency  of  micronucleated  immature  erythrocytes 
(WHO, 2005). 
Carcinogenicity 
tert-Butyl acetate has not been tested for its potential carcinogenicity.  
One of its major metabolites, tert-butanol has been evaluated for carcinogenicity in rats and mice 
(NTP, 1995). Details of these studies have been described above. In mice exposed to tert-butanol for 
2 years, the only tissue in which there was any increase in the incidence of tumours, compared to the 
controls, was the thyroid gland of females, in which there was an increase in the incidence of follicular 
cell adenomas in the high-dose group, 2 110 mg/kg b.w. per day. In rats exposed to tert-butanol for 
2 years, there was no effect of treatment on tumour incidence in females, and in males the only tissue 
in which there was an increase in the incidence of tumours compared to the controls was the kidney. 
There was some indication for an increase in the incidence of renal tubular adenomas, although this 
reached statistical significance only in the mid-dose group, 200 mg/kg b.w. per day. There was also 
some evidence for a marginal increase in the incidence of renal tubular carcinomas (NTP, 1995). 
There is evidence that the renal tumours observed only in male rats were secondary to interaction with 
alpha-2u-globulin,  followed  by  its  accumulation  in  proximal  tubular  cells.  In  the  absence  of  any 
human counterpart to this protein at levels sufficient to support a toxicologically relevant interaction, 
this  carcinogenic  response  is  considered  not  relevant  to  humans  (Cruzan  and  Kirkpatrick,  2006; 
TERA,  2009).  The  follicular  cell  adenomas  in  female  mice  were  accompanied  by  follicular  cell 
hyperplasia. In shorter term studies there was evidence for effects on the liver, consistent with enzyme 
induction, and reduced levels of circulating T4, suggesting that the adenomas in the thyroid may have 
been secondary to hepatic enzyme induction with increased clearance of thyroid hormones (Cruzan 
and Kirkpatrick, 2006). 
Developmental and reproductive toxicity 
In a 1-generation study of effects on reproduction, groups of 10 male and 10 female, SD rats were 
exposed  (whole  body)  to tert-butyl  acetate  (purity  >  99  %) at concentrations of  0, 100,  400  and 
1 600 ppm for 6 h/day, 7 days/week, for 10 weeks prior to mating. Females were exposed during 
gestation and lactation (from postnatal day 5). F1 pups were exposed directly from the day of weaning, Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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on postnatal day (PND) 22, for 5 days. Body weight and body weight gain were reduced in high dose 
F0 males. The only effect observed in F1 pups was a slight, transient reduction in mean body weight 
gain in both males and females in the high dose group exposed on PND 22-26. The NOAEC for 
reproductive and neonatal toxicity was 1 600 ppm, the highest concentration tested.
21 
The developmental toxicity of tert-butyl acetate was investigated in rats. Groups of 22 pregnant SD 
rats were administered tert-butyl acetate (purity > 99 %) in corn oil by gavage from GD6-19 at doses 
of 0, 400, 800, 1 000 and 1 600 mg/kg b.w. per day. tert-Butyl acetate was toxic to dams at the highest 
dose,  with  increases  in  the  incidences  of  clinical  signs  (reflecting  mainly  central  nervous  system 
(CNS) depression) and possibly mortality (2 animals died from unexplained causes), reduced body 
weight gain and food intake, increases in the weights of adrenal glands (absolute and relative) and 
liver (relative) and a decrease in absolute thymus weight. There was a statistically significant increase 
in the number of skeletal variations in offspring in the mid- and high-groups. Variations were typical 
of those occurring with embryo/fetotoxicity, particularly reduced ossification. There was a decrease in 
fetal body weight in the high dose group, and increased incidences of supernumerary ribs and a delay 
in fetal ossification in the mid- and high-dose groups. tert-Butyl acetate was not teratogenic in this 
study. The NOAEL for maternal toxicity was 800 mg/kg b.w. per day. The NOAEL for developmental 
toxicity was 400 mg/kg b.w. per day (Yang et al., 2007). 
In a further study by the same laboratory to clarify the maternal toxicity of tert-butyl acetate, groups of 
22 pregnant SD rats were administered tert-butyl acetate (purity > 99 %) in corn oil by gavage from 
GD6-19 at doses of 0, 400, 800, 1 000 and 1 600 mg/kg b.w. per day. One dam in the high dose-group 
died. Clinical signs indicative of effects on the CNS were observed at doses ≥ 800 mg/kg b.w. per day. 
Reductions in mean body weight, body weight gain and/or food consumption were also observed in 
these dose groups. The NOAEL for maternal toxicity was 400 mg/kg b.w. per day. Fetal body weight 
was statistically significantly reduced in the mid- and high-dose groups.
21 
The overall NOAEL for maternal toxicity was 400 mg/kg b.w. per day, based on clinical signs and 
decreased  body  weight  gain  at  800  mg/kg  b.w.  per  day  and  above.  Fetotoxicity  appeared  to  be 
secondary to maternal toxicity, with an overall NOAEL of 400 mg/kg b.w. per day. 
3.6.2.4.  Allergenicity 
In  the  Buehler  test  with  guinea  pigs,  no  indications  of  sensitization  were  observed  (Anonymous, 
1997a,  as  cited  in  ECHA,  online).  Available  data  give  no  indication  that  tert-butyl  acetate  is  an 
allergen or an adjuvant.  
3.6.3.  Conclusion 
The toxicological database on tert-butyl acetate is somewhat limited. The available data on tert-butyl 
acetate and on acetate and tert-butanol, its major metabolites, do not give rise to concerns regarding 
systemic toxicity, developmental toxicity or genotoxicity. Any carcinogenic risk would likely be from 
a non-genotoxic mode of action and would not be of concern at the levels of exposure that might occur 
from the use of tert-butyl acetate as a previous cargo for edible fats and oils. tert-Butyl acetate is not 
allergenic. There are no reaction products or impurities of toxicological concern.   
The CONTAM Panel therefore concludes that tert-butyl acetate meets the criteria for acceptability as a 
previous cargo for edible fats and oils. 
3.7.  n-BUTYL ACETATE (CAS No 123-86-4)  
n-Butyl acetate, often termed butyl acetate, is a liquid boiling at 127 °C. It is widely used as a solvent 
in lacquers, adhesives, cleaning agents and pharmaceutical solvents. 
It is prepared by esterification of n-butyl alcohol with acetic acid (with sulphuric acid as catalyst) or 
acetic anhydride. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.7.1.  Previous evaluations 
The SCF evaluated n-butyl acetate as a previous cargo in 1996 and considered it acceptable (SCF, 
1997a). This conclusion was based on the fact that n-butyl acetate had a temporary ADI of 0-6 mg/kg 
b.w. and was temporarily acceptable as an extraction solvent. A temporary ADI was established by the 
SCF in 1981, based on the results of short term studies. The Committee required information on the 
levels of residues in extracted food by 1983.  In the 2003 SCF evaluation of acceptable previous 
cargoes,  n-butyl  acetate  was  not  further  evaluated  as  it  was  already  considered  acceptable  (SCF, 
2003).  
n-Butyl acetate was given GRAS status by FEMA in 1965. 
The Council of the European Communities approved the use of n-butyl acetate as an extraction solvent 
for food, and it was included in Part 1 of the Annex to Directive 88/344/EEC.
22 
The SCF issued its second report on extraction solvents in 1992. No further information on levels in 
food was  available, so the SCF extended the temporary ADI of 0 -6 mg/kg b.w. The Committee 
reiterated its request for analytical data on residues in food or for other reassurance that the ADI would 
not be exceeded (SCF, 1992b). 
The Expert Committee on Flavourings of the Council of Europe classified n-butyl acetate as category 
A, i.e. substances which may be used in foodstuffs (CoE, 1992). 
JECFA (1998) evaluated n-butyl acetate as a flavouring agent and concluded that there was ‗no safety 
concern at current levels of intake‘, estimated to be 170-1 200 µg/person per day. This was because n-
butyl acetate is a Cramer class I substance, and can be predicted to be metabolised to innocuous 
products. Hence, exposures below a TTC of 1 800 µg/person per day (30 µg/kg b.w. per day) would 
not be expected to be of safety concern.   
n-Butyl  acetate  is  included  in  the  EU  register  of  flavouring  substances  used in  or  on  foodstuffs, 
according to Commission Decision 2009/163/EC, amending Decision 1999/217/EC, with  FL No. 
09.004, and a note that no further evaluation is needed.
23 
n-Butyl acetate is on the approved list of substances
24 for making food contact materials, without limit 
(other than the generic limit of 60 mg/kg food). 
n-Butyl  acetate  has  been  evaluated  under  the  OECD  Screening  Information  Sata  Set  ( SIDS) 
programme on High Production Volume (HPV) chemicals (OECD, 2001a ). OECD concluded that 
n-butyl acetate was currently of low priority for further work. 
n-Butyl acetate  is approved under US Food and Drug Administration   (FDA), Title  21  US CFR 
citations for  resinous and polymeric coatings for polyolefin films , without any specific limitations  
(FDA, 2011b). 
3.7.2.  Current evaluation 
3.7.2.1.  Expected impurities 
n-Butyl acetate is synthesised from substances, the impurities of which are not expected to be of 
concern. Also the esterification step is not expected to result in impurities of concern. 
                                                       
22   Council Directive of 13 June 1988 on the approximation of the laws of the Member States on extraction solvents used in 
the production of foodstuffs and food ingredients. OJ L 157, 24.6.1988, p. 28. 
23   Database  of  Flavouring  Substances.  DG  Health  and  Consumers.  European  Commission.  Available  at: 
http://ec.europa.eu/food/food/fAEF/flavouring/index_en.htm (accessed 18/05/2012). 
24   Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and articles intended to come into 
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3.7.2.2.  Reactivity and reaction products 
n-Butyl acetate may be hydrolysed to n-butanol and acetic acid or transesterified with lipids. Neither 
these nor any other reaction products are expected to be of concern when n-butyl acetate is transported 
as a previous cargo. 
3.7.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
There is little specific information on the absorption and disposition of n-butyl acetate following oral 
administration. Given its physicochemical characteristics (log Pow 2.3; molecular weight 116.2) it is 
likely  to  be  readily  absorbed  from  the  gastrointestinal  tract  and  distributed  throughout  the  body. 
n-Butyl acetate partitions more readily into tissues than blood, with tissue/blood ratios of 2-3 for most 
tissues, but 17 for fat (Kaneko et al., 1994). Metabolism is by hydrolysis to acetic acid and n-butanol, 
most  likely  by  carboxylesterases,  which  are  found  in  a  variety  of  tissues,  including  liver  and 
gastrointestinal tract (Longland et al., 1977; Dahl et al., 1987). Hydrolysis half-lives on addition to 
whole blood from female rats and male human volunteers were 12 min and 4 min, respectively. As 
anticipated from its rapid hydrolysis, n-butyl acetate has a very short half-life in rats, as does its 
hydrolysis products, in the order of minutes (Teeguarden et al., 2005, as cited in ECHA online). Acetic 
acid is oxidised via the citric acid cycle to carbon dioxide and water. n-Butanol is rapidly metabolised 
by alcohol dehydrogenase (mainly class 1) to butyraldehyde and then by aldehyde dehydrogenase to 
butyric acid. These are further oxidised to carbon dioxide. A small amount of n-butanol is excreted as 
the  glucuronide  conjugate  (WHO/IPCS,  1987;  WHO,  2005).  Several  studies  on  n-butyl  acetate 
administered by inhalation or by intraperitoneal injection have confirmed the rapid elimination of this 
compound, with a half-life in rats of the order of minutes 
25 (WHO, 2005). There is evidence that the 
microsomal P450 system, in particular CYP2E1, may play a role in the metabolism of n -butyl acetate 
(Peng et al., 1995). Barton et al. (2000) have developed a pharmacokinetic model for the disposition of 
n-butyl acetate and its major metabolites following inhalation exposure. 
Acute toxicity 
n-Butyl acetate is of low acute toxicity by the oral route, with LD50 values of approx. 3-13 g/kg b.w. in 
mice,  rats,  guinea  pigs  and  rabbits  (OECD,  2001a; WHO,  2005).  Rats  appear  to  be  slightly  less 
sensitive than some other species.  
n-Butyl acetate is not irritating to the skin and at worst only slightly irritating to the eyes (OECD, 
2001a; WHO, 2005). n-Butyl acetate has not been classified in the ECHA database for irritation to 
skin or eyes.
26 
Subacute, subchronic and chronic toxicity studies 
No repeat dose toxicity studies on n-butyl acetate administered by the oral route could be identified. 
Groups of 15 male and 15 female SD rats were exposed by inhalation (whole body) to n-butyl acetate 
(purity > 99  %) for  6 h/day, 5 days/week   for 13 weeks, at concentrations of 0, 500, 1   500 and 
3 000 ppm (to provide target concentrations of  0, 2  400, 7  200  and 14  000 mg/m
3).  Groups  of 
5 animals/sex were killed after 30 days for interim assessment. Exposure to n-butyl acetate had no 
effects on mortality. Animals in the high-dose group, and minimally in the mid-dose group, showed 
minor  clinical  signs  indicative  of  sedation.  Males  and  females  in  the  mid-  and  high-dose  groups 
                                                       
25   European  Chemicals  Agency  (ECHA).  n-Butyl  acetate.  CAS  No  123-86-4.  Available  at: 
http://apps.echa.europa.eu/registered/data/dossiers/DISS-9d933481-e0e5-623f-e044-00144f67d249/DISS-9d933481-e0e5-
623f-e044-00144f67d249_DISS-9d933481-e0e5-623f-e044-00144f67d249.html  
26   European  Chemicals  Agency  (ECHA).  Summary  of  Classifications  and  Labelling.  Available  at:  http://clp-
inventory.echa.europa.eu/SummaryOfClassAndLabelling.aspx?SubstanceID=56478&HarmOnly=no?DisclaimerAgr=Agre
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showed a statistically significant reduction in body weight, body weight gain and food intake. Changes 
in the weight of a number of organs were observed in mid and/or high-dose males and/or females and 
included decreased liver and kidney weights, decreased spleen weights, increased adrenal and lung 
weights, decreased brain weights and increased relative testes weight. The only lesions observed, 
either macroscopically or histopathologically, were in the stomach and nasal passages, indicative of 
local irritation and degeneration, apparent in both mid- and high-dose groups. This may be due to local 
formation of n-butanol and acetic acid. The NOAEC was 2 400 mg/m
3 (ca. 700 mg/kg b.w. per day) 
(David et al., 2001). 
Studies  of  rats  exposed  to  n-butyl  acetate  by  inhalation  (whole  body)  at  concentrations  of  up 
3 000 ppm showed no evidence of neurotoxicity, as assessed by a functional observational battery, 
motor activity, neurohistopathology and schedule-controlled operant behaviour (WHO, 2005).  
Genotoxicity 
n-Butyl acetate has been tested relatively extensively for genotoxicity in vitro. n-Butyl acetate was 
negative in an Ames/Salmonella test with Salmonella typhimurium strains TA92, TA94, TA97, TA98, 
TA100,  TA1535,  TA1537  and  TA1538  with  and  without  metabolic  activation  by  hepatic 
postmitochondrial supernatant (S9 preparation) from rats and/or hamsters treated with Aroclor 1254 
(OECD,  2001a;  WHO,  2005;  CCRIS,  2009).  n-Butyl  acetate  was  also  negative  in  tests  for 
genotoxicity  using  Escherichia  coli  strain  WP2  uvrA,  with  and  without  metabolic  activation  by 
hepatic  postmitochondrial  supernatant  (S9  preparation)  from  rats  treated  with  a  combination  of 
phenobarbital and beta-naphthoflavone, Saccharomyces cerevisiae strain D61.M without metabolic 
activation, in a test for mitotic aneuploidy, and in Chinese hamster lung fibroblasts, without metabolic 
activation, in a test for clastogenicity (OECD, 2001a; WHO, 2005; CCRIS, 2009).  
n-Butanol, a major metabolite of n-butyl acetate, was negative in tests for mutagenicity in Salmonella 
typhimurium strains TA98, TA100, TA102, UTH8413, and UTH8414, with and without metabolic 
activation with hepatic postmitochondrial supernatant (S9 preparation) from Aroclor 1254 treated rats 
(CCRIS, 1996), clastogenicity (sister chromatid exchanges) in Chinese hamster ovary (CHO) cells and 
did not produce any effects on the chromosomes of cultured human lymphocytes (WHO/IPCS, 1987). 
n-Butanol was also negative in a bone marrow micronucleus test in NMRI mice at doses of up to 
2 000 mg/kg b.w. 
25 (OECD, 2001a). 
Carcinogenicity 
n-Butyl acetate has not been tested for its carcinogenic potential.  
According to WHO/IPCS (1987), two long-term studies of n-butanol in rats have been recorded by the 
US National Cancer Institute, but these were not adequate for assessment of the carcinogenicity of the 
substance.  
Developmental and reproductive toxicity 
The  reproductive  toxicity  of  n-butyl  acetate  has  been  investigated  in  rats  following  exposure  by 
inhalation. Groups of Crl:CD(SD) rats (30/sex/group) were exposed (whole body) to n-butyl acetate 
(purity > 99 %), by inhalation for 6 h/day, 7 days per week, for at least 70 days prior to mating. Target 
concentrations were 750, 1 500 and 2 000 ppm for all three generations. Exposure of the F0 and 
F1 males continued throughout mating, until termination. Exposure of dams continued until GD 20 
and recommenced on lactation day 4. During lactation days 1-4, dams were administered n-butyl 
acetate by oral gavage at doses of 0, 1 125, 2 250 and 3 000 mg/kg per day (as 3 equal doses, 2 hours 
apart). F1 animals were exposed by inhalation from PND 22. Adults in the F0, F1 and F2 generations 
all showed signs of systemic toxicity in the mid- and high-dose groups, with reduced body weight, 
body weight gain and food consumption. Site of contact degeneration of the olfactory epithelium was 
apparent on exposure to ≥ 750 ppm. The NOAEC for systemic toxicity in adult rats was 750 ppm. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Exposure to n-butyl acetate had no effect on reproduction. Pups born to dams in the mid- and high-
dose groups had lower mean body weights and body weight gains and some delay in attainment of 
post-weaning developmental landmarks, secondary to the reduction in body weights. The NOAEC for 
effects on fertility was 2 000 ppm (ca. 4 000 mg/kg b.w. per day), the highest concentration tested, 
whilst that for developmental toxicity was 750 ppm (ca. 1 500 mg/kg b.w. per day).
25 
Groups of pregnant SD rats (19-21 rats/dose group) were exposed (whole body) to n-butyl acetate by 
inhalation at concentrations of 0, 500, 1 000, 2 000 and 3 000 ppm 6 h/day from day 6 to 20 of 
gestation.  Maternal  toxicity  was  evident  at  concentrations  of  ≥  1  000  ppm,  with  reduced  food 
consumption, and at ≥ 2 000 ppm there was a reduction in body weight gain. Exposure of dams to 
n-butyl acetate had no effects on development other than to cause a reduction in fetal weight at the 
highest  dose,  which  was  maternally  toxic.  The  NOAEC  for  maternal  toxicity  was  500  ppm  (ca. 
1 000 mg/kg  b.w.  per  day),  whilst  the  NOAEC  for  developmental  toxicity  was  2  000  ppm  (ca. 
4 000 mg/kg b.w. per day).
25 
The developmental toxicity of n-butyl acetate has also been studied in rats and rabbits following 
inhalation exposure at a single high concentration. Groups of female SD rats (37-43 per group) were 
exposed (whole body) to 1 500 ppm (7 200 mg/m
3) n-butyl acetate (purity > 99 %) for 7 h/day on GD 
7-16,  GD  1-16,  or  for  5  days/week  for  3  weeks  prior  to  mating  and  then  on  GD  1-16.  Food 
consumption of dams was decreased in all exposed groups, with reduced body weight gain noted in 
the groups exposed for longer. Relative kidney and lung weights were increased in all groups. There 
were no effects on mating or reproductive performance. Fetal body weights and crown-rump length 
were  reduced  in  all  exposed  groups.  There  was  no  treatment-related  effect  on  the  incidence  of 
malformations (OECD, 2001a; WHO, 2005). The NOAEC for teratogenicity was 1 500 ppm, the only 
concentration tested (ca. 3 400 and 800 mg/kg b.w. per day for rats and rabbits, respectively). 
Groups of 30 artificially inseminated New Zealand White rabbits (21-25 pregnant animals/group at 
termination) were exposed (whole body) to 1 500 ppm (7 200 mg/m
3, ca. 800 mg/kg b.w. per day) 
n-butyl acetate (purity > 99 %) by inhalation for 7 h/day on GD 7-19 or GD 1-19. There was no effect 
on either maternal or fetal body weight. There was no effect of exposure on reproductive performance. 
There was an increase in the incidences of misaligned sternebrae, retinal folds and clear gall bladders 
in fetuses of dams exposed from GD1-19. There were no major malformations (OECD, 2001a). 
3.7.2.4.  Allergenicity 
n-Butyl  acetate  is  mildly  to  moderately  irritating  (OECD,  2001a;  WHO,  2005).  n-Butyl  acetate 
showed no sensitization potential in the guinea pig maximization test and in a mouse ear swelling test 
(Gad et al., 1986). Similarly negative results with regard to dermal sensitization were obtained in 
humans using a repeated-insult patch test (Roed-Peterson, 1980; Eiermann et al., 1982).  
The  available  data  give  no  indication  that  n-butyl  acetate  is  an  allergen  or  an  adjuvant  at 
concentrations expected from its use as a previous cargo. 
3.7.3.  Conclusion 
The SCF established a temporary ADI of 0-6 mg/kg for n-butyl acetate, on the basis of limited data. 
The toxicological database has several data gaps (no repeat dose studies by the oral route, no studies of 
chronic toxicity or carcinogenicity). However, there were sufficient data on its major metabolites, 
acetate and n-butanol, for the CONTAM Panel to conclude previously that these are not of concern, 
when used as previous cargoes. n-Butyl acetate is not genotoxic. The CONTAM Panel considers that 
the available information on the acute effects of n-butyl acetate and on its subchronic, reproductive 
and developmental toxicity following exposure by the inhalation route, together with information on 
its major metabolites, was sufficient to conclude that the risk from short-term exposure to n-butyl 
acetate when used as a previous cargo would not give rise to any toxicological concern. There are no 
concerns regarding the allergenicity of n-butyl acetate. There are no reaction products or impurities of 
toxicological concern.   Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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The CONTAM Panel therefore concludes that n-butyl acetate meets the criteria for acceptability as a 
previous cargo for edible fats and oils. 
3.8.  PROPYLENE TETRAMER (CAS No 6842-15-5)  
In  the  catalogues  available  on  the  internet,  propylene  tetramer  has  a  variety  of  descriptions. The 
majority of the sources indicate a linear dodecane with a terminal double bond, which, however, 
cannot be obtained from propylene. Often dodeca-1,4,7,10-tetraene is given as a synonym, but this is 
not consistent with the name 1-dodecene and again cannot be obtained from propylene. As it is made 
by condensation of propylene, it is expected to have the structure of a tetramethyl octane, possibly 
with a terminal double bond depending on the method of production.  
According  to  the  Substance  Registry  Service  of  the  US-EPA,  the  systematic  name  is  1-propene, 
tetramer with a molecular formula of (C3H6)4. 
According to the information provided to EFSA (...) ‗the material which is shipped seems to be a 
blend of isomers of which about 65 % are 1-propene (tetramer). Another Material Safety Data Sheet 
(MSDS) lists a detailed breakdown of the isomers which are present: > 71 % C12 alkene, < 22 % 
C10/C11 olefins and < 15 % C13-C15 alkenes with a total of > 98 % olefins‘ (see documentation 
provided to EFSA). 
Propylene tetramer is described as a liquid with a melting point of -31 °C. 
Propylene tetramer is produced by polymerizing propylene with a phosphate catalyst. This yields a 
broad mixture from which the tetramer is isolated by fractionation.  
As condensation of propylene cannot produce hydrocarbons with 10, 11, 13 or 14 carbon atoms, either 
highly impure propylene is used or addition reactions interfere. It is concluded that propylene tetramer 
is a complex and probably variable mixture. 
Propylene tetramer is used as a starting substance to make dodecyl phenol, tridecyl alcohol, branched 
dodecylbenzene  sulphonic  acids  used  as  surfactants,  emulsifiers  and  to  produce  plasticizers  or 
lubricating oil additives.  
3.8.1.  Previous evaluations 
The SCF evaluated propylene tetramer as a previous cargo in 1996 and considered it acceptable (SCF, 
1997a). This conclusion was based on the fact that some toxicological data were available. It was not 
of structural concern. Subject to the examination of ongoing genotoxicity studies this substance was 
acceptable as a previous cargo. Low residue levels were expected, as it is easily removed by tank 
cleaning and it will easily be removed from vegetable oil if it is refined. In the 2003 SCF evaluation of 
acceptable previous cargoes, propylene tetramer was not further evaluated as it was already considered 
acceptable, and no reference was made to the results of ongoing genotoxicity studies (SCF, 2003).  
Propylene tetramer is approved under US Food and Drug Administration (FDA), Title 21 US CFR 
citations for indirect food additives: ‗paper and paperboard components‘, and ‗adjuvants, production 
aids, and sanitizers‘ (FDA, 2011c, d). 
Within the OECD SIDS programme on HPV chemicals, it was concluded that for olefins, amongst 
which are those comprising propylene tetramer, ‗the weight of evidence indicates alpha and internal 
olefins with carbon numbers between C6 and C24 have a similar and low level of mammalian toxicity, 
and the toxicity profile is not affected by changes in the location of the double bond or the addition of 
branching to the structure‘. It was further concluded that these compounds are currently of low priority 
for further work (OECD, 2001b, 2004c).   Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.8.2.  Current evaluation 
3.8.2.1.  Expected impurities 
Propylene tetramer is a crude mixture largely of olefins (see above).  
3.8.2.2.  Reactivity and reaction products 
Propylene tetramer is not expected to react with edible fats and oils. 
3.8.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
There  is little specific  information on the  absorption  and  disposition  of  propylene  tetramer  or its 
components  following  oral  administration.  Given  the  physicochemical  characteristics  of  the  main 
olefins present (average molecular weight 168 to 169; highly lipid soluble), they are likely to be 
absorbed from the gastrointestinal tract to a reasonable extent and distributed throughout the body.  
Metabolism  appears  to  involve  initial  microsomal  epoxidation  by  P450  enzymes  to  an  unstable 
epoxide, which is then either hydrolysed to the corresponding diol, catalysed by epoxide hydrolase, or 
conjugated with glutathione. The glutathione conjugates are further metabolised to form mercapturic 
acids,  which  are  excreted  in  the  urine  (White  et  al.,  1986;  OECD,  2001b).  In  general,  alkenes 
accumulate in the body with increasing number of carbon atoms, starting at around C6-C7, with the 
highest concentrations in rats having being observed in brain, liver, kidneys and perirenal fat (OECD, 
2004c; EFSA, 2012b).  
Acute toxicity 
The alkenes comprising propylene tetramer are of low acute toxicity. The oral LD50 of individual 
alkenes and mixtures of alkenes is > 5 g/kg b.w. in rats and, when tested, in mice. In most cases, the 
LD50 was > 10 g/kg b.w. (OECD, 2001b, 2004c). 
Some olefins appear to be mildly irritating to rabbit skin when tested as pure chemicals, and slightly to 
severely irritating when tested as mixtures. Olefins are either non-irritating or slightly irritating to 
rabbit eyes, regardless of whether tested individually or as mixtures (OECD, 2001b, 2004c).  None of 
the olefins is classified on the ECHA database for irritation to skin or eyes.
27 
Subacute, subchronic and chronic toxicity studies 
In general, olefins  are  not very toxic on repeat dose administration by the oral route. The most 
common effect observed is on the kidney of male rats, due to binding with alph a-2u-globulin and its 
accumulation in proximal tubular cells. As there is no equivalent protein in humans at a level 
sufficient to support such a reaction, the male rat specific renal affects are not considered relevant for 
human risk assessment (OECD, 2001b, 2004c; EFSA, 2012b). In repeat dose studies in rats with a 
variety of alkenes administered orally as either the individual compounds or as mixtures, the lowest 
NOAEL for systemic toxici ty other than alpha -2u-dependent renal toxicity in male rats, was for 
1-octene administered by gavage. A NOAEL of 50 mg/kg b.w. per day was identified on the basis of 
marginal effects on kidney weight and serum creatinine in females at 500 mg/kg b.w. per day (OECD, 
2001b, 2004c). 
Genotoxicity 
The  olefins  found  in  propylene  tetramer  and  mixtures  thereof  have  been  tested  for  possible 
genotoxicity  in  vitro  and  to  a  lesser  extent  in  vivo.  The  main  test  systems  used  were  the 
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Ames/Salmonella assay for bacterial mutagenicity and the mouse micronucleus test in vivo. A number 
of additional test systems were employed with some of the compounds or mixtures. None of the 
olefins was genotoxic (OECD 2001b; 2004c).  
Carcinogenicity 
No studies of the potential carcinogenicity of propylene tetramer could be located. 
Developmental and reproductive toxicity 
1-Hexene  and  1-tetradecene  have  been  tested  for  effects  on  reproduction  in  combined  studies  of 
reproductive/developmental toxicity in which rats were treated prior to mating and during mating, 
gestation  and  lactation  by  oral  gavage  with  doses  of  up  to  1  000  mg/kg  b.w.  per  day.  Neither 
compound had any effect on reproduction or on development. Hence, the NOAEL was 1 000 mg/kg 
b.w. per day, the highest dose tested, for both of these compounds (OECD, 2001b). In their evaluation 
of higher olefins, OECD (2004c) summarised oral studies of reproductive and developmental toxicity 
of several mixtures of alkenes. These were: alkenes, C6 (internal branched /linear stream); C16/18 
internal  linear  and  branched;  C18  internal  linear  and  branched.  In  all  cases,  the  NOAEL  for 
reproductive and developmental toxicity was 1 000 mg/kg b.w., the highest dose tested. 
3.8.2.4.  Allergenicity 
In the Buehler test in guinea pigs, propylene tetramer was not found to be a sensitizer (Cushman et al., 
1992). Similarly, in the Buehler test in guinea pigs, 1-dodecene was not found to be a sensitizer 
(Morris, 1992, as cited in ECB, 2002a). No information has been found regarding adjuvanticity. The 
available data give no indication that propylene tetramer is an allergen or an adjuvant at concentrations 
expected from its use as a previous cargo. 
3.8.3.  Conclusions 
Although specific studies on propylene tetramer itself are somewhat limited, data are available on 
many of its main components and mixtures of these. In general, the toxicological profile of alkenes 
depends on carbon length, and is similar for those with similar carbon length. The CONTAM Panel 
considers that propylene tetramer would not be of toxicological concern at the levels that would occur 
when  used  as  a  previous  cargo  for  edible  fats  and  oils.  Although  there  are  no  studies  of 
carcinogenicity, the CONTAM Panel concludes that in the absence of genotoxicity or of pathological 
changes in subchronic studies indicative of a potential carcinogenic hazard, there was no concern for 
possible carcinogenicity from the use of propylene tetramer as a previous cargo. Propylene tetramer is 
not allergenic. There are no reaction products or impurities of toxicological concern. 
The CONTAM Panel therefore concludes that propylene tetramer meets the criteria for acceptability 
as a previous cargo for edible fats and oils. 
3.9.  MONTAN WAX (CAS No 8002-53-7)  
Montan wax is a hard, brittle, lustrous wax with a melting point around 80 °C extracted with toluene 
from lignites/brown coal, principally from Central Europe.  
Montan wax is formed from resins, waxes and fats of plants. It consists of about 50 % esters of 
C22-34 fatty acids with C24-C28 alcohols, about 20 % fatty acids and resins of phenols, ketones and 
asphaltenes. 
Montan wax is used for technical purposes, such as sealing concrete, in cleaning agents, lubricants, 
adhesives, and for electrical insulation in cables. 
Montan  wax  should  be  distinguished  from  a  variety  of  products  called  ‗montan  acid  esters‘  or 
‗montanic acid esters‘, which are purified (e.g. by bleaching) and modified products. Fatty acids from Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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montan waxes are esterified, e.g., with ethylene glycol or fatty alcohols. Other isolates from montan 
wax are partially saponified. This entry does not deal with these purified products. 
3.9.1.  Previous evaluations 
The SCF evaluated montan wax (CAS no. 8002-53-7) as a previous cargo in 1996 and considered it 
provisionally acceptable, noting its solubility (SCF, 1997a). This conclusion was based on the fact the 
SCF had concluded that montan wax esters (E192) were temporarily acceptable as a food additive, 
used as a glazing agent for food (SCF, 1992c). In the 2003 SCF evaluation of acceptable previous 
cargoes, the Committee reconsidered montan wax and concluded that the information available was 
inadequate. The SCF therefore maintained their opinion as provisionally acceptable (SCF, 2003).  
No previous evaluations of natural montan wax have been carried out, by JECFA, SCF, EFSA or other 
regulatory agencies. Natural montan wax is not authorised as a food additive in the EU,
15 although 
montan acid esters are authorised for the surface treatment of certain fruits, with the E number E 912. 
Montan  wax  is  approved  for  use  as  a  food  contact  additive  in  plastics  under  Regulation  (EU) 
10/2011,
24 with no restrictions other than the generic overall migration limit of 60 mg/kg food. Montan 
wax is also on the US FDA list of approved indirect additives used in food contact materials (FDA, 
2011e).   
3.9.2.  Current evaluation 
3.9.2.1.  Expected impurities 
As montan wax is a complex mixture with a composition depending on its source, the toxicological 
evaluation  should  consider  the  whole  mixture,  taking  into  account  variability  in  composition. 
Anticipated impurities have not been specifically considered in this opinion.  
3.9.2.2.  Reactivity and reaction products 
The large majority if not all of the components in montan wax are not expected to react in edible fats 
and oils. 
3.9.2.3.  Toxicological profile 
Absorption, distribution, metabolism and excretion  
Montan wax has a high melting point relative to other waxes, is insoluble in water and is hydrophobic 
in  nature.  Overall  the  CONTAM  Panel  considered  that  absorption  of  montan  wax  from  the 
gastrointestinal tract will be limited. Any alkane constituents of the absorbed wax will be slowly 
metabolised  to  the  corresponding  fatty  alcohols  and  then  fatty  acids,  with  some  metabolism  also 
occurring in the small intestine, and enter normal biochemical pathways (EFSA, 2012b). 
Acute toxicity 
Montan wax can be anticipated to be of low acute oral toxicity. An LD50 of > 12 000 mg/kg b.w. has 
been reported.
28 Montan wax has been reported to be only very slightly irritat ing to skin and eyes, 
based on the results of in vitro tests.
28 
Subacute, subchronic and chronic toxicity studies 
A 90-day toxicity study in Fisher 344 rats has been carried out with montan wax, administered in the 
diet at levels  of 0, 0.56, 1.67 or 5 %  (about  260, 835 or 2 500 mg/kg b.w. per day) (Ikeda et al., 
2008). Haematological changes occurred in all treated rats, and aspartate aminotransferase (AST) and 
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alanine  aminotransferase  (ALT)  in  serum  were  elevated.  Liver,  spleen,  lung  and  kidney  weights 
relative to body weight were also increased. Diffuse multiple granulomatous change occurred in the 
liver  in  all  treated  rats,  together  with  severe  hepatocyte  damage  and  lymphocytic  infiltration.  A 
NOAEL could not therefore be identified in this study.  
No chronic toxicity study is available on montan wax.  
Genotoxicity 
Montan wax was non-mutagenic in a bacterial mutagenicity study using Salmonella typhimurium with 
and without metabolic activation.
28  
Carcinogenicity 
No carcinogenicity study is available on montan wax. 
3.9.2.4.  Allergenicity 
Montan wax was tested in the mouse local lymph node assay (LLNA) according to OECD Guideline 
429. Montan wax did not induce skin sensitization in this test (Anonymous, 2009, as cited in ECHA, 
online). No other information has been found regarding sensitization, adjuvanticity or irritancy of 
Montan wax. The available data give no indication that montan wax is an allergen or an adjuvant at 
concentrations expected from its use as a previous cargo. 
3.9.3.  Conclusion 
No ADI or TDI has been established for montan wax by the SCF, JECFA or EFSA. Data recently 
provided to ECHA indicate that montan wax is not mutagenic in a bacterial mutagenicity test, and the 
CONTAM Panel considers that it is not likely to be a significant sensitizer, adjuvant or irritant. In a 
subchronic toxicity study in rats, haematological changes and hepatotoxicity were observed at the 
lowest  dose  tested,  of  approximately  260  mg/kg  b.w.  per  day,  and  hence  no  NOAEL  could  be 
identified. There are no data on chronic toxicity or carcinogenicity. 
Montan wax is an ill-defined material for which it cannot be excluded that it contains components of 
concern. 
The CONTAM Panel therefore concludes that, given the deficiencies in the available data on montan 
wax, it does not meet the criteria for acceptability as a previous cargo. 
3.10.    PARAFFIN WAX (CAS No 8002-74-2 / 63231-60-7)  
Waxes  are  mixtures  of  mineral  hydrocarbons  having  a  melting  point  above  ambient  temperature. 
There are hard waxes (like those used in candles), but also soft waxes, e.g. used for cosmetics. For 
chemists, the term ‗paraffin‘ suggests that the wax consists of saturated, open-chain hydrocarbons, i.e. 
that it neither contains saturated cyclic components (naphthenes) nor aromatic components. The term 
is also used, however, to distinguish waxes of mineral sources from waxes of other origin and may, 
therefore, not in itself exclude appreciable amounts of aromatic components. 
CAS No 8002-74-2 has entries as ‗paraffin wax‘, but also as ‗paraffin wax and other hydrocarbon 
waxes‘,  which  means  that  aromatic  hydrocarbons  can  be  present.  CAS  No  63231-60-7  refers  to 
microcrystalline wax. Microcrystalline waxes differ from paraffin waxes in the size and structure of 
crystals: microcrystalline wax is almost amorphous, whereas paraffin wax is macrocrystalline. To 
achieve these properties, they contain a higher proportion of saturated hydrocarbons other than n-
alkanes.  Microcrystalline  waxes  used  in  foods  (E  905)  are  hydrogenated  to  remove  the  aromatic 
compounds. However, microcrystalline waxes are not per se food grade. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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Waxes are obtained by solvent crystallisation from mineral oil fractions. To be solids they must have a 
high  concentration  of  n-alkanes  (usually  > 90  %)  and  be  of  molecular  masses  above  about  C20. 
Crystallisation reduces the content of aromatics to at most a few percent. Other characteristics may 
vary, such as the molecular mass distribution. The higher the molecular mass, the higher may be the 
percentage of the branched and cyclic hydrocarbons still resulting in a melting point above ambient.  
Waxes are used e.g. for candles, tyres and other rubber articles, treatment of surfaces to improve 
water-resistance, cosmetics and electrical insulation. This includes both the paraffin waxes and the 
microcrystalline waxes. 
3.10.1.  Previous evaluations 
The  SCF  evaluated  paraffin  wax  as  a  previous  cargo  in  1996  and  considered  it  provisionally 
acceptable (SCF, 1997a), noting that ‗Existing SCF opinion on mineral hydrocarbons - waxes states 
that there are insufficient data to establish the safety of paraffin  waxes. (SCF, 37
th report, 1997). 
However given the nature of the toxicity of paraffin waxes it would not be expected that very low 
residues would give rise to problems. The normal cleaning process involving heating of the tank 
should ensure the removal of paraffin waxes to acceptable residual levels‘. In the 2003 SCF evaluation 
of  acceptable  previous  cargoes,  the  Committee  reconsidered  paraffin  wax  and  concluded  that  the 
information available was inadequate. SCF therefore maintained their opinion  on paraffin wax  as 
provisionally acceptable previous cargo (SCF, 2003).  
Mineral hydrocarbons including paraffin wax and microcrystalline wax (E 905) have been evaluated 
several times for the safety for use as food additives by both the Scientific Committee on Food (SCF) 
in  1990  and  1995  (SCF,  1992d,  1997b)  and  the  Joint  FAO/WHO  Expert  Committee  on  Food 
Additives (JECFA) on several occasions, most recently in 2009 (JECFA, 2010).  
JECFA noted at its 39
th meeting that long-term toxicity studies had indicated that petroleum-derived 
paraffin  waxes  and  microcrystalline  waxes  were  non-toxic  and  non-carcinogenic  (JECFA,  1992, 
1993a). The Committee therefore established an ADI ‗not specified‘ for these waxes for the following 
uses: chewing-gum base, protective coating, defoaming agent, and surface finishing agent. The ADI 
‗not specified‘  for  paraffin  waxes  was  withdrawn  in  1995,  and  an  ADI  of  0-20  mg/kg  b.w.  was 
established for hydrotreated, high-melting point microcrystalline wax and clay-treated microcrystalline 
wax at the 44
th JECFA meeting, based on new short-term feeding studies showing no adverse effects 
up to the highest dose tested of 2 % microcrystalline wax in the diet (JECFA, 1995, 1996). Based on 
the  same  studies,  the  SCF  likewise  established  an  ADI  of  0-20  mg/kg  b.w.  (SCF,  1997b).  Only 
microcrystalline wax is authorised as a food additive within the EU. 
In the USA petroleum wax including microcrystalline wax is classified as Generally Recognized As 
Safe (GRAS) by the US FDA, and is permitted in chewing gum base, on cheese and raw fruits and 
vegetables and as a defoamer in food (FDA, 1977). 
Microcrystalline wax is approved for use as a food contact additive in plastics under Commission 
Regulation  10/2011
24  with  the  name  waxes,  refined,  derived  from  petroleum  based  or  synthetic 
hydrocarbon  feedstocks  and  with  no restrictions  other  than  the  generic  overall  migration limit  of 
60 mg/kg food. 
3.10.2.  Current evaluation 
In view of concerns regarding the toxicity and carcinogenicity of aromatic hydrocarbons, the current 
evaluation is restricted to paraffin waxes that have been treated to remove aromatic hydrocarbons and 
which otherwise meet relevant standards to be considered as ‗food grade‘. 
3.10.2.1. Expected impurities 
Waxes of mineral origin predominantly consist of n-alkanes. Branched and cyclic hydrocarbons may 
reach a few percent of the wax (mostly < 10 %). The food grade waxes being considered here as Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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previous cargoes for edible fats and oils will always contain less than 3 % highly alkylated aromatic 
hydrocarbons. No other impurities of concern are anticipated.  
3.10.2.2. Reactivity and reaction products 
Mineral waxes do not react with edible fats and oils. 
3.10.2.3. Toxicological profile 
Absorption, distribution, metabolism and excretion  
In a 90-day study in which rats were fed five different microcrystalline or lower melting point paraffin 
waxes (LMPW) at a level of 2 mg/kg in the diet, mineral hydrocarbons were found in liver, mesenteric 
lymph nodes, and perirenal fat of all groups with the exception of animals fed microcrystalline waxes 
(Smith et al., 1996). The SCF concluded from this study that microcrystalline wax is not absorbed 
after oral administration but is excreted unchanged in the faeces (SCF, 1997b), in contrast to mineral 
hydrocarbon oils and lower melting point paraffin waxes. It has been reported that absorption of 
aliphatic hydrocarbons was inversely proportional to the number of carbon atoms and ranged from 60 
% for C14 compounds to 5 % for C28 compounds, while no absorption was detected for carbon 
numbers greater than C30 (Albro and Fishbein, 1970). The results of  a number of extraction and 
migration tests on waxes and wax-bearing products were used by JECFA as indirect evidence that  
hydrocarbon waxes consumed in the diet are unlikely to be absorbed or metabolized in detectable or 
significant amounts (JECFA, 1993a). Any absorbed paraffin wax (high carbon number alkanes) will 
be slowly metabolised to the corresponding fatty alcohols and then fatty acids, with some metabolism 
also occurring in the small intestine, and enter normal biochemical pathways (EFSA, 2012b). 
Acute toxicity 
Paraffin waxes are anticipated to be of low acute oral toxicity. An LD50 of greater than 5 000 mg/kg 
b.w. has been reported
29 (US-EPA, 2011). They have been reported to be only very slightly irritant to 
skin and eyes.
29 
Subacute, subchronic and chronic toxicity studies 
Both JECFA and the SCF have extensively reviewed the results of subacute, subchronic and chronic 
oral toxicity studies and human data on a number of mineral and synthetic oils and waxes including 
paraffin waxes (JECFA, 1993a; SCF, 1997b). The SCF (1997b) reported some of these substances 
‗not only accumulate with repeated dosing, but also give rise to effects which are not confined solely 
to  localised  foreign  body  reactions  and  provide  clear  evidence  of  toxicity  in  animals.  […].  The 
following effects were observed: increased organ weights, especially liver and lymph nodes; altered 
serum  enzyme  levels;  increased  monocyte  and  neutrophil  counts;  reduced  red  blood  cells, 
haemoglobin,  haematocrit,  mean  corpuscular  hemoglobin  concentration  (MCHC).  The  main 
histopathological  findings  were  granulomata  in  the  liver  and  focal  collections  of  vacuolated 
macrophages  (histiocytosis)  in  the  lymph  nodes.  In  animals  dosed  with  certain  of  the  waxes,  an 
inflammatory lesion at the base of the mitral valve in the heart was observed‘.  
In the most recent of these studies (Smith et al., 1996), a range of mineral oils and waxes were 
administered in the diet to groups of F344 rats (20/sex) at levels of 0.002, 0.02, 0.2 or 2 % for 90 days 
(equivalent to 2, 20, 200 or 2 000 mg/kg b.w. per day). The results confirmed the toxicity of the 
mineral  oils  and  low  melting  point  wax  tested,  as  described  by  the  SCF  (1997b),  however  no 
treatment-related effects were associated with administration of the high melting point wax and high 
sulphur wax (both microcrystalline waxes) other than minor haematological changes in females only, 
receiving the high sulphur wax. A NOAEL of 0.002 % in diet (about 1.5 mg/kg b.w. per day) was 
                                                       
29   European  Chemicals  Agency  (ECHA).  Paraffin  waxes  and  hydrocarbon  waxes.  CAS  No  8002-74-2.  Available  at: 
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identified for the low melting point wax, while for the microcrystalline waxes the NOAEL was ≥ 2 % 
in diet (about 1 500 mg/kg b.w. per day).  
In a 60-day study with Fischer-344 (F-344) and SD rats, 2 % LMPW (low melting point paraffin wax) 
was administered in the diet for 60 day (Hoglen et al., 1998). The results of this study indicated that 
2 % LMPW altered the morphology and functional capacity of Kupffer cells of F-344 rats, but not of 
SD rats. The authors suggested that these effects may ultimately lead to the formation of hepatic 
granuloma.  
No treatment-related effects were reported in a chronic toxicity/carcinogenicity study in which SD rats 
were fed 5 types of refined waxes (three of the waxes were microcrystalline and the other two were 
refined paraffin waxes, not further specified) at a dietary concentration of 10 % (about 5 000 mg/kg 
b.w. per day) for two years (Shubik et al., 1962).  
Genotoxicity 
The results of a range of in vitro genotoxicity studies conducted with paraffin wax and reported in the 
ECHA  database,
29  including  a  bacterial  mutagenicity  study  with  Salmonella  typhimurium  and 
Escherichia coli, a mouse lymphoma mutation assay and a chromosome aberration test in CHO cells, 
all conducted with and without metabolic activation, indicate no genotoxic potential. In genotoxicity 
studies, high viscosity and medium viscosity white oils also do not show genotoxic effects (EFSA, 
2009c). 
Carcinogenicity 
In a chronic toxicity/carcinogenicity study in which rats were fed 5 types of refined waxes (three of 
the waxes were microcrystalline and the other two were refined paraffin waxes, not further specified) 
at a dietary concentration of 10 % (about 5 000 mg/kg b.w. per day) the incidence of tumours was 
comparable in test animals and controls (Shubik et al., 1962). The polycyclic aromatic hydrocarbon 
(PAH) content of the waxes tested was determined analytically, and the two refined paraffin waxes 
were found to have detectable levels of PAHs, while the three microcrystalline waxes did not.  As 
reported by the authors, however, all five waxes were negative in the 2-year oral carcinogenicity study 
and also in a skin painting study in mice (Shubik et al., 1962). Both JECFA and the SCF concluded 
that (microcrystalline) paraffin wax is not carcinogenic, based on the results of this study. EFSA has 
also concluded  that, in  chronic  toxicity/carcinogenicity  studies  conducted  with  high  viscosity  and 
medium viscosity white oils, no carcinogenic effects were observed in any of the studies in F344 rats 
or in skin painting studies in mice (EFSA, 2009c).  
Developmental and reproductive toxicity  
No  data  are  available  on  the  reproductive  and  developmental  toxicity  of  paraffin  wax  or 
microcrystalline wax. There are also no data on high viscosity or medium viscosity white oils. EFSA 
concluded, however, that studies on low viscosity white mineral oils can be used to support the lack of 
reproductive or developmental effects for white oils (EFSA, 2009c). The CONTAM Panel considered 
that this could also be applied to the paraffin waxes.  
3.10.2.4. Allergenicity 
In the guinea pig maximization test, no skin reactions were observed in groups treated with 100 % or 
50 % paraffin wax in liquid paraffin (Anonymous, 1997b, 2007, both as cited in ECHA, online). 
Negative  results  for  paraffin  wax  have  been  recorded  also  in  a  human  patch-test  study  (Dooms-
Goosens and Degreef, 1983, as cited in ECHA, online).  
Clinical studies in humans with two undiluted paraffin waxes and formulated products containing 
various concentrations of paraffinic (5-16 %) and microcrystalline (4.35-15 %) waxes recorded, at 
most, slight erythema, and none of the test substances caused skin sensitization (Elder, 1984). No data Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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on adjuvanticity or irritancy have been found. The available data give no indication that paraffin wax 
is an allergen or an adjuvant at concentrations expected from its use as a previous cargo. 
3.10.3.  Conclusion 
Paraffin wax may contain aromatic hydrocarbons, some of which are genotoxic carcinogens. Hence, 
the CONTAM Panel concluded that this entry to the Annex should be restricted to paraffin waxes that 
have been treated to remove aromatic hydrocarbons and which also meet other relevant standards to be 
considered as ‗food grade‘. Accordingly, the CONTAM Panel recommends that the entry for these 
waxes in Annex to Commission Directive 96/3/EC be amended to ‗Paraffin Wax (CAS No 8002-74-2 
/ 63231-60-7) (food grade)‘. 
An ADI of 0-20 mg/kg b.w. has been established by both JECFA and the SCF for high molecular mass 
food-grade microcrystalline wax, with specifications as laid down according to Commission Directive 
2008/84/EC
30 and JECFA. The CONTAM Panel (EFSA, 2012b) noted that this ADI was established 
from toxicological studies in which no effects were observed at any tested dose. Food grade  paraffin 
wax is not genotoxic or allergenic. It will not give rise to  any reaction products with fats and oils of 
toxicological concern. No impurities of toxicological concern are known or anticipated.  
The CONTAM Panel therefore concludes that paraffin wax (food grade, CAS No. 8002-74-2 / 63231-
60-7) meets the criteria for acceptability as a previous cargo. 
3.11.  CARNAUBA WAX (Brazil wax) (CAS No 8015-86-9)  
Carnauba wax is one of the hardest and highest-melting point natural waxes, with a melting point 
range  between  82  and  86  °C.  It  is  modestly  soluble  in  solvents,  virtually  insoluble in  water, i.e. 
difficult to remove from a container in solid form. The cleaning of a vessel might be inefficient. 
Carnauba  wax  is  mechanically  obtained  from  the  leaves  of  the  Brazilian  palm  trees  Copernicia 
prunifera and Copernicia cerifera. For purification it is melted and filtered.  
Carnauba wax contains about 85 % esters of long chain fatty acids, hydroxy fatty acids and cinnamic 
acid with long chain alcohols and diols. The remaining material consists of long chain free acids, long 
chain fatty alcohols and saturated hydrocarbons. 
Carnauba wax is used for polishing surfaces (e.g. shoes, furniture, floors, cars), as a release agent for 
bakery ware and sugar products, in chewing gums, as coatings of fruits, in cosmetics or to protect 
printed surfaces. 
3.11.1.  Previous evaluations 
The SCF evaluated carnauba wax as a previous cargo in 1996 and considered it acceptable (SCF, 
1997a). This conclusion was based on the fact that carnauba wax was temporarily acceptable as a food 
additive,  E903,  for  use  as  a  glazing  agent  for  food  (SCF,  1992d,  1997c).  The  SCF  noted  the 
insolubility of carnauba wax. In the 2003 SCF evaluation of acceptable previous cargoes, carnauba 
wax was not further evaluated as it was already considered acceptable (SCF, 2003).  
The SCF has evaluated carnauba wax as a food additive on several occasions (SCF, 1992d, 1997c, 
2001). The  SCF  did not establish  an  ADI  for  carnauba  wax, and  in  its  1992  and  1997 opinions 
considered its use as a glazing agent as temporarily acceptable. In 2001, based on new toxicological 
and exposure data the SCF accepted the use of carnauba wax as a glazing agent up to a maximum use 
level of 200 mg/kg of food and withdrew its temporary status (SCF, 2001).  
An ADI of 0-7 mg/kg b.w. for carnauba wax was established by JECFA in 1993 (JECFA, 1993b). 
                                                       
30   Commission Directive 2008/84/EC of 27 August 2008 laying down specific purity criteria on food additives other than 
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In USA carnauba wax is classified as GRAS and is permitted with no other limitation than good 
manufacturing practice (GMP) in a variety of food products (FDA, 1983a). 
Carnauba wax is approved for use as a food contact additive in plastics under Commission Regulation 
(EU) 10/2011,
24 with no restrictions other than the generic overall migration limit of 60 mg/kg food.  
EFSA re-evaluated carnauba wax (E 903) as a food additive in 2012 (EFSA, 2012c). The Panel on 
Food Additives and Nutrients added to Food (ANS Panel) did not establish an ADI due to the lack of 
long-term  toxicity  data.  It  noted,  however, that  available  toxicity  studies consistently  reported  no 
adverse effects associated with carnauba wax intake, and that the available data suggests no concern 
for genotoxicity. In addition, the exposure estimates to carnauba wax indicated sufficient ‗margins of 
safety‘, and therefore concluded that its use as a food additive within the currently authorised uses 
would not be of safety concern.    
3.11.2.  Current evaluation 
3.11.2.1. Expected impurities 
Carnauba wax is not expected to contain impurities of concern when transported as a previous cargo. 
3.11.2.2. Reactivity and reaction products 
Carnauba wax is not expected to produce reaction products with edible fats and oils which are of 
concern when it is transported as a previous cargo. 
3.11.2.3. Toxicological profile 
Absorption, distribution, metabolism and excretion  
Carnauba  wax  has  a  high  melting  point  relative  to  other  waxes,  is  insoluble  in  water  and  is 
hydrophobic  in  nature.  There  are  no  specific  experimental  data  on  the  absorption,  distribution, 
metabolism  and  elimination    of  carnauba  wax  (EFSA,  2012c).  Overall  the  CONTAM  Panel 
considered, however, that absorption of carnauba wax from the gastrointestinal tract will be low, if 
any, and that the wax is unlikely to be susceptible to metabolism by digestive enzymes or the intestinal 
microbiota. Any degradation products, e.g. long-chain aliphatic esters which are the main components 
of  carnauba  wax,  will  be  incorporated  into  normal  cellular  metabolic  pathways  and  eliminated 
thereafter.  
Acute toxicity 
Carnauba wax is of low acute toxicity, an oral LD50 of greater than 1 100 mg/kg b.w. has been 
reported (Liebert, 1984). Carnauba wax is not anticipated to have irritant properties. 
Subacute, subchronic and chronic toxicity studies 
As reported by the SCF (2001) and EFSA (2012c), a 90-day oral study in Wistar rats was carried out 
with carnauba wax (Rowland et al., 1982) at levels of up to 10 % in the diet, in which no treatment-
related effects were reported. A NOAEL of 8 800 mg/kg b.w. per day, the highest dose tested, was 
identified  in  this  study.  A  further  90-day  feeding  study  in  Fischer  F-344  rats  was  designed  to 
investigate whether components of carnauba wax could be absorbed and accumulate in the liver and 
other organs of this strain, as seen with high molecular mass mineral oils and other waxes (Edwards, 
1998). Groups of 20 male and 20 female rats were fed diets containing carnauba wax corresponding to 
intakes of 0, 15, 150 and 1 500 mg/kg b.w. per day. No treatment-related effects were identified, there 
were  no  dose-related  histopathological  changes  in  liver  and  other  tissues,  and  a  NOAEL  of 
1 500 mg/kg b.w. per day, the highest dose tested, can be identified in this study (Edwards, 1998). A 
6-month feeding study has also been carried out in Beagle dogs, using dietary levels of up to 1 % in Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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the diet (equivalent to up to 250 mg/kg b.w. per day) (Parent et al., 1983a). No treatment-related 
effects were identified. No studies on the chronic toxicity of carnauba wax are  available (EFSA, 
2012c). 
Genotoxicity 
As reported by JECFA (1993b) and the SCF (2001), carnauba wax was not mutagenic in in vitro tests 
with Salmonella typhimurium and Saccharomyces cerevisiae, with and without metabolic activation. 
As reported by SCF (2001), there was no evidence of clastogenicity of carnauba wax in in vitro 
chromosome aberration tests using human lymphocytes (Edwards, 1996, 1998). The SCF and, more 
recently, the EFSA ANS Panel (EFSA, 2012c) concluded that carnauba wax was not genotoxic in 
vitro,  based  on  the  results  of  these  studies.  There  are  no  in  vivo  genotoxicity  data  available  on 
carnauba wax. 
Carcinogenicity 
No studies on the carcinogenicity of carnauba wax are available (EFSA, 2012c). 
Developmental and reproductive toxicity 
No  treatment-related  effects  were reported in a  reproductive  toxicity  study  with  carnauba  wax in 
which Wistar rats were administered levels of 0, 0.1, 0.3 or 1 % in the diet for 4 weeks prior to mating 
and through gestation and lactation (Parent et al., 1983b). This study was used by JECFA as the basis 
for setting the ADI of 7 mg/kg b.w. per day for carnauba wax (rounded up), by applying a 100 
uncertainty factor to the NOAEL of approximately 670 mg/kg b.w. per day. As reported by the SCF 
(2001), no developmental toxicity was evident in a study in which rats were fed 0, 0.1, 0.3 or 1 % 
carnauba wax in the diet for two weeks before mating and throughout gestation. 
3.11.2.4. Allergenicity 
One report of a test-proven case of sensitization to carnauba wax has been published (Chowdhury, 
2002). In addition, Jacob et al. (2008) report one case of supposed sensitization to carnauba wax, 
based on reaction to a product containing propolis and carnauba wax and test-proven sensitization to 
cinnamic acid/cinnamaldehyde, which is a component of both the mentioned substances. However, no 
testing with carnauba wax was performed. Chowdhury (2002) state that sensitization to carnauba wax 
is very rare. No other information on sensitizing properties, adjuvanticity or irritancy has been found. 
The CONTAM Panel considers that taking into account the scarcity of reports of sensitization in the 
literature as well as the relevant dilution factor, carnauba wax when used as a previous cargo is not 
likely to be a significant sensitizer, adjuvant or irritant. 
3.11.3.  Conclusion 
JECFA has established an ADI of 0-7 mg/kg b.w. for carnauba wax, while the SCF concluded that its 
use as a glazing agent up to a maximum use level of 200 mg/kg of food was acceptable. The EFSA 
ANS Panel noted that available toxicity studies consistently reported no adverse effects associated 
with  carnauba  wax  intake,  and  that  the  available  data  suggests  no  concern  for  genotoxicity.  In 
addition,  the  exposure  estimates  to  carnauba  wax  indicated  sufficient  ‗margins  of  safety‘,  and 
therefore concluded that its use as a food additive within the currently authorised uses would not be of 
safety concern. The CONTAM Panel considered, based on the outcome of these expert evaluations, 
the likely limited absorption of carnauba wax and the toxicological profile of its main component 
groups of chemicals, that this wax will not pose any toxicological concern when used as a previous 
cargo, based on normal assumptions regarding worst case carryover. There is no evidence that it is 
genotoxic and there is no allergenic potential of concern. It will not give rise to any reaction products 
with fats  and  oils  of  toxicological concern.  No  impurities  of toxicological  concern  are  known  or 
anticipated. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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The CONTAM Panel noted however, the insolubility of carnauba wax in water, its high melting point 
(82 to 86 °C) and the fact that heating of ships‘ tanks is normally to a maximum of 80 °C. The 
CONTAM Panel therefore has concerns regarding the feasibility of tank cleaning following transport 
of  carnauba  wax  as  a  previous  cargo,  such  that  carryover  may  exceed  the  worst  case  normally 
assumed.  
The CONTAM Panel concludes that carnauba wax does not meet the criteria for acceptability as a 
previous cargo because of doubts concerning the efficiency of tank cleaning following transport of 
carnauba wax as a previous cargo. 
According to the information provided to EFSA, carnauba wax does not appear to be transported as a 
previous cargo. 
3.12.  CANDELILLA WAX (CAS No 8006-44-8)  
Candelilla wax is yellowish to brown, hard (melting point around 70 °C), brittle, aromatic and opaque 
to translucent. It is insoluble in water, but soluble in many organic solvents.  
Candelilla wax is obtained from the leaves and stems of a shrub from the family Euphorbiaceae 
growing in Mexico and the south-western United States by boiling with dilute sulphuric acid. The 
resulting ‗cerote‘ is skimmed and purified.  
Candelilla wax consists mainly of n-alkanes C29-33 (about 50 %), wax esters, sterol esters, free acids 
and resins.  
Candelilla wax is used for making varnish. It is an approved food additive (glazing agent for fruits and 
sweets, E 902), and is also used in cosmetics. One of its major uses is as a binder for chewing gums. It 
is often used to replace the more expensive beeswax. 
3.12.1.  Previous evaluations 
The SCF evaluated  candelilla wax as previous cargo in 1996 and considered it  acceptable (SCF, 
1997a). This conclusion was based on the fact that candelilla wax was temporarily acceptable as a 
food additive, E902, for use as a glazing agent for food (SCF, 1992e). In the 2003 SCF evaluation of 
acceptable previous cargoes, candelilla wax was not further evaluated as it was already considered 
acceptable (SCF, 2003).   
The  SCF  evaluated  the  safety  of  candelilla  wax  as  a  food  additive  in  1990  (SCF,  1992e).  The 
Committee did not establish an ADI for candelilla wax, but took into consideration the available 
toxicity data, its long established use without apparent adverse effects and the expected limited intake 
when used as a glazing agent, and accepted the temporary continued use of candelilla wax (SCF, 
1992e).  
JECFA evaluated the use of candelilla wax as a glazing agent, chewing gum base component, surface 
finishing agent and carrier for flavours in 1993 and again in 2005 (JECFA, 1993c, 2006). JECFA 
estimated dietary exposure to candelilla wax using the conservative assumption that an individual 
would  consume  all  the  foods  (and  tablets  or  capsules)  containing  candelilla  wax  at  the  highest 
percentile in each food category and that all those foods contained candelilla wax, and calculated that 
the dietary exposure would be < 650 mg per person per day. JECFA concluded that the functional uses 
indicated did not raise any toxicological concerns provided the dietary exposure was less than 650 mg 
per person per day. 
EFSA re-evaluated candelilla wax (E 902) as a food additive in 2012 (EFSA, 2012d). The Panel on 
Food Additives and Nutrients added to Food (ANS Panel) did not establish an ADI due to the lack of 
long-term toxicity data. It noted, however, that the available toxicity studies consistently reported no 
adverse effects associated with intake of the main components constituting candelilla wax, and that the Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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available data suggest that candelilla wax is not genotoxic. In addition, the exposure estimates (using 
the maximum permited levels of carnauba wax) indicated a sufficient ‗margin of safety‘ and therefore 
concluded that its use as a food additive within the currently authorised uses would not be of safety 
concern.     
In the USA candelilla wax is classified as GRAS and is permitted with no other limitation than GMP 
in a variety of food products (FDA, 1983b). 
Candelilla wax is approved for use as a food contact additive in plastics under Commission Regulation 
(EU) 10/2011,
24 with no restrictions other than the generic overall migration limit of 60 mg/kg food. 
3.12.2.  Current evaluation 
3.12.2.1. Expected impurities 
Candelilla wax does not include impurities that would be of concern when it is used as a previous 
cargo. 
3.12.2.2. Reactivity and reaction products 
Candelilla wax does not contain substances which could react with edible fats and oils to produce 
compounds of concern. 
3.12.2.3. Toxicological profile 
Absorption, distribution, metabolism and excretion  
No specific data on absorption, distribution, metabolism or excretion of candelilla wax were available 
to the Panel for evaluation. Overall, the CONTAM Panel considered that absorption of candelilla wax 
from the gastrointestinal tract will be low, if any, and that degradation by digestive enzymes or the 
intestinal  microbiota  would  be  limited.  The  components  of  candelilla  wax,  e.g.  straight-chain 
hydrocarbons (C29-C33 n-alkanes) together with esters of acids and alcohols with even-numbered 
carbon  chains  (C28-C34)  (JECFA,  2006),  are  also  expected  to  have  limited  absorption  and  if 
absorbed,  will  be  incorporated  into  normal  cellular  metabolic  pathways  and  eliminated  thereafter 
(EFSA, 2012d). 
Acute toxicity 
Candelilla wax is of low acute  toxicity. As reported by the EFSA ANS  Panel in 2012, the SCF 
reviewed a number of acute oral toxicity studies on candelilla wax (no further details) and reported 
that ‗none of the studies reported any adverse treatment-related toxicological findings‘ (SCF, 1992e). 
Liebert (1984) reported that the acute oral toxicity of candelilla wax following gavage administration 
has been investigated in SD and Hooded Long Evans rats and other rats of undefined strain without 
report of any toxic effects. JECFA reported an oral LD50 of  > 5 000 mg/kg b.w. for candelilla wax in 
rats (JECFA, 1993c).  
Subacute, subchronic and chronic toxicity studies 
JECFA  in  their  evaluation  of  candelilla  wax  described  four  unpublished  short-term  studies 
(8-27 weeks in duration) in rats and one study in dogs (6 months in duration) (JECFA, 1993c). The 
studies in rats used a mixture of candelilla wax and either gum base or a butadiene-styrene polymer. 
The composition of the mixtures administered is not clear from the JECFA report, but the intakes of 
candelilla wax could have been up to 2 400 mg/kg b.w. per day in rats. No treatment-related effects 
were reported in any of these studies (JECFA, 1993c). In the 6-month study in dogs, candelilla wax 
was given in a gum base in the diet at levels equivalent to up to 600 mg candelilla/kg b.w. per day; 
again, no treatment-related effects were reported.   Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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As also reported by JECFA (1993c), in a study in which groups of 30 rats were fed diets containing 0, 
0.8, 2.0 or 5.0 % mixture of gum base containing 25 % candelilla wax for 89 weeks, no significant 
differences  were  reported  between  the  groups  regarding  food  intake,  urinalysis,  haematology  or 
histopathology of major organs (Harrisson, 1953).  
Genotoxicity 
As reported by JECFA (1993c), candelilla wax was not mutagenic in four bacterial mutagenicity 
studies  using  Salmonella  typhimurium,  at  test  concentrations  of  up  to  10  000  µg/plate,  with  and 
without  metabolic  activation.  Candelilla  wax  also  gave  negative  results  in  two  other  studies 
respectively using Escherichia coli and Saccharomyces cerevisiae D4 (JECFA, 1993c). No other in 
vitro or in vivo genotoxicity studies appear to have been carried out with candelilla wax. Available 
studies  on  the  main  components  of  candelilla  wax  (e.g.  straight-chain  hydrocarbons  (C29-C33 
n-alkanes) together with esters of acids and alcohols with even-numbered carbon chains (C28-C34) 
(JECFA, 2006)) do not give rise to concern regarding genotoxicity. 
Carcinogenicity 
As  reported  by  JECFA  (1993c),  a  mixture  of  gum  base  containing  25  %  candelilla  wax  was 
administered to mice at levels of 0, 0.8 or 5.0 % in the diet, corresponding to 0, 1 200 or 7 500 mg/kg 
b.w. per day of gum mixture and approximately 0, 300 or 1 900 mg candelilla wax/kg b.w. per day for 
a period of 12-13 months (Hodge, 1973). The number of deaths in the 5 % dose group was reported by 
the authors to exceed those in the lower or control groups, but the cause of death was not defined. The 
authors concluded that there was no evidence of a carcinogenic effect of candelilla wax in this study 
(JECFA, 1993c).  
JECFA  concluded  that  the  long  term  study  of  Harrisson  (1953)  in  rats  described  above  under 
‗Subacute,  subchronic  and  chronic  toxicity  studies‘  also  did  not  provide  any  evidence  of 
carcinogenicity. 
The  CONTAM  Panel  noted  that  the  main  components  of  candelilla  wax  (e.g.  straight-chain 
hydrocarbons (C29-C33 n-alkanes) together with esters of acids and alcohols with even-numbered 
carbon chains (C28-C34) (JECFA, 2006)) do not give rise to concern with respect to carcinogenicity. 
Developmental and reproductive toxicity  
As reported by JECFA (1993c), in a very limited short-term study three male and three female rats 
were  fed  a  diet  containing  a  1:1  mixture  of  styrene-butadiene  polymer  and  candelilla  wax  at 
concentrations of 0, 680 or 3 420 mg/kg b.w. per day for 5 months prior to mating (Harrisson, 1949). 
The authors reported that two of the three females from each dose group conceived and produced 
normal litters.  
3.12.2.4. Allergenicity 
No information has been found regarding sensitizing capacity, adjuvanticity or irritancy of candelilla 
wax. The CONTAM Panel considers that it is unlikely that candelilla wax after dilution when used as 
a previous cargo will be of concern with regard to sensitization, adjuvanticity or irritancy. 
3.12.3.  Conclusions 
JECFA  concluded  that  dietary  exposures  to  candelilla  wax  of  less  than  650  mg/person  per  day 
(approximately 10 mg/kg b.w. per day), the intake calculated by JECFA from a conservative exposure 
estimate based on the indicated uses of candelilla wax as a food additive, do not raise concern about 
safety. The EFSA ANS Panel noted that the available toxicity studies consistently reported no adverse 
effects  associated  with  intake  of  the  main  components  constituting  candelilla  wax  and  that  the 
exposure estimates allowed to conclude that candelilla wax, within the currently authorised uses as Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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food additive, would not be of safety concern. The CONTAM Panel agreed with this position, and 
concluded that given the likely limited absorption of candelilla wax and the toxicological profile of its 
main component groups of chemicals, this wax will not pose any toxicological concern when used as a 
previous cargo. There is no evidence that it is genotoxic and there is no allergenic potential of concern. 
It will not give rise to any reaction products with fats and oils of toxicological concern. No impurities 
of toxicological concern are known or anticipated. 
The CONTAM Panel therefore concludes that candelilla wax meets the criteria for acceptability as a 
previous cargo. 
According to the information provided to EFSA, the CONTAM Panel noted that candelilla wax does 
not appear to be transported as a previous cargo.  
3.13.  WHITE MINERAL OILS (CAS No 8042-47-5)  
White mineral oil (CAS 8042-47-5) is defined by ECHA
31 as ‗a highly refined petroleum mineral oil 
consisting  of  a complex  combination  of  hydrocarbons  obtained  from  the intensive  treatment  of a 
petroleum  fraction  with  sulfuric  acid  and  oleum,  or  by  hydrogenation,  or  by  a  combination  of 
hydrogenation  and  acid  treatment.  Additional  washing  and  treating  steps  may  be  included  in  the 
processing operation. It consists of saturated hydrocarbons having carbon numbers predominantly in 
the range of C15 through C50‘. Often white mineral oils are deparaffinated (removal of n-alkanes) to 
ensure liquid properties. 
White mineral oils are used mainly in the food industry (e.g. as release agents and for dedusting of 
grain and rice) and for pharmaceuticals. 
Most edible oils contain mineral oil hydrocarbons from the environment, harvesting and/or processing. 
Concentrations around 10-50 mg/kg are common, but some edible oils also regularly contain above 
100 mg/kg mineral oil (such as olive pomace oil, grapeseed oil or cottonseed oil; Wagner et al., 2001; 
Moret  et  al.,  2003,  Biedermann  et  al.,  2009;  EFSA  2012b).  Mostly  the  mineral oils also  contain 
aromatic components. 
3.13.1.  Previous evaluations 
The SCF evaluated white mineral oils as previous cargo in 1996 and considered that oils with a carbon 
number of not less than 25, an average molecular mass not less than 480 and a viscosity not less than 
8.5 centistokes at 100 °C were provisionally acceptable pending submission of further data on chronic 
toxicity/carcinogenicity  (SCF,  1997a).  The  SCF  considered  that  there  were  insufficient  data  to 
establish the safety of other mineral oils. In the 2003 SCF evaluation of acceptable previous cargoes, 
the  Committee  reconsidered  white  mineral  oils  and  concluded  that  the  information  available  was 
inadequate. The SCF therefore maintained their opinion as provisionally acceptable previous cargo 
(SCF, 2003).  
Mineral oil hydrocarbons have been evaluated on a number of occasions for their safety for use as 
food additives by the SCF, EFSA and JECFA.   
An ADI of 0-20 mg/kg b.w. was established by JECFA (1995) for high viscosity (> 11 mm
2/s at 
100 °C)  mineral  oils (synonyms:  liquid  paraffin;  liquid  petrolatum;  food  grade  mineral  oil;  white 
mineral oil). In 2002 JECFA established an ADI of 0-10 mg/kg b.w. for medium- and low-viscosity, 
class I (8.5-11 mm
2/s at 100 °C) mineral oils (synonyms: liquid paraffin; liquid petrolatum; food grade 
mineral oil; white mineral oil) (JECFA, 2002). A temporary group ADI of 0-0.01 mg/kg b.w. was 
established by JECFA (2002) for medium- and low-viscosity, class II (7.0-8.5 mm
2/s at 100 °C) and 
                                                       
31   European  Chemicals  Agency  (ECHA),  online.  White  mineral  oil.  CAS  8042-47-5.  Available  at: 
http://apps.echa.europa.eu/registered/data/dossiers/DISS-9ea08dfc-55a5-3699-e044-00144f67d031/DISS-9ea08dfc-55a5-
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class III (3.0-7.0 mm
2/s at 100 °C) mineral oils, but this was withdrawn in 2012, due to the absence of 
suitable information to enable an ADI to be established or confirmed (JECFA, 2012). 
The  EFSA  ANS  Panel  evaluated  the  safety  of  high  viscosity  white  mineral  oils  (CAS  Registry 
Number  8042-47-5,  chain  lengths  C22-C60,  average  molecular  weight:  > 500  g/mol,  viscosity  at 
100 °C ≥ 11 mm
2/s, carbon number > 25 at 5 % distillation point) when used as food additives and 
established an ADI of 12 mg/kg b.w. based on a NOAEL of 1 200 mg/kg b.w. per day in a chronic 
(12 months) study in Fischer 344 rats (highest dose tested) (EFSA, 2009c). 
The  CONTAM  Panel  has  provided  a  scientific  opinion  on  Mineral  Oil  Hydrocarbons  in  Food, 
concluding that revision of the existing ADIs for some food grade mineral oil saturated hydrocarbons 
is warranted on the basis of new toxicological information (EFSA, 2012b). EFSA (2012b) noted that 
established ADIs are based on toxicological studies with poorly characterised products with regard to 
chemical  composition.  The  CONTAM  Panel  concluded  that  for  high-viscosity  mineral  oils  and 
medium- and low viscosity class I mineral oils, the ADIs established by SCF, FAO/WHO and EFSA 
were based on toxicological studies in which no effects were observed at any tested dose. For those 
grades, it was concluded that although based on products with poor chemical characterisation, the 
existing ADIs were of low priority for revision. The upper bounds of the ADIs were all ≥ 4 mg/kg b.w. 
White mineral oils, paraffinic, derived from petroleum-based hydrocarbon feedstocks, are approved 
for use as a food contact additive in plastics under Commission Regulation (EU) No 10/2011,
24 with 
no restrictions other than the generic overall migration limit of 60 mg/kg food.  
For white mineral oil used as an active substance in pesticides, EFSA concluded that ‗In line with the 
low toxicity of paraffin oils (of high purity), no ADI, AOEL
32 or ARfD
33 would be proposed, nor 
considered necessary, and no risk assessment for operators, workers and bystanders would be 
required‘ (EFSA, 2008b, c). 
3.13.2.  Current evaluation 
3.13.2.1. Expected impurities 
White mineral oils are not expected to contain impurities of concern. 
3.13.2.2. Reactivity and reaction products 
White mineral oils do not react with edible fats and oils. 
3.13.2.3. Toxicological profile 
Absorption, distribution, metabolism and excretion  
Gastrointestinal absorption of white mineral oils is dependent on the physical properties and molecular 
composition of the oil, absorption decreasing with increasing carbon number and extent of side chain 
branching (EFSA, 2012b). Given the carbon numbers of high viscosity and medium and low viscosity 
(P70) white mineral oils, of > 28 and > 25 respectively, absorption will be limited. Any mineral oil 
absorbed is deposited mainly in the liver, mesenteric lymph nodes, spleen and perirenal fat, as shown 
by the results of toxicokinetic and toxicological studies (EFSA, 2012b). Deposited mineral oils will be 
slowly metabolised in the liver to the corresponding fatty alcohols and then fatty acids, with some 
metabolism also occurring in the small intestine, and will enter normal biochemical pathways (EFSA, 
2012b). 
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Acute toxicity 
Mineral oils (high viscosity) and mineral oils (medium and low viscosity) have low acute toxicity, 
with LD50 values > 5 000 mg/kg b.w.  
31(EFSA, 2012b).
 They are non-irritant or slightly irritant to skin 
and eyes.
31  
Subacute, subchronic and chronic toxicity studies 
As reported by SCF (1995), JECFA (2002) and EFSA (2009c, 2012b), repeated ingestion of mineral 
oils results in accumulation of the oils in various tissues, both in humans and in experimental animals, 
in a dose- and time-dependent manner, depending on the molecular composition of the particular oils, 
the carbon number and the extent of side chain branching (EFSA, 2012b). This accumulation results in 
an inflammatory response, characterised by focal histiocytosis, particularly in the mesenteric lymph 
nodes, and granulomas or microgranulomas in the liver and mesenteric lymph nodes. Increases in 
relative  organ  weights  of  liver,  lymph  nodes,  spleen  and  kidneys  also  occur,  together  with 
haematological  changes  indicative  of  a  chronic  inflammatory  reaction  and  biochemical  changes 
associated with mild hepatic damage. It has been demonstrated in a number of studies that the Fischer 
344 rat is markedly more susceptible to the development of these changes than Sprague Dawley rats or 
other strains. The CONTAM Panel in their evaluation of mineral oil hydrocarbons considered that ‗the 
presence  of  microgranulomas/histocytosis  in  MLN
34  is a non specific, adaptative change of low 
toxicological concern‘  (EFSA,  2012b).  The  CONTAM  Panel  concluded  however  that  the  liver 
microgranulomas induced by mineral oils in Fischer 344 rats could be potentially relevant to humans 
and were the critical effect for risk assessment of mineral oils. The NOAEL for the critical effect in 
studies showing these effects was at least 100-fold greater than that for histiocytosis in the mesenteric 
lymph nodes. The lowest NOAEL identified for development of liver microgranulomas following 
administration of mineral hydrocarbons was 19 mg/kg b.w. per day, in a 90-day study in Fischer rats 
(Smith et al., 1996). This was however for mineral waxes, whereas in general the NOAEL for class II 
and II mineral oils was one order of magnitude greater. 
These changes were not seen in toxicological studies with high viscosity mineral oils (e.g. P100) and 
medium and low viscosity class I mineral oils (e.g. P70(H)) and P100(H). For the high viscosity 
P100(H) mineral oils, the ADI of 20 mg/kg b.w. established by JECFA (2002) was based on a no-
observed-effect level (NOEL) of 2 000 mg/kg b.w. per day,  the highest dose tested in a 90 day study 
in Fischer rats. For the class I intermediate and low viscosity P70 mineral oils, the ADI of 10 mg/kg 
b.w. per day was based on an increased incidence of pigmented macrophages in male rats at a dose 
level  of  2  000  mg/kg  b.w  per  day,  an  effect  considered  of  doubtful  biological  significance.  A 
temporary group ADI of 0-0.01 mg/kg b.w. was established by JECFA (2002) for class II and III 
mineral oils, based on the occurrence of histiocytosis of mesenteric lymph nodes in 90-day studies in 
rats, with a NOAEL of 2 mg/kg b.w. per day and an uncertainty factor of 200. This effect is now 
considered to be of no toxicological relevance (EFSA, 2012b), and JECFA withdrew the ADIs of 
these classes in 2012, due to the absence of suitable information to enable an ADI to be established or 
confirmed (EFSA, 2012b). 
Genotoxicity 
The expert reviews carried out by the SCF, JECFA and EFSA have all concluded that refined high 
viscosity mineral oils (e.g. P100) and medium and low viscosity mineral oils with a very low content 
of aromatic compounds are not genotoxic. Negative results were obtained in bacterial  mutagenicity 
tests  without  or  with  metabolic  activation  (Granella  and  Clonfero,  1991;  Mackerer  et  al.,  2003). 
Highly  refined  base  oil  was  negative  in  a  mouse  lymphoma  assay,  with  and  without  metabolic 
activation.
31 As reported by EFSA (2009c), a series of five paraffinic base stocks and two naphthenic 
base stocks were tested in the rat bone marrow cytogenetic assay (CONCAWE, 1984,  as cited in 
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EFSA, 2009c). Negative findings in these base stock oils, all of which are less refined than white 
mineral oils, supports the lack of genotoxicity in refined white mineral oils. 
Carcinogenicity 
Refined high viscosity mineral oils (e.g. P100) and medium and low viscosity class I (e.g.P70) mineral 
oils (with a very low content of aromatics) have not shown any effects of toxicological significance, 
including carcinogenicity, in chronic toxicity/carcinogenicity studies. In the pivotal carcinogenicity 
study for these mineral oils, rats were administered P70H and P100H mineral oils at doses of 0, 60, 
120, 240, or 1 200 mg/kg b.w. per day via the diet. No carcinogenic potential or chronic toxicity was 
observed (Exxon Biomedical Sciences, 2001, as cited in JECFA, 2002). EFSA has also concluded 
that, in chronic toxicity/carcinogenicity studies conducted with high viscosity and medium viscosity 
white oils, no carcinogenic effects were observed in any of the studies in F344 rats or in skin painting 
studies in mice (EFSA, 2009c, 2012b). 
Developmental and reproductive toxicity  
Refined high viscosity mineral oils (e.g. P100) and medium and low viscosity (e.g.P70) mineral oils 
are not considered to show developmental or reproductive toxicity, although there are limited data 
following  administration  by  the  oral  route  (EFSA,  2012b).  As  reported  by  EFSA  (2012b),  in  a 
developmental toxicity study, a sample of white mineral oil (no detail available) was administered to 
female SD rats (20 rats/group) at dose levels of 0 or 5 000 mg/kg b.w. per day from days 6 through 
19 of gestation. No maternal or fetal toxicity were observed 
31. As also reported by EFSA (2012b), a 
light paraffinic distillate extract with a low viscosity and carbon numbers predominantly in the range 
of C15 to C30 was administered by gavage at a dose level of 1000 mg/kg per day in a screening 
reproductive and development toxicity study to rats. 
31 There were no treatment-related effects on pup 
body weights, sex ratios, live litter sizes, viability indices, and general physical conditions and no 
treatment-related  effects  were  observed  on  the  parental  animals.  Studies  by  other  routes  of 
administration support the lack of developmental or reproductive toxicity of white mineral oils (EFSA, 
2012b). 
3.13.2.4. Allergenicity 
In a skin sensitization study in guinea pigs undiluted highly refined base oil was tested, and found not 
to be a sensitizer (Anonymous, 1987g, as cited in ECHA, online). White mineral oil was found not to 
be  sensitizing  in  the  guinea  pig  maximization  test  (Magnusson  and  Kligman,  1969;  Exxon 
Corporation, 1994, as cited in ECB, 2000b). 
White mineral oil appears to be a non-irritant or only slightly irritating for the skin (Hoekstra and 
Phillips, 1963; Anonymous, 1987c, as cited in ECHA, online; Exxon Corporation, 1994, as cited in 
ECB,  2000b).  However,  the  use  of  mineral  oils  of  unspecified  purity  in  cutting  fluid  has  been 
associated with dermatitis in metal workers (Pryce at al., 1989). Emulsions of purified mineral oil with 
allergens have been much used as immune adjuvants in particular in animals (White, 1963) and the 
question  has  been  raised  whether  mineral  oil  exposure  may  under  some  circumstances  promote 
autoimmunity (Whitehouse, 2012). 
Considering the high dilution factor, the CONTAM Panel considers that white mineral oils are not of 
concern with regard to sensitization, irritancy or adjuvanticity when used as a previous cargo.   
3.13.3.  Conclusions 
The SCF, JECFA and/or EFSA have established ADIs of ≥ 4 mg/kg b.w. for  high viscosity and 
medium- and low-viscosity, class I mineral oils. Whilst the CONTAM Panel considers that these may 
need to be revised as they were based on products with poor chemical characterisation, this is not a 
high priority given their toxicological profile, and there would be no toxicological concern from their 
use as previous cargoes. There are no ADIs for class II and III mineral oils. However, the lowest Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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relevant NOAEL available is 19 mg/kg b.w. per day from a 90-day study in Fischer rats. This was for 
mineral waxes, whereas in general the NOAEL for class II and III mineral oils was one order of 
magnitude greater. White mineral oils are not genotoxic and they would not be expected to be of 
concern for  allergenicity when  used  as  previous cargoes. They  will not  give  rise to any  reaction 
products with fats and oils of toxicological concern. The only potential impurities of toxicological 
concern are PAHs, which are controlled to low levels in these mineral oils.  
The CONTAM Panel notes that some aliphatic hydrocarbons bioaccumulate in the body,  such as 
branched and cyclic species in the mass range of 16-35 carbon atoms. However, since exposure to 
mineral oil hydrocarbons via contamination of edible fats and oils from previous cargoes occurs only 
rarely and mostly at levels lower than those observed in edible oils, it will contribute little to overall 
exposure. Further, humans are exposed to mineral oil hydrocarbons from numerous sources. 
The CONTAM Panel therefore concludes that white mineral oils meet the criteria for acceptability as 
a previous cargo. 
3.14.  GLYCERINE (glycerol; glycerin) (CAS No 56-81-5)  
The CONTAM Panel noted that the term glycerine is rarely used to refer to this substance. It is more 
normally  referred  to  as  glycerol  (glycerin  is the  German  name  of  the  substance),  and  this  is the 
preferred name. The IUPAC name is propane-1,2,3-triol.    
Glycerol is a viscous liquid, miscible with water. It is the backbone of triglycerides (fats and oils). It is 
obtained  from  fats  and  oils,  either  from  saponification  or  from  transesterification  with  methanol 
(biodiesel;  today  the  main  source).  It  is  also  produced  from  propene  via  allyl  chloride, 
dichloropropanol and epichlorohydrine. Synthetic glycerol is used only when the highest purity is 
required, as in pharmaceuticals and some food grade products. 
Glycerol  is  used  to  produce  e.g.  glycerol  trinitrate  (nitroglycerol,  dynamite),  alkyd  resins, 
polyurethanes,  hydraulic  fluids,  antifreeze,  cosmetics,  humectants  (e.g.  in  foods)  and  for  the 
production of various food components, such as emulsifiers. 
3.14.1.  Previous evaluations 
The SCF evaluated glycerol as a previous cargo in 1996 and considered it as acceptable (SCF, 1997a). 
This conclusion was based on the fact that glycerol was a food additive, E 422, and component of 
food, with an ADI not specified (SCF, 1981). In the 2003 SCF evaluation of acceptable previous 
cargoes, glycerol was not further considered as it was already considered acceptable (SCF, 2003).  
JECFA evaluated glycerol as a food additive and established an ADI ‗not specified‘ at its 20
th meeting 
(JECFA, 1976). JECFA evaluated glycerol again in 2001 as a flavouring substance and maintained the 
ADI ‗not specified‘ (JECFA, 2001).  
The SCF evaluated glycerol as a food additive and as an extraction solvent for food, and agreed with 
the JECFA 1976 evaluation, that an ADI need not be specified (SCF, 1981).  
The CONTAM Panel has evaluated crude glycerol derived from biodiesel production and concluded 
that such glycerol up to a level of 15 % in the diet of ruminants and up to 10 % in the diet of 
monogastric animals had no adverse effects on animal health (EFSA, 2010). Glycerol is considered as 
a feed material under Commission Regulation (EU) 892/2010,
35 with no maximum levels assigned.   
Glycerol has been evaluated under the OECD SIDS programme on HPV  chemicals (OECD, 2002). 
Overall, it was concluded that it was of low priority for further work.  
                                                       
35   Commission  Regulation  (EU)  No  892/2010 of  8  October  2010 on  the  status of  certain  products with  regard  to  feed 
additives within the scope of Regulation (EC) No 1831/2003 of the European Parliament and of the Council, OJ L 266, 
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Glycerol is approved for use as a food contact additive in plastics under Commission Regulation (EU) 
No 10/2011,
24 with no restrictions other than the generic overall migration limit of 60 mg/kg food.  
3.14.2.  Current evaluation 
3.14.2.1. Expected impurities 
Crude glycerol from transesterification will contain alkali and methanol as the main impurities. When 
prepared by saponification it will contain alkali and free fatty acids as impurities. These impurities will 
not be of any concern when glycerol is used as a previous cargo. 
Crude  glycerol  obtained  by  chemical  synthesis  could  contain  some  unreacted  allyl  chloride, 
dichloropropanol and epichlorohydrin. Epichlorohydrin is fairly reactive in the presence of acid, but it 
is uncertain whether it reacts with components of edible fats and oils. However, as synthetic glycerol 
is only used after substantial purification, these impurities are not expected to be of concern when 
glycerol is used as a previous cargo. 
3.14.2.2. Reactivity and reaction products 
Glycerol may react with fats and oils through transesterification, but this is not expected to yield 
products of concern. 
3.14.2.3. Toxicological profile 
Absorption, distribution, metabolism and excretion  
Glycerol occurs endogenously in the body as a result of hydrolysis of glycerol esters in the intestine, 
followed by absorption from the intestinal mucosa (JECFA, 2001). Following metabolism to glycerol-
3-phosphate in the liver and to a minor extent in the kidney, intestine and other tissues, it is oxidized in 
several  steps  to  pyruvic  acid.  Glycerol  also  combines  with  free  fatty  acids  in  the  liver  to  form 
triglycerides. There is generally no excretion of free glycerol in the urine, due to complete metabolic 
conversion to other products (JECFA, 2001; OECD, 2002).  
Acute toxicity 
As reported by OECD (2002), glycerol is of low acute oral toxicity, with LD50s > 20 000 mg/kg b.w. 
in  rats,  mice  and  rabbits.  At  doses  approaching  the  LD50,  signs  of  toxicity  include  tremors, 
convulsions, CNS depression and hyperaemia of the gastrointestinal tract (OECD, 2002).  Glycerol is 
slightly irritant to skin and eyes (OECD, 2002).  
Subacute, subchronic and chronic toxicity studies 
Rats were administered glycerol in the diet at levels of up to 60 %, providing intakes of  0, 1 000, 
3 000, 6 000, 10 000, 15 000, 20 000, 30 000, 40 000, 500 00 or 60 000 mg/kg b.w. per day for 
20 weeks (Guerrant and Whitlock, 1947, as cited in JECFA, 2001). Treatment-related changes were 
restricted to reduced body-weight gain in rats receiving > 40 000 mg/kg b.w. per day and hydropic and 
fatty degeneration of hepatocytes in rats receiving > 10 000 mg/kg b.w. per day. The NOAEL in this 
study was identified as 6 % glycerol in the diet, equivalent to 6 000 mg/kg b.w. per day (Guerrant and 
Whitlock, 1947, as cited in JECFA, 2001). 
JECFA in 1976 reported the results of a long-term study in which rats were given glycerol in the diet 
at a concentration of 0, 5, 10 or 20 % (equivalent to 0, 2 500, 5 000, or 10 000 mg/kg b.w. per day) for 
2 years, also including an interim kill at 12 months. No treatment-related effects were reported on 
body weight or on histological examination of major organs. The only treatment-related change was 
an  increase  in  relative  kidney  weights  at  10  000  mg/kg  b.w.  per  day,  unaccompanied  by 
histopathological changes. The author of the study identified a NOEL of 10 000 mg/kg b.w. per day, 
the highest dose tested (Atlas Chemical Co., 1969, as cited in JECFA, 1976). Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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In another 2-year rat study reported by both JECFA (2001) and OECD (2002) male rats received  
2 000, 4 000 or 8 000 mg/kg b.w. per day glycerol in the diet and females received 2 500, 5 000 and 
10 000 mg/kg b.w. per day. No treatment-related effects were reported in this study other than a slight 
increase in food consumption in males receiving 4 000 or 8 000 mg/kg b.w. per day glycerol. The 
author of the report concluded that the NOAEL was greater than 10 000 mg/kg b.w. (Hine et al., 1953, 
as cited in JECFA, 2001 and OECD, 2002).  
Genotoxicity 
As reported by both JECFA (2001) and OECD (2002), glycerol did not induce mutations in a bacterial 
mutagenicity study, with and without metabolic activation and was negative in a mammalian cell gene 
mutation  test  (HGPRT).  Glycerol  did  not  induce  chromosomal  aberrations  or  sister  chromatid 
exchanges in CHO cells (JECFA, 2001; OECD, 2002). In a bone marrow chromosome aberration test 
with  rats,  glycerol  did  not  induce  a  statistically  significant  increase  in  chromosomal  aberrations 
compared  to  controls  (Varilyak  and  Kozachuk,  1985).  OECD  noted  however  that  no  reliable 
conclusions could be drawn from this study due to the limited details available, the small number of 
animals used and the absence of a positive control (OECD, 2002). Overall, glycerol is considered to 
possess no genotoxic potential. 
Carcinogenicity 
There was no evidence of carcinogenicity in two 2-year oral toxicity studies in the rat, reported under 
‗chronic  toxicity‘  above.  Data  from  tumour  promotion  studies  in  male  mice  indicated  that  oral 
administration of glycerol for up to 20 weeks had a weak promotion effect on the incidence of lung 
tumour formation (Nagahara, 1987; Inayama, 1986, as cited in OECD, 2002). Overall, these data do 
not indicate that glycerol has carcinogenic potential. 
Developmental and reproductive toxicity  
As reported by OECD (2002), a two generation study was conducted with glycerol administered by 
gavage as a 20 % solution in water (providing 2 000 mg/kg b.w. per day). No effects were found on 
the reproductive efficiency of the parents, nor on the growth, fertility or reproductive performance of 
the untreated F1 generation, and no histological changes occurred in the tissues of either the F1 or F2 
generation.  The  NOAEL  was  therefore  identified  as  2  000  mg/kg  b.w.,  the  highest  dose  tested 
(Wegener, 1953, as cited in OECD, 2002). 
In an oral gavage study, rats, mice and rabbits were administered glycerol at doses of 1 310, 1 280 and 
1 180 mg/kg b.w. during part of the gestation period. No maternal toxicity or teratogenic effects were 
seen at the highest dose levels tested (N.T.I.S., 1974, as cited in OECD, 2002).  
A study of fertility in 64 male workers involved in glycerol manufacture reported no significant effects 
on sperm quality parameters (Venable et al., 1980). The CONTAM Panel noted that although the 
workers  were  involved  in  glycerol  manufacture,  exposure  to  epichlorhydrin,  allyl  chloride  and 
1,3-dichloropropene was the specific focus of the study.  
3.14.2.4. Allergenicity 
Glycerol has low irritancy and is considered to be a weak sensitiser based on human data (El-Nagdy et 
al., 1973; Preston and Finch, 2003; Fairhurst and Wilkinson, 2007; Tamagawa-Mineoka et al., 2007). 
A guinea pig study on glycerol found no capacity for sensitization (Hine et al., 1953, as cited in 
JECFA,  2001  and  OECD,  2002).  No  information  has  been  found  regarding  adjuvanticity.  The 
CONTAM Panel considers that the available data indicate that glycerol when used as a previous cargo 
would be of no concern as an allergen or adjuvant. Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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3.14.3.  Conclusions 
The CONTAM Panel notes that the name glycerine is rarely used to refer to this substance. It is more 
normally referred to as glycerol, which is the preferred name. The IUPAC name is propane-1,2,3-triol. 
The  CONTAM  Panel  therefore  recommends  that  the  entry  for  the  substance  in  the  Annex  to 
Commission  Directive  96/3/EC
5  is  amended  to ‗Glycerol  (glycerine;  glycerin;  propane-1,2,3-triol) 
(CAS No 56-81-5)‘.  
Both JECFA and the SCF have established an ADI not specified for glycerol, which the CONTAM 
Panel  considers  appropriate.  Glycerol  is  not  genotoxic  and  there  are  no  concerns  regarding  its 
allergenicity when it is used as a previous cargo. There are no reactions of concern with edible fats and 
oils, nor are any anticipated impurities likely to be present at levels of toxicological relevance.  
The  CONTAM  Panel  therefore  concludes  that  glycerol  meets  the  criteria  for  acceptability  as  a 
previous cargo. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
  Substances  transported in bulk  as  previous  cargoes are  often  rather  crude  and  usually  no 
specific  information  is  available  on  the  impurities  present.  Hence,  the  EFSA  Panel  on 
Contaminants in the Food Chain (CONTAM Panel) often had to determine which impurities 
might be present primarily from assessment of the source or starting material and method of 
preparation of the substance to be transported. Chemicals transported as previous cargoes may 
vary  in  composition,  depending  on  their  method  of  preparation,  details  for  which  were 
obtained, in part, from information obtained from FOSFA. The CONTAM Panel based its 
evaluations on worst case assumptions on these aspects.
36  
  The  CONTAM  Panel  considered  that  it  should  be  possible  to  measure  the  relevant 
components  of  a  previous  cargo  in  the  edible  oil  or  fat  transported  later.  However,  it  is 
unrealistic to expect that corresponding analytical methods are immediately available, since 
fats  and  oils  are  not  routinely  analysed  for  the  presence  of  most  previous  cargoes.  It  is 
sufficient  that  the  development  of  a  corresponding  method  is  feasible  with  standard 
techniques.
 36 
  Sodium silicate (water glass) solution (CAS No 1344-09-8). Toxicological effects of sodium 
silicate  following  acute  and  repeat  dosing  are  mostly  due  to  high  alkalinity.  However, 
following  ingestion  it  will  be  diluted  and  buffered  by  the  neutralising  capacity  of  the 
gastrointestinal tract. Thus the CONTAM Panel considered that the levels that would occur 
following  oral  ingestion  of  fats  and  oils  transported  subsequent  to  sodium  silicate  as  a 
previous  cargo  would  not  give  rise  to  any  toxicological  concern.  Although  there  are  no 
carcinogenicity studies available sodium silicate did not show any genotoxic activity in a 
variety of in vitro and in vivo assays thus indicating no genotoxic potential. Available data 
give no indication that sodium silicate is an allergen or an adjuvant at concentrations expected 
from its use as a previous cargo. Exposure to sodium silicates can be irritating or corrosive to 
the skin, however the potential levels arising in fats and oils following its transport as previous 
cargo would be of no concern. There are no reactions of concern with edible fats and oils, nor 
are any anticipated impurities likely to be present at levels of toxicological concern. The 
CONTAM  Panel  therefore  concludes  that  sodium  silicate  solution  meets  the  criteria  for 
acceptability as a previous cargo for edible fats and oils. 
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on this topic (Part I of III (EFSA, 2011) and Part II of III (EFSA, 2012a)).   Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
 
 
61  EFSA Journal 2012;10(12):2984 
  Iso-octanol (isooctyl alcohol) (CAS no 26952-21-6), iso-nonanol (isononyl alcohol) (CAS 
no 27458-94-2) and iso-decanol (isodecyl alcohol) (CAS no 25339-17-7). Iso-octanol, iso-
nonanol and iso-decanol were classified by the former Scientific Committee on Food (SCF) in 
its last  re-evaluation  in  2003  as  provisionally  acceptable  as  previous  cargoes  because  the 
information available was considered inadequate or limited. The CONTAM Panel used a ‗read 
across‘ from the assessment profile of oxo-alcohols C9-C13 category (OECD, 2006) to fill 
data gaps on the toxicological profile of iso-octanol, iso-nonanol and iso-decanol. They are of 
a  low  order  of  toxicity  following  acute  and  repeated  exposures  upon  oral,  dermal  or 
inhalational exposure. The lack of effects found in the limited studies available suggests that 
they are not genotoxic. They are not allergenic and there are no reactions of concern with 
edible  fats  and  oils,  nor  are  any  anticipated  impurities  likely  to  be  present  at  levels  of 
toxicological concern. The CONTAM Panel therefore concludes that iso-decanol, iso-nonanol 
or iso-octanol meet the criteria for acceptability as previous cargoes for edible fats and oils. 
  1,3-Propanediol  (1,3-Propylene  glycol;  trimethylene  glycol)  (CAS  No  504-63-2).  1,3-
Propanediol is of low systemic toxicity when administered by the oral route. There are no 
carcinogenicity data but the available evidence indicates that 1,3-propanediol does not have 
any genotoxic potential. 1,3-Propanediol is not an allergen. There are no reactions of concern 
with edible fats and oils, nor are any anticipated impurities likely to be present at levels of 
toxicological concern. Therefore, the CONTAM Panel concludes that 1,3-propanediol meets 
the criteria for acceptability as a previous cargo for edible fats and oils. 
  Isobutyl acetate (2-methylpropyl acetate) (CAS No 110-19-0). The toxicity of acetate, one 
of  the  major  metabolites of  isobutyl  acetate,  was addressed in  a  previous  Opinion  of  the 
CONTAM  Panel  (EFSA,  2012a),  when  it  was  considered  that  there  would  be  no  health 
concerns  following  the  maximum  potential  carryover  into  edible  fats  and  oils  when  it  is 
transported  as  a  previous  cargo.  In  its  evaluation  of  previous  cargoes  in  1996,  the  SCF 
concluded that isobutanol, the other major metabolite, was ‗not acceptable‘, because ‗limited 
toxicological data indicates a suspicion of carcinogenic concerns.‘ In a re-evaluation in 2003, 
the SCF maintained its previous opinion that this substance was not acceptable as a previous 
cargo because the Committee was aware of a number of issues that still needed clarification. 
The CONTAM Panel considered isobutanol as a previous cargo for edible fats and oils in 
2009, and concluded that it was acceptable, based on the low level of toxicity observed in a 
more recent chronic study, as well as its volatility and ease of tank cleaning (EFSA, 2009b). 
Although  the  toxicological  database  for  isobutyl  acetate  is  limited,  available  data  on  this 
substance and on its hydrolysis products, acetic acid and isobutanol, suggest that isobutyl 
acetate is of relatively low systemic toxicity. It is not genotoxic or allergenic. There are no 
reaction products or impurities expected to be of toxicological concern. The CONTAM Panel 
therefore concludes that  isobutyl  acetate  meets the criteria for  acceptability  as  a  previous 
cargo for edible fats and oils.  
  Sec-butyl acetate (CAS No 105-46-4). There are no data on repeated-dose toxicity of sec-
butyl acetate. It is a Cramer class I substance, with a threshold of toxicological concern of 
1 800 µg/person per day. It is rapidly metabolised to acetate and sec-butanol, which can be 
further  metabolised  to  methyl  ethyl  ketone  (MEK).  The  CONTAM  Panel  has  previously 
evaluated acetic acid and MEK for their suitability as previous cargoes for edible fats and oils 
and concluded that they meet the criteria for acceptability (EFSA, 2012a). sec-Butanol is not 
genotoxic.  The  information  available  on  sec-butanol  does  not  indicate  any  toxicological 
concern at the exposure levels that might occur from the transport of sec-butyl acetate as a 
previous cargo to edible fats and oils. sec-Butyl acetate is not allergenic. There are no reaction 
products or impurities of toxicological concern. The CONTAM Panel therefore concludes that 
sec-butyl acetate meets the criteria for acceptability as a previous cargo for edible fats and 
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  Tert-butyl acetate (CAS No 540-88-5). The toxicological database on tert-butyl acetate is 
somewhat limited. The available data on tert-butyl acetate and on acetate and tert-butanol, its 
major metabolites, do not give rise to concerns regarding systemic toxicity, developmental 
toxicity or genotoxicity. Any carcinogenic risk would likely be from a non-genotoxic mode of 
action and would not be of concern at the levels of exposure that might occur from the use of 
tert-butyl  acetate  as  a  previous  cargo  for  edible  fats  and  oils.  tert-Butyl  acetate  is  not 
allergenic.  There  are  no  reaction  products  or  impurities  of  toxicological  concern.  The 
CONTAM Panel therefore concludes that tert-butyl acetate meets the criteria for acceptability 
as a previous cargo for edible fats and oils. 
  n-Butyl  acetate  (CAS  No  123-86-4).  The  SCF  established  a  temporary  acceptable  daily 
intake (ADI) of 0-6 mg/kg for n-butyl acetate, on the basis of limited data. The toxicological 
database has several data gaps (no repeat dose studies by the oral route, no studies of chronic 
toxicity or carcinogenicity). However, there were sufficient data on its major metabolites, 
acetate and n-butanol, for the CONTAM Panel to conclude previously that these are not of 
concern, when used as previous cargoes. n-Butyl acetate is not genotoxic. The CONTAM 
Panel considers that the available information on the acute effects of n-butyl acetate and on its 
subchronic,  reproductive  and  developmental  toxicity  following  exposure  by  the  inhalation 
route, together with information on its major metabolites, was sufficient to conclude that the 
risk from short-term exposure to n-butyl acetate when used as a previous cargo would not give 
rise to any toxicological concern. There are no concerns regarding the allergenicity of n-butyl 
acetate. There are no reaction products or impurities of toxicological concern. The CONTAM 
Panel therefore concludes that n-butyl acetate meets the criteria for acceptability as a previous 
cargo for edible fats and oils. 
  Propylene tetramer (CAS No 6842-15-5). Although specific studies on propylene tetramer 
itself are somewhat limited, data are available on many of its main components and mixtures 
of these. In general, the toxicological profile of alkenes depends on carbon length, and is 
similar for those with similar carbon length. The CONTAM Panel considers that propylene 
tetramer would not be of toxicological concern at the levels that would occur when used as a 
previous cargo for edible fats and oils. Although there are no studies of carcinogenicity, the 
CONTAM Panel concludes that in the absence of genotoxicity or of pathological changes in 
subchronic studies indicative of a potential carcinogenic hazard, there was no concern for 
possible carcinogenicity from the use of propylene tetramer as a previous cargo. Propylene 
tetramer  is  not  allergenic.  There  are  no  reaction  products  or  impurities  of  toxicological 
concern. The CONTAM Panel therefore concludes that propylene tetramer meets the criteria 
for acceptability as a previous cargo for edible fats and oils. 
  Montan  wax  (CAS  No  8002-53-7).  No  ADI  or  tolerable  daily  intake  (TDI)  has  been 
established for montan wax by the SCF, the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) or the European Food Safety Authority (EFSA). Data recently provided to 
the European Chemicals Agency (ECHA) indicate that montan wax is not mutagenic in a 
bacterial mutagenicity test, and the CONTAM Panel considers that it is not likely to be a 
significant  sensitizer,  adjuvant  or  irritant.  In  a  subchronic  toxicity  study  in  rats, 
haematological  changes  and  hepatotoxicity  were  observed  at  the  lowest  dose  tested,  of 
approximately 260 mg/kg body weight (b.w.) per day, and hence no no-observed-adverse-
effect  level  (NOAEL)  could  be  identified.  There  are  no  data  on  chronic  toxicity  or 
carcinogenicity. Montan wax is an ill-defined material for which it cannot be excluded that it 
contains components of concern. The CONTAM Panel therefore concludes that, given the 
deficiencies in the available data on montan wax, it does not meet the criteria for acceptability 
as a previous cargo. 
  Paraffin wax (food grade) (CAS No 8002-74-2 / 63231-60-7). Paraffin wax may contain 
aromatic hydrocarbons, some of which are genotoxic carcinogens.  Hence, the CONTAM 
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been treated to remove aromatic hydrocarbons and which otherwise meet relevant standards to 
be considered as ‗food grade‘.   
An ADI of 0-20  mg/kg b.w. has been established by both JECFA and the SCF for high 
molecular mass food-grade microcrystalline wax, with specifications as laid down according 
to  Commission  Directive  2008/84/EC  and  JECFA  (2008).  The  CONTAM  Panel  (EFSA, 
2012b) noted that this ADI was established from toxicological studies in which no effects 
were observed at any tested dose. Food grade paraffin wax is not genotoxic or allergenic. It 
will not give rise to any reaction products with fats and oils of toxicological concern. No 
impurities of toxicological concern are known or anticipated. The CONTAM Panel therefore 
concludes that paraffin wax (food grade, CAS No. 8002-74-2 / 63231-60-7) meets the criteria 
for acceptability as a previous cargo.  
  Carnauba  wax  (Brazil  wax)  (CAS  No  8015-86-9).  JECFA  have  established  an  ADI  of 
0-7 mg/kg b.w. for carnauba wax, while the SCF concluded that its use as a glazing agent up 
to a maximum use level of 200 mg/kg of food was acceptable. The EFSA Panel on Food 
Additives and Nutrient Sources added to Food (ANS Panel) noted in its re-evaluation of 
carnauba  wax  as  a  food  additive  carried  out  in  2012,  that  available  toxicity  studies 
consistently reported no adverse effects associated with carnauba wax intake, and that the 
exposure  estimates  to  carnauba  wax  allowed  the  conclusions  that,  within  the  currently 
authorised  as  a  food  additive,  it  would  not  be  of  safety  concern.  The  CONTAM  Panel 
considered, based on the outcome of these expert evaluations, the likely limited absorption of 
carnauba wax and the toxicological profile of its main component groups of chemicals, that 
this wax will not pose any toxicological concern when used as a previous cargo, based on 
normal assumptions regarding worst case carryover. There is no evidence that it is genotoxic 
and there is evidence that the allergenic potential is very low and therefore of no concern in 
the context of previous cargoes. It will not give rise to any reaction products with fats and oils 
of toxicological concern. No impurities of toxicological concern are known or anticipated. 
The  CONTAM  Panel  noted  however,  the insolubility  of  carnauba  wax  in  water, its  high 
melting point (82 to 86 °C) and the fact that heating of ships‘ tanks is normally to a maximum 
of  80  °C.  The  CONTAM  Panel  therefore  has  concerns  regarding  the  feasibility  of  tank 
cleaning following transport of carnauba wax as a previous cargo, such that carryover may 
exceed the worst case normally assumed. The CONTAM Panel concludes that carnauba wax 
does not meet the criteria for acceptability as a previous cargo because of doubts concerning 
the efficiency of tank cleaning following transport of carnauba wax as a previous cargo.  
  Candelilla Wax (CAS No 8006-44-8). JECFA concluded that dietary exposures to candelilla 
wax of less than 650 mg/person per day (approximately 10 mg/kg b.w. per day), the intake 
calculated by JECFA from a conservative exposure estimate based on the indicated uses of 
candelilla wax as a food additive, do not raise concern about safety. The ANS Panel noted in 
its re-evaluation of candelilla wax as a food additive carried out in 2012, that the available 
toxicity studies consistently reported no adverse effects associated with intake of the main 
components  constituting  candelilla  wax  and  that  the  exposure  estimates  allowed  the 
conclusion that, within the currently authorised uses as a food additive, it would not be of 
safety concern. The CONTAM Panel agreed with this position, and concluded that given the 
likely limited absorption of candelilla wax and the toxicological profile of its main component 
groups of chemicals, this wax will not pose any toxicological concern when used as a previous 
cargo. There is no evidence that it is genotoxic and there is no allergenic potential of concern. 
It will not give rise to any reaction products with fats and oils of toxicological concern. No 
impurities of toxicological concern are known or anticipated. The CONTAM Panel therefore 
concludes that candelilla wax meets the criteria for acceptability as a previous cargo.    
  White mineral Oils (CAS No 8042-47-5). The SCF, JECFA and/or EFSA have established 
ADIs of ≥ 4 mg/kg b.w. for high viscosity and medium- and low-viscosity, class I mineral 
oils. Whilst the CONTAM Panel considers that these may need to be revised as they were Re-evaluation of acceptable previous cargoes for edible fats and oils – Part III of III 
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based on products with poor chemical characterisation, this is not a high priority given their 
toxicological profile, and there would be no toxicological concern from their use as previous 
cargoes. There are no ADIs for class II and III mineral oils. However, the lowest relevant 
NOAEL available is 19 mg/kg b.w. per day from a 90-day study in Fischer rats. This was for 
mineral waxes, whereas in general the NOAEL for class II and III mineral oils was one order 
of magnitude greater. White mineral oils are not genotoxic and they would not be expected to 
be of concern for allergenicity when used as previous cargoes. They will not give rise to any 
reaction products with fats and oils of toxicological concern. The only potential impurities of 
toxicological concern are polycyclic aromatic hydrocarbons (PAHs), which are controlled to 
very  low  levels  in  these  mineral  oils.  The  CONTAM  Panel  notes  that  some  aliphatic 
hydrocarbons bioaccumulate in the body, such as branched and cyclic species in the mass 
range  of  16-35  carbon  atoms.  However,  since  exposure  to  mineral  oil  hydrocarbons  via 
contamination of edible fats and oils from previous cargoes occurs only rarely and mostly at 
levels lower than those observed in edible oils, it will contribute little to overall exposure. The 
CONTAM Panel therefore concludes that white mineral oils meet the criteria for acceptability 
as a previous cargo 
  Glycerol (Glycerine; glycerine; propane-1,2,3-triol) (CAS No 56-81-5). Both JECFA and 
the  SCF  have  established  an  ADI  not  specified  for  glycerol,  which  the  CONTAM  Panel 
considers  appropriate.  Glycerol  is  not  genotoxic  and  there  are  no  concerns  regarding  its 
allergenicity when it is used as a previous cargo. There are no reactions of concern with edible 
fats and oils, nor are any anticipated impurities likely to be present at levels of toxicological 
relevance.  The  CONTAM  Panel  therefore  concludes  that  glycerol  meets  the  criteria  for 
acceptability as a previous cargo. 
RECOMMENDATIONS 
The  CONTAM  Panel  recommends  that  a  number  of  amendments  be  made  to  the  entries  of  the 
substances in the Annex to Commission Directive 96/3/EC.
5 
  The entry for ‗Sodium silicate (water glass) (CAS No 1344-09-8‘ be amended to ‘Sodium 
silicate (water  glass) solution (CAS No 1344-09-8)’ to reflect contemporary shipping 
practices. 
  The entry for ‗1,3-Propylene glycol (trimethylene glycol; 1.3-propanediol) (CAS No 504-
63-2)‘ be amended to ‘1,3-Propanediol (1,3-propylene glycol; trimethylene glycol (CAS 
No 504-63-2)’ to reflect accepted chemical nomenclature. 
  The entry for ‗iso-Butyl acetate (CAS No 110-19-0)‘ be amended to ‘Isobutyl acetate (2-
methylpropyl acetate) (CAS No 110-19-0)’ to reflect accepted chemical nomenclature.  
  The entry for ‗Paraffin wax (CAS No 8002-74-2 / 63231-60-7)‘ be amended to ‘Paraffin 
wax (food grade) (CAS No 8002-74-2 / 63231-60-7)’ since other grades may contain 
aromatic hydrocarbons which could pose an unacceptable risk if such waxes were to be 
transported as previous cargoes to edible fats and oils.  
  The CONTAM Panel recommends that the entry for ‗Glycerine (glycerol; glycerin) (CAS 
No 56-81-5)‘ be amended to ‘Glycerol (glycerine; glycerin; propane-1,2,3-triol) (CAS 
No 56-81-5)’ to reflect accepted chemical nomenclature.    
The  entries  in  the  Annex  to  Commission  Directive  96/3/EC  for  the  substances  evaluated  in  this 
Opinion as previous cargoes for edible fats and oils are listed in Table 4, amended as recommended by 
the CONTAM Panel. 
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Table 4:   Substances in the list to Annex to Commission Directive 96/3/EC
5 listed as acceptable 
previous cargoes for edible fats and oils with amendments recommended by the CONTAM Panel 
(entries in bold).  
Substance (synonyms)  CAS Number 
Sodium silicate (water glass) solution  1344-09-8 
iso-Octanol (isooctyl alcohol)  26952-21-6 
iso-Nonanol (isononyl alcohol)  27458-94-2 
iso-Decanol (isodecyl alcohol)  25339-17-7 
1,3-Propanediol (1,3-propylene glycol; trimethylene glycol)  504-63-2 
Isobutyl acetate (2-methylpropyl acetate)   110-19-0 
sec-Butyl acetate  105-46-4 
tert-Butyl acetate  540-88-5 
n-Butyl acetate  123-86-4 
Propylene tetramer  6842-15-5 
Paraffin wax (food grade)  8002-74-2 / 63231-60-7 
Candelilla wax  8006-44-8 
White mineral oils  8042-47-5 
Glycerol (Glycerine; glycerine; propane-1,2,3-triol)  56-81-5 
 
The CONTAM Panel recommends that when new substances are to be evaluated as previous cargoes 
for the bulk transport by sea of edible fats and oils, the interested party should provide information 
adequate for EFSA to carry out a scientific evaluation, including information on:  
  the identity and specification (including impurities) of the substances to be evaluated, 
  their chemical composition, 
  the form in which they are transported (e.g. in solution), 
  the chemical reactivity with fats and oils, 
  published  data  on  toxicological  studies  (including  acute  and  chronic  toxicity  studies, 
reproductive and developmental toxicity studies, carcinogenicity and genotoxicity studies) and 
allergenicity and adjuvanticity.  
  similar information on the toxicity of any significant impurities and reaction products with fats 
and oils. 
  where an impurity (or reaction product) is not considered significant, an explanation for this 
conclusion. 
Information should also be supplied on ease of tank cleaning, including any need for heating of the 
transfer equipment.      
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DOCUMENTATION PROVIDED TO EFSA 
1.  FOSFA International. Response from FOSFA International following a meeting the EFSA 
Working Group on Previous Cargoes, 3 April 2012. Submitted to EFSA on 18 April 2012. 
WAXES 
Question: the WG requested information on the current transport of the different waxes listed 
as acceptable previous cargoes for edible fats and oils. 
With regard to the various waxes, the IBC Code does not differentiate but simply contains an entry 
―Waxes‖, which is pollution Category Z and ship type 3 (lowest safety requirement ship). My contacts 
understand that in most cases where wax is carried, it is petroleum wax. They have never heard of 
anyone  carrying  beeswax,  candelilla  wax  or  carnauba  wax,  but  they  will  check  with  the  trade 
association membership to ensure they are not carried. 
(Follow-up reply submitted by FOSFA to EFSA on 30.05.2012). I have made further enquiries into the 
carrying of waxes in bulk by sea. As far as I can determine, these waxes are not carried in bulk. There 
is not enough shipment to justify bulk cargoes. I believe that they are not carried in bulk by sea. Also, 
these products do not appear in the IBC Code, and products which do not appear in the code, and are 
not covered by a tripartite agreement (an agreement between the exporting country, the importing 
country and the flag state of the ship carrying the cargo) cannot be carried in bulk by sea.  
PROPYLENE TETRAMER 
Question:  the  WG  requested  information  on  the  identity  of  the  material  that  is  carried  as 
previous cargo for edible fats and oils.  
Propylene Tetramer  is  a branched  olefin  produced by  the  polymerization  of  propylene.  It  is  also 
commonly referred to as dodecene. Propylene Tetramer is used in the production of dodecylphenol, 
tridecyl alcohol, branched dodecylbenzene sulfonic acid, and dodecylsuccinic anhydride which in turn 
are  used  to  produce  plasticizers,  surfactants,  lube  oil  additives,  emulsifiers  for  herbicides,  and 
corrosion inhibitors in alkyd and epoxy coatings. 
The material which is shipped seems to be a blend of isomers of which about 65% are 1-propene.  
Another MSDS lists a detailed breakdown of the isomers which are present: 
Components                              CAS Registration Number   Weight %    
Trimethylheptene Isomers     102943-77-1       0.5 to 2     
Tetramethylheptene Isomers     103982-56-5       3 to 6     
Trimethyloctene Isomers     103985-01-9       3 to 6     
Tetramethyloctene Isomers     105902-19-0       20 to 25     
Trimethylnonene Isomers     54410-98-9       40 to 50     
Dimethyldecene Isomers     55170-80-4       20 to 25     
Tetramethylnonene Isomers     55771-41-0       0.5 to 2    
I have not been able to get much information about the material which is shipped apart from a Material 
Safety Data Sheet (MSDS) which is rather vague on the various components. Thus, I have attached the 
detailed MSDS from TEXAS PETROCHEMICALS LP which gives much more information about the 
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2.  FOSFA International. Response from FOSFA International. Submitted to EFSA on 16 July 
2012. 
1,3-PROPYLENE GLYCOL   
Question: the WG requested information on the grade(s) of 1,3-propylene glycol most commonly 
transported.  
The vast majority of propylene glycol carried by the chemical tanker fleet is 1,2-propylene glycol.  
The 1,3-propylene glycol which is carried is typified by the attached MSDS from Du Pont (1). This 
has  a  composition  of  > 99.7 %  purity  although  many  manufacturers  quote  99%  minimum,  and 
occasionally  98 %  min.  It  has  been  available  in  commercial  quantities  in  the  past,  but  is  not  an 
important  product  now.  It  was  obtained  as  a  by-product  in  the  production  of  glycerol  by  either 
saponification or fermentation of animal fats, but is also produced from acrylaldehyde. 
ISO-DECANOL, ISO-NONANOL, ISO-OCTANOL  
Question: the WG requested information on the composition of the iso-decanols, iso-nonanols 
and iso-octanols as traded.   
The iso-decanol, iso-nonanol, iso-octanol products which are traded are mixtures of isomers and are 
mainly produced by Oxo-process from olefins by addition of CO and hydrogen. They are generally 
described as, for example, 'ALCOHOLS, C9–C11 -ISO, C10-RICH', or 'C9-RICH'. The compositions 
are typified by the MSDS for Exxal 10 (2) and Neodol 9 (3). The purity is difficult to define. The 
multinational manufacturers such as Exxon have 99.0 % minimum purity, but some just state "rich", 
meaning that this is the majority chemical present. I believe that both types are carried in bulk by sea.  
Octanol  Technical  Grade (4)  is  sometimes  carried and  is  described  as  99.5 %  minimum  2  ethyl-
hexanol isomers. 
PARAFFIN WAX - EDIBLE GRADE  
Question: It was noted that this entry appears in the FOSFA list of acceptable previous cargoes 
as  ‘Paraffin  wax  -  edible  grade’.  The  WG  requested  information  on  the  specifications 
understood by FOSFA for ‘edible grade’? (The same applies for the entry White Mineral Oils).    
Paraffin wax - edible grade is a highly refined paraffin wax.  When a manufacturer states that their 
product is edible, FOSFA understands that it complies with all the relevant food ingredient legislation 
of the country in which it is to be used. 
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ABBREVIATIONS 
ACGIH     American Conference of Industrial Hygienists 
ADH      Alcohol dehydrogenase 
ADI      Acceptable daily intake 
ALDH      Aldehyde dehydrogenases 
ALT      Alanine aminotransferase 
ANS Panel    EFSA Panel on Food Additives and Nutrient Sources added to Food 
AST      Aspartate aminotransferase 
b.w.      Body weight 
CAC      Codex Alimentarius Commission 
CCFO      Codex Committee for Fats and Oils 
CHO      Chinese hamster ovary 
CONTAM Panel  EFSA Panel on Contaminants in the Food Chain 
CNS      Central nervous system 
DIDP      Diisodecyl phthalate 
DINP      Diisononyl phthalate 
ECHA      European Chemicals Agency 
EFSA      European Food Safety Authority 
EU      European Union 
FAO      Food and Agriculture Organization of the United Nations 
FDA      United States Food and Drug Administration 
FEMA      Flavor and Extract Manufacturers Association of the US 
FOSFA     Federation of Oils, Seeds and Fats Associations 
GD      Gestation day 
GMP      Good manufacturing practice 
GRAS      Generally Recognized As Safe 
HPV      High Production Volume 
IUCLID    International Uniform Chemical Information Database 
JECFA     Joint FAO/WHO Expert Committee on Food Additives 
LLNA      Local lymph node assay 
LMPW     Low melting point paraffin wax 
LMWPW    Lower melting point paraffin waxes 
LOAEL    Lowest-observed-adverse-effect level 
MCHC     Mean corpuscular hemoglobin concentration  
MEK      Methyl ethyl ketone 
MSDS      Material Safety Data Sheet 
MTBE      Methyl tertiary butyl ether 
NOAEC    No-observed-adverse-effect concentration 
NOAEL    No-observed-adverse-effect level 
NOEL      No-observed-effect level 
OECD      Organisation for Economic Co-operation and Development 
PAH      Polycyclic aromatic hydrocarbon 
PCE      Polychromatic erythrocytes 
PND      Postnatal day 
PTT      Polytrimethylene terephthalate 
SCF      Scientific Committee on Food 
SD      Sprague-Dawley (rats) 
SIDS      Screening Information Sata Set   
TDI      Tolerable daily intake 
TTC      Threshold of toxicological concern 
WHO      World Health Organization  